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 i 
Abstract 
There is increasing clinical need for bone substitutes because of the limited supply of 
autogenous tissue, and the significance of inherited or other bone diseases. The ultimate 
aim of this study was to form calcium phosphate (CaP) based matrices as bone grafts for 
medical applications. Amongst CaP based materials, CaP gels made by the sol-gel 
process have attracted much interest since they can be processed at room temperature 
allowing the incorporation of environmentally sensitive molecules such as growth factors. 
CaP gels can be engineered by changing process conditions. There is little previous work 
however on the effect of drying regimes on the CaP materials formed using the sol-gel 
process. The objectives of this research were to investigate the influence of drying 
conditions on the physicochemical properties of CaP gels and the effect of the resultant 
structures of CaP gels on the function of the incorporated therapeutic molecules. In 
addition, surface modification of the CaP gels was investigated as a means to enhance 
biological interaction and also a potential way of creating primary bonds between apatite 
crystals enabling mechanical reinforcement of the material, which is currently too weak 
to bear load. This work has confirmed that different drying regimes have a significant 
influence on the formation of the gel pore structure, with the storage of gel in humid 
conditions, enabling reprecipitation of an apatitic phase. This variation in pore structure 
has a significant influence on the catalytic of encapsulated enzymes. In addition, the pH 
fluctuation of CaP based matrices during processing determines the activity of 
biomolecules after incorporation. It has also been shown that it is possible to form thiol 
functional groups on the surface of CaP gels, which could be used in future for 
mechanical reinforcement or for the attachment of biological moieties.   
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Chapter 1 Introduction 
Human life expectancy has increased dramatically since the discovery of antiseptics, 
penicillin and other antibiotics, chemical treatment to improve hygiene, and vaccination 
[Hench and Wilson (1993)]. Since the mean age of the population of the developed world 
is continuosly increasing there is a large and growing need for materials to replace 
diseased and damaged hard tissues. At present, there are two possible treatments for bone 
disease, which are both used to replace hard tissue: 1) transplantation and 2) implantation. 
Although autograft is preferable, it is in limited supply, and lacks mechanical integrity. 
Alternative sources of hard tissue are obtained from other humans (allograft) or animals 
(xenograft). This resolves one difficulty-supply, but raises others, including 
immunological rejection and disease transmission. There is a need, therefore, for 
developing synthetic biomaterials for bone graft replacement. As the mineral component 
of bone consists mainly of calcium phosphate salts, calcium phosphate materials have 
become widely used as bone substitutes [LeGeros (2008)]. Calcium phosphate materials 
are osteoconductive, but for a successful clinical outcome, it is sometimes necessary to 
incorporate antibiotics, enzymes or other therapeutic molecules that are able to provide 
prophylactic treatment for osteomyelitis or can stimulate local bone formation.  
 
Calcium phosphate materials have been used for clinical bone augmentation for over 30 
years. Most of them are synthesised at high sintering temperatures [Itokazu et al. (1998), 
Saito et al. (2002)], which may destroy the activity of environmentally sensitive 
therapeutic molecules. In contrast, calcium phosphates formed by the sol-gel process are 
advantageous for the encapsulation of these molecules since this process can occur at 
room temperature. In a delivery system, there are many factors determining the activity 
of the incorporated molecules and their loading-efficiency. The activity of the therapeutic 
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molecules also depends on the physicochemical properties of the calcium phosphates, 
such as pore structure, and adhesive forces between the calcium phosphates and the 
biomolecules [Komleva et al. (2002), Fellah et al. (2007)]. Amongst these factors, pore 
structure has been demonstrated to be most important as it is critical to the rate of release 
from the structure. In previous studies, the pore structure of calcium phosphate based 
matrices has been modified by adding a porogen [Gabriel Chu et al. (2002), Ramay and 
Zhang (2003)], or using a freeze-drying processes [Lu et al. (1998), Zhang and 
Yokogawa (2008)], or controlled sintering temperature [Best and Bonfield (1994)]. There 
is little information about using different drying processes to control pore structure. 
 
Effective delivery is partly related to the loading efficiency of the incorporated 
therapeutic molecules. Therefore, most research focuses on increasing efficacy of loading 
biomolecules into CaP ceramics [Habraken et al. (2009), Rawat et al. (2008)]. Few 
studies, however, have considered the causes of the reduction or loss of therapeutic 
activity. For example, a change in pore size distribution may result in mass transport 
limitations and influence the release behaviour of the incorporated molecules. In addition, 
variables such as pH may control both the release and performance of these biomolecules. 
Although there is little change in the temperature of CaP cements during setting which is 
similar to the CaP gel, there can be significant fluctuations in the pH of the setting 
cement slurries. Furthermore, the bonding between materials and biomolecules may 
control the loading efficiency. It has been demonstrated that chemical bonding increases 
the amount of loading of proteins, drugs, and enzymes [Wright et al. (2006), Nishioka et 
al. (2006)]. With effective loading, it is possible to avoid side effects, and toxic reactions 
because of overdoses [Radin et al. (1997)], in addition to promoting healing. 
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Alternatively, the type of bonding within materials may strengthen the structure of 
linking networks.  
 
In this study, a variety of process conditions were applied during the fabrication of CaP 
gels on the assumption that the regimes would allow control over pore structure. The 
physicochemical properties of these resulting CaP gels were investigated. The resulting 
CaP gels were used as carriers or stores of antibiotics or enzymes. Although one major 
limitation of CaP gels is their low strength, the mechanical performance of the material is 
considered beyond the scope of this project. The effect of pore size on the release of 
vancomycin hydrochloride, horseradish peroxidase, and alkaline phosphatase was 
discussed. In addition, it was hypothesised that the bonding can be strengthened by 
forming a covalent bond with the surface of the CaP gels. Therefore, the introduction of 
thiol functional groups by reacting organosilanes with silicon substituted CaP gels is 
suggested in the expectation of increase the numbers of potential binding sites of 
functional groups.  
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Chapter 2 Bone and Bone replacement 
 
2.1 Bone 
2.1.1 Composition of bone 
Bone is a living tissue composed predominantly of mineral (inorganic material) and 
protein (organic material). The biological component includes cells, fat, natural polymers 
such as polysaccharides, collagen, and polyphosphates [Ravaglioli and Krajewski (1992)]. 
Bone cells include osteoblasts, osteoclasts, osteocytes, osteoprogenitors and bone-lining 
cells [LeGeros (2008), Miller (1987)]. The main constituents of bone are 70 wt% of 
calcium phosphate minerals, 22 wt% of collagen, and 8 wt% of water [Suchanek and 
Yoshimura (1998), Bilezikian et al. (1996)]. The mineral constituent of bone is 
hydroxyapatite (HA) (formed predominantly of calcium and phosphate ions) with a trace 
amount of ions such as CO32-, Mg2+, Fe2+, Na+, K+, and F-, Cl-. Some specific heavy 
metals, for example, Ba2+, S2+, Pb2+, may occasionally be found [Ravaglioli and 
Krajewski (1992)]. Amongst these minor ions, carbonate (7.4 wt%), sodium (0.9 wt%) 
and magnesium (0.72 wt%) are the most important. The collagens are fibrous proteins 
composed of tropocollagen macromolecules [Hancox (1972)].  
 
2.1.2 Bone cells 
Bone cells play important roles in maintaining and remodelling the structure of bone. 
There are five types of bone cells present in the matrix of bone (Figure 2.1). The 
following section describes the function of these cells. 
 
Osteoblasts 
Osteoblasts are responsible for the production and mineralisation of the bone matrix 
[LeGeros (2008)]. To produce bone, osteoblasts of mesenchymal origin secrete collagen 
fibres, which then self-assemble to form segments or plates of the osteoids (non-calcified 
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bone matrix) and this subsequently becomes mineralised. The process of mineralisation 
occurs by the addition of HA to the collagen matrix, which is mediated by matrix vesicles 
exocytosed by the osteoblasts [Hessle et al. (2002)]. As mineralisation proceeds, the 
number of osteoblasts progressively reduces with time. Osteoblasts are localised 
particularly in the periosteal membrane. Osteoblasts are confined within their osteoid 
shells inside the bone matrix. When osteoblasts approach the end of their activity, they 
are encapsulated in bone matrix and subsequently differentiate to form osteocytes. The 
presence of osteoblasts is often evidenced by the activity of alkaline phosphatase, an 
enzyme synonymous with bone formation [Ravaglioli and Krajewski (1992)].  
 
 
Figure 2.1 A schematic diagram showing the location of cells on bone (taken from 
Mark and Popoff 1988). Osteoblasts, osteoclasts, and bone lining cell are present on 
the bone surface, but osteocytes are encapsulated in the mineralised interior. In 
addition, osteoblasts, osteocytes, and bone-lining cells are derived from local 
osteoprogenitor cells. The osteoclast, however, originates from the fusion of 
mononuclear precursors.  
 
Osteocytes 
Osteocytes are mature osteoblasts within the bone matrix and are thought to be 
responsible for osteoblast maintenance, among other roles [Bilezikian et al. (1996)]. Each 
osteocyte is derived from an osteoblast through a complex change of form and activity. 
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The function of osteocytes is controversial, but most probably they act as a mechanical 
and metabolic pump for the bone lymphatic flow, a regulator of mineralisation and enable 
bone to respond to the application of applied loads [Ravaglioli and Krajewski (1992)]. 
 
Osteoclasts 
Osteoclasts are responsible for resorption of bone and maintain the bone matrix [LeGeros 
(2008)]. Osteoclasts are derived from the mononuclear lineage of cells found in blood 
[Vaughan (1981)]. Active osteoclasts are polarised cells, originating from haemopoietic 
precursors in the bone marrow where they are composed of a baso-lateral membrane and 
an apical zone. An apical zone includes the light zone and the brush border (or striated 
border). The working space where osteoclasts dissolve the bone matrix is defined by the 
brush border and forms an envelope. This enclosed environment where the osteoclasts 
cause resorption exhibits a pH value of 4.5 (ruffled border). The ruffled border is often 
used to identify active osteoclasts [Ravaglioli and Krajewski (1992), Teitelbaum (2000)].  
 
Osteoprogenitors 
Osteoprogenitors are derived from cells present in the bone marrow or an inducing agent, 
capable of forming bone. Osteoprogenitors are located in the periosteum and the bone 
marrow [Vaughan (1981)]. Osteoprogenitor cells are the cells from which osteoblasts and 
osteocytes are differentiated [Ravaglioli and Krajewski (1992)]. 
 
Bone-lining cells 
The bone-lining cells are flat mesenchymal cells that inactively line bone surfaces. 
Bone-lining cells contain the greatest fraction of membranes in an adult skeleton, and 
they separate the bone fluids from the interstitial fluids, and regulate mineral homeostasis. 
The bone-lining cell is also considered as support cells for osteocytes [Miller (1987)].  
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2.1.3 The structure of bone 
Mineralised bone can be organised to form woven or lamellar bone (Figure 2.2). 
Microscopically, the collagenous fibres are 80-100 nm in thickness and 100-2000 Ả in 
diameter [Suchanek and Yoshimura (1998), Dorozhkin and Epple (2002)]. The calcium 
phosphate ions are in the form of crystalline hydroxyapatite (HA) and/or amorphous 
calcium phosphates. The crystals of HA are plates or needles with size of length 50 nm, 
width 25 nm, and thickness 4 nm (Figure 2.3) [Suchanek and Yoshimura (1998)].  
 
 
 
Figure 2.2 (A) Woven bone is composed of large and tortuous channels; (B) lamellar 
bone is formed by Haversian canals and a regular arrangement of osteocytes (taken 
from Hancox (1972)) 
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Figure 2.3 The mineralised collagen fibrils which range from a few µm in length and 
100 nm in diameter and are composed of polypeptides with approximately 300 nm in 
length and 1.5 nm in diameter. The crystal of carbonated deficient HA (CDHA) is 
5000 nm3 (taken from Dorozhkin and Epple (2002)). 
 
Both woven and lamellar bones may form either compact or cancellous bone, depending 
on the volume of vascular spaces [Hancox (1972]. Woven bone is composed of coarse 
collagenous fibres interweaving in all spatial directions and without an ordered 
arrangement. In addition, the osteocytes of woven bones are randomly distributed. In 
lamellar bones, the fibres are finer and organised into unit layers or sheets, and the 
osteocytes are evenly distributed. Bone exhibits a hierarchical structure usually consisting 
of a dense outer layer (compact bone) surrounding a less dense core (cancellous bone) 
[Hancox (1972), Dorozhkin and Epple (2002)].  
 
Generally, bone formation can be divided into two stages. The first includes synthesis 
and extracellular assembly of the collagen I matrix, which is followed by mineralisation. 
The HA crystals precipitate in a parallel orientation into the regions known as hole-zones 
of the collagen matrix [Dorozhkin and Epple (2002)].  
 
9 
2.1.4 Types of bone 
Compact bone (Cortical bone) 
Compact bones are made up of densely packed vascular canals, which form concentric 
lamellae. Fibrils in neighbouring lamellae are arranged perpendicular to one another 
[Bilezikian et al. (1996)]. Such a vascular canal together with its adjacent concentric 
lamellae is defined as a Haversian canal or osteon [Hancox (1972)]. In the Haversian 
system, there are blood vessels which deliver nutrients to the cellular components of the 
bone along Haversian canals [Suchanek and Yoshimura (1993)]. Compact bone has a low 
surface area because of its high density [Dorozhkin (2007)]. The structure of compact 
bone fulfils mechanical and protective functions, including: supporting the body, 
protecting organs, and providing levers for movement. 
 
Cancellous bone (Spongy bone) 
Cancellous bones are composed of loosely packed trabeculae with an open network-like 
structure, and therefore, they have a high surface area [Dorozhkin (2007)], precluding the 
need for the presence of significant numbers of blood vessels. The structure of cancellous 
bone provides the metabolic function such as hematopoiesis, exchange of calcium ions 
[Bilezikian et al. (1996)]. In addition, cancellous bone is considerably lighter than 
compact bone and so plays a weight saving role. It is also thought that cancellous bone 
has greater impact resistance. 
 
2.2 Clinical need for bone replacement 
Over time, medical care has developed and, for this and other reasons, human life 
expectancy has increased. In terms of bone disease, this poses particular problems since 
the mechanical integrity of the skeleton tends to decrease with age. In addition, the highly 
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organised structure of bone can make treatment very difficult. Here, both bone disease 
and synthetic biomaterials for bone replacement are described.  
 
2.3 Bone disease and treatment 
Bone diseases can occur because of congenital disorder; age; or infection. Whatever the 
cause, it is without doubt that new and effective treatment is required. In this section, 
some frequently encountered diseases are briefly described. 
 
2.3.1 Disease 
Osteomyelitis 
Osteomyelitis is a kind of bacterial infection caused by pyrogenic bacteria, mycobacteria 
or fungi. Osteomyelitis, depending on its aetiology, is either a haematogenous or a 
contiguous focus of infection. Haematogenous osteomyelitis usually occurs in paediatric 
patients. A contiguous focus of infection results from inoculation of bacteria into bone at 
the time of trauma or during surgical operation on a fracture. Staphylococcus aureus is 
usually the microorganism responsible for the infection [Conterno and da Silva Filho 
(2009)]. The treatment of osteomyelitis includes antibiotic therapy, and resection of 
infected bone which, sometimes requires a bone replacement. 
 
Osteoporosis 
Osteoporosis is a disorder characterised by the reduction of bone density, which may 
cause thinner trabeculae and larger resorption cavities. There is no alteration of the 
external structure of remnant bone. Osteoporosis is associated with ageing, especially of 
women after the menopause. It is rarely found in younger people, except for idiopathic 
osteoporosis. Oestrogen is used as a treatment [Vaughan (1981), Hancox (1972),]. Also, 
it has been demonstrated that bone graft combined with pulsing electromagnetic fields 
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reduce bone loss [Bassett et al. (1982)] and the administration of oestrogen directly or 
indirectly to osteoblasts and osteoclasts by delivering oestrogens from HA [Ishizaki et al. 
(2009)].  
 
Hypophosphatasia 
Hypophosphatasia is an inherited disorder, characterised by defective bone and tooth 
mineralisastion and deficiency of serum and bone alkaline phosphatase activity. This 
disease results from mutations in the liver/bone/kidney alkaline phosphatase gene. The 
treatment includes bone marrow cell transplantation and plasma cell membrane 
glycoprotein-1 gene [Mornet (2008)]. Alkaline phosphatase was delivered to the bone by 
incorporating into HA, it was suggested that the localisation of alkaline phosphatase can 
induce bone mineralisation [Ishizaki et al. (2009)].  
 
Osteogenesis imperfecta 
Osteogenesis imperfecta is a rare autosomal disorder of bone characterised by brittle bone 
and defective connective tissue. This disease is due to the deficiency of Type I collagen. 
As a genetic disorder, osteogenesis imperfecta mostly occurs through parental inheritance, 
but in a few cases it is due to an individual genetic mutation [Vaughan (1981)]. An 
intramedullary rod system composed of stainless steel has been developed to treat 
osteogenesis imperfecta [Wilkinson et al. (1998)]. 
 
2.4 Autograft 
Autograft is bone obtained from another anatomic site of the same human body [LeGeros 
(2008), Hench (1998)]. Autograft is the gold standard for bone repair, but it has 
limitations, including possible morbidity of the donor site, the limited volume of donor 
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bone, and also anatomical and structural problems, and increased resorption during 
healing [Ducheyne and Qiu (1999)].  
 
2.5 Allograft 
An alternative to autograft is allogeneic bone. Allograft is harvested from another human 
body. The allograft, however, has disadvantages including limited supply, viral or 
bacterial transmission, and immune rejection [LeGeros (2008)]. The mechanism of 
allograft for the bone substitute is osteoconduction. Due to the chemical treatments 
applied to the tissue prior to treatment, however, no osteogeneration or osteoinduction 
occurs following implantation of allografts [Urist et al. (1994)]. 
 
2.6 Xenograft 
Xenografts are bone which has been obtained from animal sources. Xenograft, however, 
is not widely used as a bone graft because of the risk of acute immune response. To avoid 
this biological reaction, donor bone is deproteinated and defatted, both of which reduce 
antigenic response. This treatment process results in the osteoinductive proteins found in 
the bone becoming damaged and thus xenografts are less likely to stimulate bone 
formation than other forms of tissue graft. This causes failure in a large proportion of 
implantations [Damien and Parsons (1991), Urist et al. (1994)].  
 
2.7 Biomaterials for bone replacement 
Due to both the shortcomings of allografts and the increasing requirement of materials for 
bone replacement, repair, and augmentation, there has been a considerable need to 
develop alternative biomaterials. The chief characteristics of suitable implant materials 
are biocompatibility in a bony site, ease of sterilisation and use, and price. Various 
commercial bone substitutes are already in use, including metals, polymers, corals, 
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processed cadaver bone, cow bone, and synthetic bioceramics [LeGeros (2008)]. The 
most clinically used bioceramics are calcium phosphates such as hydroxyapatite (HA), 
ß-tricalcium phosphates (β-TCP) as their compositions are similar to the mineral 
components of hard tissue. In this section, the bioceramic materials used as hard tissue 
replacements are described. 
 
2.7.1 Bioceramics  
The word ceramic derives from the Greek “Keramos”, meaning burnt-stuff or pottery 
[Anderson et al. (1990)]. Ceramics are inorganic and non-metallic materials, usually 
inorganic, including silicate, metallic oxides, and sulphides. Oxides such as Al2O3, MgO, 
SiO2, and ZrO2 contain metallic and non-metallic elements as well as ionic salts for 
example, NaCl, CsCl, and ZnS [Park and Bronzino (2003)]. According to the 
arrangement of their atoms, ceramics can be classified as amorphous and crystalline. In 
amorphous ceramics such as glasses, the order is only in the short-range. Polycrystalline 
ceramics are solids in which the atoms or ions are arranged in regular arrays [Park and 
Bronzino (2003), Hench and Jones (2005)].  
 
Bioceramics are those ceramics mainly used for medical applications such as repair and 
reconstruction of bone defects and diseased or damaged musculoskeletal systems 
[Habraken et al. (2007)]. According to the biological response, bioceramics can be 
classified as 1) bioinert (alumina, zirconia, carbons), 2) bioactive (bioglass and Ceravital, 
and sintered HA), and 3) bioresorbable (biphasic calcium phosphate, β-TCP). These 
definitions are developed from the definitions put forward by Hulbert et al. who classified 
bioceramics as inert, surface reactive, and resorbable [Shackelford (1999)]. The distinct 
feature of a bioinert ceramic is extremely slow reaction kinetics with their environments. 
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In contrast, bioactive materials exhibit faster reaction kinetics that results in the formation 
of a bond with bone at the interface with the material. Hench et al. defined bioactivity as 
the formation of bonds between materials and bone. All bioactive materials are also 
osteoconductive [LeGeros (2008)]. A suitable bone substitute should lead to new bone 
forming from the graft bed into the bone defect [Urist et al. (1994)]. Osteoconductivity 
means that the matrix serves as a template or scaffold resulting in the formation of bone 
along its surface. The majority of calcium phosphates are known to be osteoconductive. 
Bioresorbable materials are those bioactive materials which can be replaced by hard 
tissue [Park and Bronzino (2003), Vallet-Regí (2001)] and include β-TCP and biphasic 
calcium phosphate.  
 
2.7.2 Alumina, zirconia based ceramics 
Alumina and zirconia ceramics were the first ceramics used for medical applications 
because of their perceived bioinertness in vivo [Vallet-Regí (2001), Urist et al. (1994)]. 
Due to their relatively high mechanical strengths, alumina and zirconia are suitable for 
bearing surfaces in joint replacement. Alumina used as an implant should contain 99.5 % 
pure alumina and less than 0.1 % of SiO2 and alkali oxides according the American 
Society for Testing and Materials [Park and Bronzino (2003)]. Zirconia combined with 
Y2O3 has been used for implantation of bone [Hentrich et al. (1971)].  
 
2.7.3 Poly(methyl methacrylate) (PMMA) 
Poly(methyl methacrylate) (PMMA) beads or cements have been used widely as bone 
grafts. One problem, however, is that they do not form an intimate attachment to bone 
and some authors have reported bone resorption around PMMA cement following 
implantation. Furthermore, on mixing of the PMMA cement, the exotherm associated 
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with polymerisation has been shown to locally increase temperature to over 100˚C and 
has been shown to damage bone [Hench and Wilson (1993)]. 
 
2.7.4 Calcium phosphate (CaP) ceramics 
CaP ceramics have been used as implant materials for over three decades because of their 
potential bioactivity [LeGeros (2008), Urist et al. (1994)]. They include HA, β-TCP, 
biphasic calcium phosphate (BCP), amorphous calcium phosphate (ACP), calcium 
deficient apatite, and carbonated apatite (CA). CaP ceramics are generally bioactive, but 
only some of them are bioresorbable. Bioresorbability depends on composition, particle 
size, porosity, and preparation conditions of CaP ceramics. The rate of dissolution of CaP 
ceramics can be arranged in a decreasing order: β-TCP>CA>HA, which has been 
determined by monitoring dissolution in real-time [LeGeros (2008)].  
 
HA is the most used CaP product in implantation because it forms an intimate bond with 
bone. HA has been used for alveolar ridge augmentation and the filling of bone defects 
[Damien and Parsons (1991)]. HA has, however, only been used for non-load bearing 
applications since it is brittle and failure can be catastrophic. These limitations can be 
compensated by combining HA with other materials such as metallic particles or 
polymers, or by increasing the porosity of the HA and encouraging rapid bone in growth 
to augment the structure [Suchanek and Yoshimura (1998), Damien and Parsons (1991)]. 
Porosity (100-600 µm) can be incorporated into CaPs by adding porogens, such as 
paraffin or naphthalene or hydrogen peroxide. The Food and Drug Administration (FDA) 
has approved porous HA for the treatment of bone defects caused by trauma [Damien and 
Parsons (1991)]. It has reported that resorption is related to porosity [Damien and Parsons 
(1991)]. 
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Another dominant problem with HA is its low solubility in physiological conditions. 
Although HA has been used in dental applications due to the lack of resorption, HA has 
not been extensively used for orthopaedic applications other than to coat metallic 
prostheses. 
 
TCP can exist as α-TCP and β-TCP. The rate of dissolution of TCP is greater than HA. It 
has been demonstrated that most TCP implants are resorbed within one month of 
implantation. β-TCP has been used for the repair of periodontal defects and augmentation 
of bone and has been formed into a cylindrical geometry for use as a drug delivery matrix 
[Park and Bronzino (2003), Damien and Parsons (1991)].  
 
2.7.5 Calcium phosphate (CaP) cement 
CaP cements are formed by mixing a powder phase of calcium and/or phosphate salts 
with an aqueous phase, which might be distilled water, phosphate buffered saline, sodium 
orthophosphate, orthophosphate acid or citric acid in ambient conditions. After mixing 
the powder and aqueous phase together, a moldable paste is formed that typically sets to 
form a hardened graft within a few minutes. The biggest advantages of CaP cements are 
that it can be easily shaped to an irregular defect and will then harden in-situ, making it 
suitable for filling bone defect as compared with the HA solid blocks or granules 
[Suchanek and Yoshimura (1998)], which can migrate from the implant site. In addition, 
CaP cements can be injected directly into fractures and bone defects [Dorozhkin (2008)]. 
 
2.7.6 Ceramic/polymer composites 
Composite materials such as porous bioceramics combined with polymers such as poly 
(lactic acid), chitosan, and collagen have effectively replaced CaP because of their 
improved mechanical properties [Habraken et al. (2007), Hench and Jones (2005)]. 
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Bonfield et al. have demonstrated that HA with polyethylene composites increased 
Young’s modulus and reduced ductility, whilst retaining the bioactivity of HA [Bonfield 
(1988)]. Medical applications of the HA/polymer composites have not been as 
load-bearing implants, but only for bone repairs [Hench and Wilson (1993)]. 
 
2.7.7 Glasses and glass ceramics 
The bioactive glasses developed for implantation are composed of SiO2, Na2O, CaO, and 
P2O5 (Bioglass) and Li2O, ZnO, and SiO2 [Park and Bronzino (2003)]. The most 
important characteristic of Bioglass is its rapid rate of surface reaction, which results in 
the rapid formation of tissue bonding [Hench and Wilson (1993)]. Ceravital, a number of 
different products with various compositions of glass and glass-ceramics is similar to 
Bioglass to the extent that it includes SiO2, with several other components to induce 
crystallisation within the glass matrix [Hench and Wilson (1993), Park and Bronzino 
(2003)]. 
 
2.8 Surface modification of CaP based materials 
The functionality of CaP based materials can be improved by introducing functional 
groups onto the surface of CaP crystals. The surface modification of CaP materials can 
promote the bonding between the matrix and bone which improves bone formation and 
can assist in promoting cell adhesion and the attachment of type I collagen and 
fibronectin. Generally, surface modification can be categorised into: a) introduction of 
desirable functional groups onto the surface, b) formation of functional topographies by 
conversion of the original surface and, c) the creation of functional topographies by 
removal of compositions from the original surfaces [Duan and Wang (2006)].  
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These modifications can be obtained through physical methods and chemical methods. 
The physical methods include plasma spray coating, physical vapour deposition, ion 
implantation, and surface machining. The chemical methods comprise the addition of 
functional groups, electrochemical oxidation, and acidic etching. Amongst these 
preparations, the chemical methods are most widely as they can be undertaken at 
relatively low temperatures (<100 ˚C) which is tolerable for most temperature sensitive 
molecules, enables the formation of crystals at micro scale and even nano scale, and the 
incorporation of organic or biological components [Duan and Wang (2006)]. In this 
section, the incorporation of functional groups on the surface of CaP materials is 
described. 
 
2.8.1 Surface modification with polymers 
As it has been shown that the surface hydroxyl groups of HA can react with organic 
isocyanate groups, polymers such as polyethylene glycol (PEG), poly (methyl 
methacrylate) (PMMA), poly (n-butyl methacrylate) (PBMA), and poly (hydroxyethyl 
methacrylate) have been used in combination with HA. The HA/polymer composites are 
formed by introducing coupling reagents capable of forming covalent bonds between the 
crystal surfaces and the polymers. The coupling reagents include isocyanateoethyl 
methacrylate (ICEM), hexamethylene diisocyanate (HMDI), and organosilanes have been 
shown to covalently bond with the hydroxyl groups of calcium phosphates [Liu et al. 
(1998a), Liu et al. (1998b), Santos et al. (2001)]. This combination was claimed to 
enhance the mechanical strength of HA. However, the lack of adhesion between the 
interfaces of HA and polymers often results in the failure of the composite materials [Liu 
et al. (1998a)].  
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2.8.2 Surface modification with alkyl phosphates 
There are a variety of organic phosphates existing in living organisms. Therefore, some 
researchers have investigated the effect of the addition of organic phosphates on CaP 
materials. CaP materials have P-OH groups to act as a site for the attachment of a range 
of moieties. The synthesis of CaPs with alkyl phosphates is undertaken using the 
hydroxyl groups of CaP materials to bond with other functional groups by soaking the 
CaP particles in alkyl phosphate containing solutions. It has found that alkyl phosphate 
layers were formed on the HA, which cause the formation of mesopores and 
consequently a high specific surface area (>200m2/g) [Tanaka et al. (1997), El-Hammari 
et al. (2008)]. Lebugle et al. reported that the modification of HA with 
(hydroxyethyl)-methacrylate phosphates and dodecanol phosphates can form a composite 
with polymers in dental and medical applications [Brown and Constatz (1994)]. 
 
2.8.3 Surface modification with phosphoric acids 
Some workers have introduced additional OH groups on the surface of CaP materials. 
Amongst the reagents that contain hydroxyl groups, phosphoric acid based reactants are 
favoured because the P-OH groups adsorb proteins such as bovine serum albumin and 
lysozyme [Tanaka et al. (2004)]. The modification is performed by mixing CaPs with 
phosphoric acids such as pyrophosphoric acid, n-alkyl and n-fluoroalkylphosphonic acid 
[Tanaka et al. (2004), D’Andrea and Fadeev (2003)]. It has been confirmed that the 
surface properties were successfully modified because the hydrophilic surface of CaPs 
became hydrophobic and mechanical strength exhibited by the resulting materials was 
improved [Tanaka et al. (2004)]. 
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Chapter 3 Calcium phosphates and apatites  
 
3.1 Calcium phosphates  
In addition to PO43-, calcium phosphates can contain acidic orthophosphate anions such 
as HPO42- or H2PO4-, and/or combine with water such as CaHPO4·2H2O. They can also 
be formed from different types of phosphates which include ortho (PO43-), meta (PO3-), 
pyro (P2O74-), and poly (PO3)n-n phosphates. Pyrophosphates are potent inhibitors of 
nucleation and crystal growth of calcium phosphates in aqueous systems [Elliott (1994)]. 
Calcium phosphates can be crystallised into different phases as summarised in Table 3.1, 
depending on temperature, partial pressure of water, and impurities [Dorozhkin (2007), 
Elliott (1994)]. The lower the Ca/P molar ratio, the more acidic and water soluble the 
calcium phosphates are [Elliott (1994)]. The solubility isotherms of calcium phosphate 
phases (Figure 3.1) show the likely conditions required for synthesis. The curve of each 
calcium phosphate composition is the saturation boundary. The calcium phosphate 
compositions below the curve are supersaturated whereas those above are under-saturated. 
Hydroxyapatite (HA) is the least soluble calcium phosphates at a pH value of > 4.2. 
Therefore, at above this pH all calcium phosphates are likely to hydrolyse to HA. The 
points where these solubility isotherms cross are described as singular points. When two 
salts are immersed in the water, despite different starting compositions, the liquid 
composition move toward the singular point: this is the attraction effect. 
 
The chemical formula of apatite is Ca5(PO4)3X, where X is commonly hydroxide or a 
halogen (F-, Cl- ) [Park and Bronzino (2003), Shi et al. (2004)]. However, the formula of 
apatite (Ca10(PO4)6X2) is often written as double as Ca5(PO4)3X.  
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Table 3.1 Physical properties of various calcium phosphate salts including the 
formula, Ca/P ratio, density and solubility (Reproduced from Elliott et al. (1994) and 
Fernandez et al. (1999)). 
a: Cannot be measured precisely. However, some values at certain pH were reported: 
25.7 ± 0.1 (pH 7.4), 29.9 ± 0.1 (pH 6), 32.7 ± 0.1 (pH 5.28). 
 
Phase Chemical formula 
Ca/P 
ratio 
Density 
(g cm-3) 
Solubility 
at 25˚C, 
-log (Ksp) 
Monocalcium 
phosphate 
monohydrate 
Ca(H2PO4)2·H2O 0.50 2.23 1.14 
Monocalcium 
phosphate anhydrate 
Ca(H2PO4)2 0.50 2.23 1.14 
Dicalcium phosphate 
dihydrate 
CaHPO4·2H2O 1.00 2.31 6.59 
Dicalcium phosphate 
anhydrate 
CaHPO4 1.00 2.89 6.9 
Octacalcium 
phosphate 
Ca8(HPO4)2(PO4)4·5H2O 1.33 2.61 96.6 
α-Tricalcium 
phosphate 
Ca3(PO4)2 1.50 2.86 25.5 
β-Tricalcium 
phosphate 
Ca3(PO4)2 1.50 3.07 28.9 
Amorphous calcium 
phosphate 
CaxHy(PO4)z·nH2O, 
n=3-4.5; 
15-20 % H2O 
1.20-2.20  a 
Hydroxyapatite Ca10(PO4)6(OH)2 1.67 3.16 116.8 
Tetracalcium 
phosphate 
Ca4P2O9 2.00 3.05 38-44 
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Figure 3.1 Solubility isotherm of calcium phosphate phases in the ternary system 
Ca(OH)2-H3PO4-H2O at 37 ˚C is present as the graph of Log [Ca] versus pH 
(reproduced from Hoffmann (2003)). 
 
In addition, ionic substitutions of apatite readily occur, and charges of apatite balance by 
removing ions from other compositions. Generally, Ca2+ ions can be partly or completely 
replaced by the same charge ions, Ba+2, Sr+2 or Pb2+, or by differently charged ions, Na+ 
and K+. PO43- ions can also be replaced by ions of the same charge, AsO43- or by 
differently charged ions such as CO32-. A.G. Werner in 1786 named apatite from the 
Greek word “apataw”, meaning to deceive [Guelcher and Hollinger (2006)], since the 
apatite was initially confused with several other minerals such as aquamarine, crystollite, 
and fluorite [Elliott (1994)]. In 1926, the apatitic form of calcium phosphate was 
identified as the main mineral phase of human bone (~50-60 wt%) [Dorozhkin (2007)].  
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In this chapter, a brief description of the calcium phosphates is addressed, including their 
structural characterisation, preparation methods, and biocompatibility when implanted in 
hard tissue.  
 
3.2 Monocalcium phosphates (monohydrate and anhydrate) 
Monocalcium phosphate occurs as the monohydrate (MCPM) and anhydrous salt 
(MCPA). MCPM and MCPA are the most acidic and water solubility calcium phosphates 
as Table 3.1 shows [Dorozhkin (2007)].  
 
Both MCPA and MCPM can be prepared by lowering the temperature of acidic solutions 
of calcium oxide and phosphorous pentoxide (P2O5). In addition, MCPM has been 
formed by adding CaO or Ca(OH)2 to concentrated H3PO4, followed by recrystallisation, 
washing, and drying. After heating the recrystallised MCPM solution to 130 ˚C, MCPA 
is formed [Lehr et al. (1967)]. 
 
The presence of MCPA and MCPM can be distinguished from the peaks of an XRD 
pattern at 7˚, 23-24˚, and 24-26˚ 2θ. In addition, the HPO42- is present at 870 cm-1 in the 
FTIR spectrum.  
 
Because of their high acidity, and solubility, MCPM and MCPA rarely exist in calcified 
tissue. Although MCPM is not biocompatible, it is used as a self-hardening component of 
calcium phosphate cements in medicine. MCPM crystallises in highly acid solutions. 
When the temperature of the precipitation conditions is above 100 ˚C, MCPM dehydrates, 
and transforms to MCPA [Elliott (1994)].  
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3.3 Dicalcium phosphate (dihydrate-brushite and 
anhydrate-monetite) 
Dicalcium phosphate anhydrate (DCPA) is the anhydrous form of dicalcium phosphate 
dihydrate (DCPD). DCPD can be precipitated by simultaneously adding aqueous 
solutions of Na2HPO4 and KH2PO4, and CaCl2 solution at room temperature [Tovborg 
and Rathlev (1953)]. DCPD is also formed by neutralising dilute H3PO4 by the addition 
of calcium sucrate (calcium carbonate and sucrose) [St. Pierre PDS (1955)]. DCPD 
crystals are grown by the diffusion of Ca+2 into silica gel containing HPO42- at pH 4 to 8 
[Mooney and Aia (1961)]. It is well known that the final product of DCPD hydrolyses to 
HA. The hydrolysis of DCPD to octacalcium phosphate (OCP) occurs in the range pH 6.2 
to 7.4 if the temperature is within 25 to 37 ˚C, but apatites are formed when the pH or 
temperature increases. In fact, OCP is formed instead of HA. This is because OCP has a 
lower solubility than DCPD, and grows faster than HA at a pH above the singular point 
of DCPD (Figure 3.1).  
 
At a temperature above 60 to 90 ˚C in water, DCPD transforms into DCPA. When 
DCPD is heated at 180 ˚C, DCPA is formed. DCPD precipitates more readily than 
DCPA because the rate of crystal growth of DCPA is slower than DCPD, even though 
thermodynamically DCPA is the more stable salt. 
 
The method to precipitate pure DCPA is similar to that for DCPD, but at 100 ˚C rather 
than room temperature [Elliott (1994)]. DCPA can also be precipitated by double 
decomposition of CaCl2 and H3PO4. Like other acid phosphates, DCPA hydrolyses to HA 
under controlled conditions: 4 to 300 mM of CaHPO4 solution were performed at CO2 
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free nitrogen gas at pH in the range 6.4 to 9 with the presence of 25-100 mM CaCl2 at 37 
˚C [Ishika and Eanes (1993)].  
 
DCPD is found in the pathological calcifications, but DCPA is not present in any 
pathological calcification. Therefore, DCPD is of more biological importance than DCPA, 
although both are used in calcium phosphate cements in medicine [Dorozhkin (2007)].  
 
3.4 Octacalcium phosphate  
OCP is often present as a transient intermediate in the precipitation of the 
thermodynamically more stable HA, and biological apatites. The growth and hydrolysis 
of OCP has been considered as an important procedure in the mineralisation process of 
bone and teeth. Because OCP has a similar structure to HA, the incorporation of 
impurities such as carbonate, magnesium, and sodium into the crystal lattice is possible.  
 
OCP can be prepared by the slow hydrolysis of DCPD at 40 ˚C. Alternatively, OCP can 
be formed by hydrolysis of DCPD at 80 to 85 ˚C in dilute nitric acid at pH 5 for 30 min. 
Pure OCP can be precipitated by the addition of calcium acetate to an equal volume of 
sodium phosphate at pH 5 and 60 ˚C or pH 4 and 70 to 80 ˚C for 3 to 4 h. However, in 
solution and gel systems, it has been verified that pyrophosphates inhibit the growth of 
OCP and result in the growth of amorphous calcium phosphates instead, but carbonate 
(CO32-) or citrate favoured the formation of apatitic calcium phosphates. Depending on 
the availability of calcium ions, OCP hydrolyses to HA in water, which can be expressed 
by the following (Equation 3.1) [Elliott (1994)].  
 
++ ++→+ HOHOHPOCaCaOHPOHCa 43)()(25)( 226410226428           Equation 3.1 
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OCP exhibits HPO42- bands at 865 and 910 cm-1 on FTIR spectra. In addition, a 1H 
resonance of HPO42- in NMR spectrum from the apatite has been demonstrated [Elliott 
(1994)]. Intense peaks are presented at 26˚ and 32˚ 2θ in the XRD pattern. Although 
OCP has not been observed in vascular calcifications, it has been suggested as precursor 
phases to biological apatites of natural and prosthetic heart valves [Dorozhkin (2007)].  
 
3.5 Tricalcium phosphates and whitlockite 
Tricalcium phosphates (TCPs) may exhibit a Ca/P ratio close to 1.5, but do not exhibit a 
typical apatitic structure. TCPs exist in four forms: amorphous TCP, apatitic TCP, α-TCP, 
and β-TCP. Amorphous TCP traditionally is fromed by double decompostions between 
calcium and hydrogen phosphate salt solution at ambient temperature at pH around 10. 
Apatitic TCP is derived from crystallisation in aqueous system of amourous TCP. α- and 
β-TCP cannot be directly precipitated in aqueous systems, but these two forms of TCP 
can be obtained by sintering mixtures of calcium phosphate salts for example, DCPA and 
calcium carbonate. α-TCP can be formed by heating β-TCP at 1125 ˚C which is the 
transition temperature for β to α [Kokubo (Ed.) (2008), Dorozhkin (2007), Elliott (1994)].  
 
The synthetic methods of β-TCP manufacture include the solid state process and wet 
chemistry [Kalita et al. (2007)]. For wet chemistry, one needs to sinter at 700 to 800 ˚C 
as the initial products are calcium deficient HA (Ca9(HPO4)(PO4)5(OH)) with the same 
Ca/P ratio of TCP as shown in Equation 3.2.  
 
OHPOCaOHPOHPOCa 22435449 )(3)())(( +→                       Equation 3.2 
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Another method is to precipitate pure β-TCP and whitlockite with Ca/P or Ca/(P+Mg) 
ratio of 1.5 at a pH value of 11.2 and then heat to a temperature of 900 ˚C for 2 h. 
Although the crystal structures of β-TCP and whitlockite are similar, the crystal 
composition of whitlockite include magnesium (Mg+2) and HPO42- ions. In addition, 
β-TCP can not form at room temperature below 100 ˚C whereas whitlockite can be 
precipitated in ambient conditions [Elliott (1994)]. Whitlockite is a TCP derivative with 
magnesium, and occurs in ectopic pathological calcification. Whitlockite may form under 
physiological conditions, and crystallise in vivo in different disease states [Kokubo (Ed.) 
(2008)]. In addition, whitlockite can be precipitated in aqueous conditions with the 
presence of Mg+2 and HPO42- ions [Kokubo (Ed.) (2008)]. 
 
The difference amongst apatitic TCP, α-TCP and β-TCP can be identified by XRD 
patterns and FTIR spectra. The characteristic of apatitc TCP is observed along with the 
phosphate band at 875 cm-1 [Kokubo (Ed.) (2008)]. The phosphorus absorption is present 
at 600 cm-1 as a single band for α-TCP, but at 550 and 616 cm-1 as split bands for β-TCP. 
For whitlockite, there is a P-OH stretching band at 850 cm-1 [Elliott (1994)].  
 
3.6 Amorphous calcium phosphates  
Amorphous calcium phosphates (ACPs) often exist as a transient phase during the 
formation of calcium phosphates in aqueous systems, particularly non-stoichiometric HA 
(ns-HA). ACPs can be made by the rapid addition of calcium and phosphate ions 
solutions, followed by washing and freeze-drying. ACPs also can be prepared with other 
ions in addition to Ca2+ and PO43- ions [Elliott (1994)]. The presence of pyrophosphate, 
carbonate, and magnesium ions retards ACPs crystallisation, but the presence of fluoride 
ions promotes crystallisation [Dorozhkin (2007)]. The Ca/P ratio of ACPs varies from 
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1.18 to 1.50, depending on the pH and the concentration of mixing solutions [Dorozhkin 
(2007), Elliott (1994)]. The transformation of ACPs with and without water results in the 
formation of different products. There is no change in the Ca/P ratio of ACPs when water 
is absent. However, ACPs usually transform to HA or ns-HA in slightly alkaline 
solutions. DCPD and OCP can also be formed from ACPs. According to the solubility, an 
OCP-like material was an intermediate phase of the transformation of ACPs [Elliott 
(1994)].  
 
The phosphate absorption of ACPs is featureless and broad in the IR spectra, which is 
similar to the phosphate ions in solution. However, there are some phosphate bands 
between 1250 and 890 cm-1 in FTIR spectra [Elliott (1994)]. ACPs are usually formed 
from spherical particles with diameter between 20 and 120 nm. According to the XRD 
patterns, ACPs are structurally distinct from HA. However, it is possible that ACPs have 
an apatitic phase, which consists of small crystals which cannot be detected by X-ray 
diffraction. ACP with sodium, magnesium, carbonate and pyrophosphate is found present 
in soft tissue pathological calcifications. In addition, pure ACPs have been used in the 
calcium phosphate cements as filling materials in dentistry [Dorozhkin (2007)].  
 
3.7 Hydroxyapatite  
Forster was first to present the formula of HA (Ca10(PO4)6(OH)2) [De Groot (1983)]. The 
Ca/P ratio of HA reflects the purity of the final material, that is whether the material 
contains only stoichiometric hydroxyapatite (1.67) or is mixed with other calcium 
phosphate phases (>1.67 or <1.67). A Ca/P ratio above 1.67 indicates the presence of 
calcium rich HA or carbonated HA, whereas a Ca/P ratio below 1.67 means that the 
apatite is calcium deficient [Hench and Wilson (1993)] or contains impurity phases. HA 
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has drawn significant interest as a biomaterial because of its similarity in composition to 
mineral component of bone [Shi et al. (2004)].  
 
The methods to produce synthetic HA may be divided into the dry chemical reaction 
(solid state processing), and the wet chemical reaction. The dry chemical reaction (solid 
state reaction) uses high temperature treatment to enhance diffusion of ions during the 
chemical reaction. However, heterogeneity and agglomeration of HA is a problem with 
the solid state reaction since the starting elements must diffuse through the layers formed 
at powder interfaces to allow chemical reactions occur [Ratner et al. (2004)]. Wet 
chemical synthesis methods include: hydrothermal synthesis; hydrolysis; and 
precipitation [Ratner et al. (2004), Koutsopoulos (2002)]. These methods are used to 
prepare stoichiometric HA (s-HA) by using stoichiometric quantities of Ca2+ and PO43- 
ions. By comparison, the wet chemical reaction allows the formation of HA at low 
temperatures because the liquid precursors are mixed at the atomic level [Kokubo et al. 
(2008)]. Drying processes may be divided into heating processes and non-heating 
processes and both affect the crystal structures of secondary particles since the powders 
coarsen easily. The heating processes include hot gas drying, hot-plate drying, infrared 
drying, spray drying and microwave drying. The non-heating processes include reduced 
pressure drying, freeze-drying, centrifuge drying, drying by using a desiccating agent, 
ultrasonic drying and critical point drying [Kokubo (Ed.) (2008)]. 
 
For stoichiometric methods, the reactants must be H3PO4 and Ca(OH)2 or salts of calcium 
and phosphates with ions such as nitrates or ammonium which are unlikely to be 
incorporated in the apatite phase. Because of the low solubility of apatites, if the calcium 
and phosphate ions have exact molar values in the reaction medium, s-HA can be 
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obtained. For stoichiometric methods based on equilibrium syntheses, the compositions 
of calcium and phosphates ions must be controlled so that the solution is supersaturated 
with HA. The other method is to assume that s-HA is the most stable phase at a pH above 
the HA/DCPD singular point. Theoretically, any calcium phosphates left in solution 
should transform to HA with sufficient time, if the pH is maintained above the singular 
point. However, in reality, the product often hydrolyses to DCPA/DCPD rather than 
calcium deficient HA. An alternative is to hydrolyse by directly precipitating HA above 
the HA/DCPD singular point. For example, HA is precipitated by the addition of 
sufficient Ca(OH)2 to saturate H3PO4 until the pH exceeds 9. The methods described 
above can also be used for the production of ns-HA [Elliott (1994)].  
 
In the solid state reaction, mixtures of calcium and phosphate reactants are heated to over 
700 ˚C to obtain s-HA, one calcium phosphate or a mixture of calcium phosphate salts.  
In solid reactions, it is of utmost importance to ensure that the reaction is complete in 
order to produce a singular, pure phase. The reactants are usually chosen from CaCO3, 
CaO, Ca(OH)2, DCPD, DCPA, and Ca2P2O7. The solid state reaction results in a 
stoichiometric and highly-crystalline HA, but high temperature treatment is necessary 
[Groot (1983), Suchanek and Yoshimura (1998)].  
 
The wet chemical reaction generally leads to a more homogeneous product than the solid 
state reaction, and results in the formation of nano- to submicron- crystals [Liu et al. 
(2001), Ferraz et al. (2004)]. The wet chemical reactions occur between calcium and 
phosphate ions at a specific rate of addition, pH value and temperature [Liu et al. (2001), 
Kumar et al. (2004) and Ferraz et al. (2004)]. The purity of the HA is determined by the 
addition rate of a reactant and pH. If the pH during the reaction falls below pH 9 it results 
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in the formation of calcium-deficient HA [Jillavenkatesa and Condrate Sr. (1998)]. The 
main problem, however, with the wet method is the incorporation of carbonate during the 
preparation of HA [Suchanek and Yoshimura (1998)]. 
 
Hydrothermal processing uses water or aqueous solutions at high pressure and 
temperature such as 12000 psi and 275 ˚C, which results in a highly crystalline and 
stoichiometric product [Norton et al. (2006)]. Hydrothermal preparation has been 
developed using different calcium phosphate precursors such as DCPA, phosphoric acid, 
DCPD, calcium acetate, and triethyl phosphate. Hydrothermal processing generally 
results in single large crystals of HA. [Shi (2004), Suchanek and Yoshimura (1998)], but 
it may cause the formation of intermediate products such as β-dicalcium pyrophosphate 
or MCPM [Jillavenkatesa and Condrate Sr. (1998)].  
 
Hydrolysis of TCP, DCPA, DCPD, or OCP at a temperature below 100 ˚C results in the 
formation of needles or blades of HA. The Ca/P ratio of the resulting HA is between 1.5 
and 1.7. In the case of precipitation of HA, the temperature is lower than 100 ˚C; 
however, a nanometric size crystal with needles, blades, or rods of HA can be obtained. 
The crystallite and stoichiometry of the HA is typically lower than with other methods 
[Suchanek and Yoshimura (1998)]. HA can also be prepared by the sol-gel processing. 
The preparation and nature of sol-gel HA is described fully in the next section (Chapter 
4). 
 
The deposition of HA coatings onto prostheses can be accomplished by spontaneously 
nucleating and growing HA using metastable synthetic body fluids composed of an 
inorganic salt composition [Ferraz et al. (2004)]. Coating HA on metal alloys provides a 
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stable fixation between bone and implant and reduces adverse reaction [Suchanek and 
Yoshimura (1998)] following implantation. The thickness of HA coating is usually in the 
range of 200 to 400 µm. Other techniques of HA coating include plasma spraying, sputter 
coating, laser deposition, and sol-gel processing. Plasma spraying uses a stream of gas 
such as pure argon or a mixture of argon and other gases to carry HA powders, which are 
then passed through plasma produced using a low voltage, and high current electrical 
discharge. However, plasma spraying has its own problems including: binding between 
coatings and the substrates, and the alteration of HA structure [Yang et al. (2005)]. Like 
plasma spraying, sputter coating coats HA layers on the substrate, but with low pressure 
during sputtering. The composition of the coating may be different from the intended 
composition, depending on the type of sputtering system and the parameters used for 
deposition [Yang et al. (2005)]. Laser deposition uses an active medium to produce the 
optical gain under proper pumping conditions, and the optical resonator is composed of a 
pair of mirrors and reflects to produce optical feedback and an amplified beam [Paital et 
al. (2008)].  
 
The IR spectra of HA has been summarised in Table 3.2 [Elliott (1994)]. HA is 
characteristic for the HPO42- ion adsorption at 870 cm-1. However, the carbonate ion 
absorption appears at 870 cm-1 because of the out-of-plane stretching. Therefore, it will 
interfere with the analysis of HA. In addition to PO43- bands, the OH- band is expected at 
3600 cm-1. 
 
Pure HA never occurs in biological system, but due to the similarity to bone and teeth, 
HA is widely used as a coating on orthopaedic prostheses, and also with biological 
components for drug delivery [Dorozhkin (2007)].  
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Table 3.2 Positions of different vibrations of hydroxyl, phosphate, and carbonate in 
FTIR analysis of HA and carbonated substituted apatite (CA) gels. All values are 
represented as wave numbers (cm-1). 
 
 
3.8 Tetracalcium phosphate (Hilgenstockite) 
Tetracalcium phosphate (TTCP) is the most basic of the calcium phosphates, but its 
solubility in water is higher than that of HA (Table 3.1). TTCP can be formed by a solid 
state reaction at temperatures of 1300 ˚C [Elliott (1994)]. The reaction occurs in a dry 
environment or in a vacuum with the combination of equimolar of DCPA and calcium 
carbonate as the Equation 3.3 shows. If there is excess water, the reaction results in the 
formation of HA (Equation 3.4). This suggests that TTCP is unstable in aqueous systems, 
and hydrolysis of TTCP results in a mixture of HA and CaO. TTCP unlike other calcium 
phosphates cannot be formed from an aqueous solution [Dorozhkin (2007), Elliott 
(1994)]. 
 
OHCOOPOCaCaCOCaHPO 2224434 2)(22 ++→+                  Equation 3.3 
 
CaOOHPOCaOHOPOCa 2)()()(3 264102244 +→+                   Equation 3.4 
 
In medicine, there is no product composed of only TTCP, but TTCP combined with 
DCPD or DCPA is used as bone cement which sets to HA in the presence of water.  
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3.9 Substitution of calcium phosphates 
Besides the major components, Ca2+, PO43-, and OH-, bone contains trace mineral ions, 
CO32-, HPO42-, F-, Si2+, Na+ which play important roles in bone. Therefore, it has been 
hypothesised that incorporating these elements into synthetic HA can further enhance the 
biological response to the ceramic [Pietak et al. (2007)]. The ionic substitutions such as 
Mg2+, Zn2+, and F- of apatites has little effect on the crystal structure since these ions are 
ions of like charge such as Ca2+ or OH-. However, ion substitution results in the crystal 
lattice when CO32- or SiO44- takes the place of PO43- since they have different valences 
[Putlyaev and Safronova (2006)]. The mineral components present in bone and s-HA are 
summarised in Table 3.3 [Dorozhkin (2007)]. The use of substituted apatites has been 
shown to exhibit favourable to bone growth when compared with non-substituted 
materials [Pietak et al. (2007)]. 
 
Table 3.3 Chemical composition of human bone and HA reproduced from Dorozhkin 
et al. 2007.  
 
Composition  Bone (wt%) HA (wt%) 
Calcium 34.8 39.6 
Phosphorus as P 15.2 18.5 
Ca/P (molar ratio) 1.71 1.67 
Sodium 0.9 - 
Magnesium 0.72 - 
Potassium 0.03 - 
Carbonate as CO32- 7.4 - 
Fluoride 0.03 - 
Chloride 0.13 - 
Pyrophosphate as P2O74- 0.07 - 
Total inorganic components 65 100 
Total organic components 25 - 
H2O 10 - 
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3.9.1 Substitution with halides 
Fluorapatite (FA) is formed by substituting the OH- of apatite with F-. The chemical 
formula of FA is Ca10(PO4)6F2. The solubility (log (Ks) =120 at 25 ˚C ) of FA is lowest 
of the apatites. The preparation of FA in solution is similar to that for HA. However, an 
additional amount of fluorine provided as sodium fluoride, calcium fluoride or 
ammonium fluoride is necessary for the formation of FA. FA readily forms a solid 
solution with HA to make fluorhydroxyapatite (Ca10(PO4)6(OH)2-xFx, where 0<x<2) 
[Dorozhkin (2007)]. FA can be precipitated by heating a stoichiometric mixture of CaF2 
and any TCP at 900 ˚C or agitation of a mixture of any CaP and CaF2 or NaF. When FA 
is heated in steam at 1360 ˚C, it can be converted to HA [Elliott (1994)]. Pure FA hardly 
exists in the biological systems. However, fluoride is found in human calcified tissue 
[Dorozhkin (2007)]. Fluoride is also added to drinking water in order to prevent the acid 
dissolution of tooth mineral [LeGeros (1981)].  
 
Chlorapatite forms by substituting OH- with Cl- -, and is represented by the formula 
Ca10(PO4)6Cl2. Chlorapatite can also be prepared either by precipitation of calcium 
chloride with sodium phosphate or by hydrolysis of CaHPO4 in sodium chloride solution 
[LeGeros (1981), Elliott (1994)]. Although in the human body 70 wt% of the total ionic 
content is Cl-, the average Cl- content of enamel is only 0.25 wt%, and less than 0.01 wt% 
of bone and dentine, which suggests Cl- does not readily incorporate into apatite in tissue 
[LeGeros (1981)].  
 
3.9.2 Substitution of Carbonate  
Carbonated apatite (CA) is closer in composition to bone and dental enamel than HA. 
The solubility of apatite that is substituted with carbonate is higher than stoichiometric 
hydroxyapatite. Furthermore, CA has been shown to have a lower thermal stability 
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[Elliott (1994), de Jonge et al. (2008)]. Carbonate is mainly present as three different 
phases in hard tissue: (a) an admixed phase either as calcite (CaCO3), dolomite ((Ca, Mg) 
CO3), or as a component of amorphous calcium phosphate; (b) a substituent in the 
apatitic structure, either substituting for hydroxyl (OH-) or phosphate (PO4-3) or both; (c) 
a lattice substitution and a surface component [LeGeros (1981)]. The mode of CA can be 
detected by infrared and Raman spectroscopy through the presence of three equal, 
symmetrical C-O bonds which are present respectively at 1063 cm-1(ν1), 879 cm -1(ν2), 
and doubly degenerated peaks at 1514 cm-1(ν3) and 680 cm-1(ν4) (Table 3.2). 
Nevertheless, the ν1 is only recognised using Raman spectroscopy, and the ν2 is only 
active for the IR spectroscopy [Elliott (1994)]. 
 
CA can be classified as type A (Ca10(PO4)6CO3) or type B substituted, or type AB 
depending on whether the carbonate substitutes hydroxyl groups (OH-, A type) or 
phosphate groups (PO43-, B type) or both (OH- or PO43-, AB type). For type A, the 
substitution of the larger planar carbonate for the smaller linear hydroxyl group results in 
an expansion in the a-axis and contraction in the c-axis dimensions. If all OH groups are 
replaced by carbonates, an A type CHA should contain 35.3 mol% of phosphates 
[Nordström (1990)]. Assuming one carbonate group substitutes two hydroxyl groups, the 
A-type substitution mechanism can be expressed as Equation 3.5 [Norton et al. (2006)].   
 
OHCOOHPOCaCOOHPOCa xx 2326410226410 )()()()()( −→+           Equation 3.5 
 
But in the case of type B, the substitution of the smaller planar carbonate for a larger 
tetrahedral phosphate (PO43-) causes a contraction in the a-axis and an expansion in the 
c-axis dimensions [LeGeros (1981), Elliott (1994)], suggesting that CO32- causes a certain 
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modification of the structure. Assuming that sodium carbonate solution is used for the 
source of carbonate during precipitation, the B-type mechanism of the phosphate group 
replaced by the carbonate group is described by Equation 3.6 [Norton et al. (2006)].  
 
236410 )()()( OHCOPONaCa xxxx −−  or 34223 −+−+ +↔+ POCaCONa       Equation 3.6 
 
If x=1, Ca10[(PO4)6-x(CO3)x](OH)2, B-type CHA contains 27.8 mol% phosphates 
[Nordström and Karlsson (1990)]. The presence of carbonate in the apatite lattice also 
affects the vibration modes of the phosphate groups. It was found that the concentration 
of carbonate is related to the loss of resolution of phosphate absorption bands [LeGeros 
(1981)]. The difference between these two types (A and B type) can be recognised by the 
infrared spectrum. LeGeros et al. showed that the substitution of carbonates for the 
phosphate groups and the substitution of sodium for calcium affect the size and shape of 
the apatite crystal. They also showed that the carbonate can be used as an effective crystal 
growth inhibitor because of the small size of carbonated substituted HA (CHA) [De 
Jonge et al. (2008)]. The shape of the crystal changes with the increasing concentration of 
the carbonate. Moreover, the solubility of the CHA is less than apatite without carbonate.  
 
A-type CHA is prepared by replacing the OH in s-HA for a carbonate group at a 
temperature from 900 to 1000 ˚C in a CO2 atmosphere. Nordström et al. reported that 
CHA was made through ion-exchange carbonate ions from solution into HA [Nordström 
and Karlsson (1990)]. In brief, the mechanism of A-type substitution is simple, but the 
reaction time is long, and also the carbon content is not easily controlled [Gibson and 
Bonfield (2002)]. 
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The substitution of CO32- for PO43- in apatite (B-type) is made by any of the following: (1) 
precipitation at 60 ˚C to 100 ˚C; (2) hydrolysis of CaHPO4 in a hot carbonated solution; 
(3) hydrolysis of CaCO3 in a phosphate solution or in a solution containing carbonate and 
phosphate ions; (4) hydrothermal treatments or pyrolysis at 600 ˚C of carbonate 
containing ACPs; (5) pyrolysis at 600 ˚C of poorly crystallised calcium carbonate 
phosphate at 37 ˚C [LeGeros (1981)]. The B-type substitution is much more complicated 
than the A-type substitution for HA. Because the problem of charge balance occurs when 
a carbonate replaces a phosphate, there will be a loss of negative charge from the 
phosphate ions. This problem can be solved by using sodium or ammonium containing 
carbonate reagents in the precipitation which results in the incorporation of sodium or 
ammonium ions [Gibson and Bonfield (2002)] into the crystal lattice.  
 
3.9.3 Substitution of Silicate 
Silicon is the second most abundant element on Earth after oxygen. The content of Si in 
the human body varies, there being for example 100 ppm in bone and ligaments and 
200-600 ppm in cartilage and other connective tissues. Since the pioneering experiments 
of Carlisle, silicon has been proposed to play a significant role in biomineralisation. 
Aqueous Si has been demonstrated to promote osteoblast proliferation, differentiation 
and collagen production [Pietak et al. (2007) and Carlisle (1970)].  
 
There are several methods by which silicon substituted HA (SiHA) and silicon 
substituted α-TCP (Si-α-TCP) may be formed. The preparations are divided into wet 
chemical methods and solid state reactions [Suchanek and Yoshimura (1998)]. For wet 
methods, the sources of silicon are tetraethyl or propyl orthosilicate (TEOS or TPOS), 
silicon tetraacetate, or nano particulate silica. But it has always been difficult to make 
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pure SiHA without producing secondary phases such as β-TCP, silicocarnotite 
(Ca10(PO4)4(SiO4)2) or α-TCP. When Si4+ is introduced as tetraethyl silicate or silicon 
tetraacetate, a lower proportion of α-TCP or Si-TCP is present. Besides those TCPs, at 
higher silicon concentration, silicocarnotite is frequently observed [Pietak et al. (2007)]. 
In the solid state, the materials are generally sintered at 700 to 1200 ˚C. However, in this 
case, the secondary ions, La3+, SO42- are also incorporated [Boyer et al. (1997)].  
 
The phase compositions of SiHA and Si-α-TCP are highly dependent on the ratio of Ca/ 
(P+Si) and Ca/P, the concentration of Si, the synthetic method and sintering temperature. 
Based on these parameters, different mechanisms are proposed to explain the 
substitutions of Si in calcium phosphates. The simple assumption is that SiO44- substitutes 
for PO43- groups. Since the substitution of SiO44- causes loss of charge, this requires other 
phases of SiHA and Si-α-TCP to compensate for the deficit. There are some effects from 
the charge compensation, including O vacancies and excess Ca, which can each 
compensate for two silicons. Pietak et al. [Pietak et al. (2007)] assumed that Si-α-TCP 
balances its charges by creating water and oxygen vacancies resulting in the formation of 
an oxygen deficient Si-α-TCP. The mechanism can be described as the following 
(Equation 3.7).  
 
OHOSiPCaSiOOHPOCa xxx 222/4132345 3)(102)(6 +→+ −−              Equation 3.7 
 
The other mechanism (Equation 3.8) is based on the hypothesis that Si-α-TCP is a 
calcium rich HA.  
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OHOSiPCaSiOOHPOCa yyy 224132345 2)(2/13)(4 +→+ −+              Equation 3.8 
 
Providing that OH and O compensate for the charge deficit, the formulae of SiHA and 
Si-α-TCP are Ca5(PO4)3-x(SiO4)xOH1-x, and Ca3(P1-xSixO4-x/2)2, respectively [Pietak et al. 
(2007)]. 
 
Alternatively, excess H+ in SiHA and Si-α-TCP can balance the charge deficit. However, 
for SiHA, OH- vacancies can also compensate for charge imbalance as shown in Equation 
3.9. In this mechanism, Gibson et al. reported that the addition of 0.4 wt% silicon resulted 
in x=0.16. 
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                    Equation 3.9 
 
In fact, there is usually a little carbonate precipitated during the formation of SiHA. As 
carbonate can replace either phosphate or hydroxyl groups, there are two hypotheses: (1) 
Assuming that carbonate locates in the B site of the apatite (the phosphate site), the 
charge balance is maintained by creating the vacancies from Ca2+ and OH-: the formula is 
Ca10-y(PO4)6-x(CO3)y(SiO4)w(OH)2-x where y is the molar of carbonate and part of initial 
silicon corresponds to y mole of carbonate, w=x-y. Therefore, there must be calcium and 
silicon existing as a secondary phase, which is identified as wollastonite, CaSiO3. The 
substitution mechanism of SiHA with carbonate can be shown as Equation 3.10, but 
wollastonite is rarely detected since the amount and crystallinity are beyond the analytical 
limits.  
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→−++−+−+− −−−−+ OHxyCOSiOyxPOxCay )2()()6()10( 2344342  
32436410 )()()()( yCaSiOOHSiOCOPOCa xwyxy +−−−                    Equation 3.10 
 
The other suggested mechanism assumes that the molar number of silicate groups 
substituted into the apatite equates to that of the carbonate. The chemical formula is 
written as Ca10(PO4)6-2y(CO3)y(SiO4)y(OH)2 where w=y=x/2; however, only when x=0.4 
(Equation 3.9). At x>0.4, there are hydroxyl vacancies because of the additional silicates 
(u). The resulting mechanism can be expressed as the following (Equation 3.11):  
 
→++++++ −−−−+ uOHyCOSiOuyPOuyCa 23
4
4
3
4
2 )()2(10
uuyyy OHSiOCOPOCa −+− 24326410 )()()()(                            Equation 3.11 
 
Similarly, there must be some silicon left, not incorporated into the apatites. Since there 
is no substitution of Ca2+, it could be present as amorphous Si(OH)4. The chemical 
formulae can be expressed as the following: (a) Ca10(PO4)6-2y(CO-
3)y(SiO4)y(OH)2ySi(OH)4 or (b) Ca10(PO4)6-2y(CO3)y(SiO4)y+u(OH)2-u + ySi(OH)4. 
However, these secondary phases might not be detected by XRD because of the poor 
crystallinity and low content [Palard et al. (2008)]. 
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Chapter 4 Sol-gel processing 
 
4.1 Sol 
A sol is a colloidal suspension of solid particles in a liquid (Figure 4.1) [Zelinski and 
Uhlmann (1984)]. Since the particles do not adhere to adjacent particles, each particle 
remains completely dispersed [Kendall (2001)]. Sols can be formed with different kinds 
of structure depending on the suspension, and are the simplest colloid dispersion. An 
aerosol, for example, is a colloidal suspension of particles in a gas (if the particles are 
liquid it is named fog; if the particles are solids called, it is smoke); an emulsion is a 
suspension of liquid droplets in another liquid [Brinker and Scherer (1990)].  
 
4.2 Colloids 
Colloids are solid particles with diameters of 1-100 nm (a suspension) [Hench and West 
(1990), Brinker and Scherer (1990)]. Colloids can mimic the behaviour of atoms in the 
dispersed: liquid, gas, and deposit a thin film with an amorphous or crystalline structure. 
Heller [Heller (1980)] classified four types of colloids: coacervates, tactoids, crystalloids, 
and flocks (Figure 4.2). Coacervates are particles that attract one another but are not 
bound together by van der Waals attraction or surface charges. Tactoids are particles 
arranged regularly, but are not bonded with one another. If tactoids are slowly dried or 
the repulsive barrier is gradually reduced, the particles will irreversibly bond in an 
ordered arrangement known as a crystalloid. However, if particles rapidly aggregate, they 
form disordered clusters termed flocks [Heller (1980)]. As a result of low adhesion 
between particles, interaction is negligible within particles which are dominated by weak 
forces, such as van der Waals attraction and surface charges. As coagulation of colloidal 
particles occurs, if the size of particles is near 0.5 µm, a colour change occurs which is 
visible to the naked eye [Kendall (2001)].  
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Figure 4.1 A sol is a suspension of discrete particles. When there is adhesion between 
particles, a gel is formed. The method of water removal from the gel leads to different 
structures which are termed xerogel, aerogel, and cryogel. Most gels are amorphous 
(non-crystalline) after drying, but become crystalline after the heat treatment.  
 
 
 
 
 
Figure 4.2 The four types of aggregated colloids (Adapted from Heller, Polymer 
colloids II, 1980). 
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4.3 Gels 
A gel is an interconnected network with pores of submicrometric dimensions which are 
formed of condensed polymers or aggregated particles linked with one another by 
adhesive contact (Figure 4.1) [Hench and. West (1990), Kendall (2001), Brinker and 
Scherer (1990)]. A gel is a colloidal or polymeric solid containing a fluid component 
which has an internal network so that solid and fluid components are highly dispersed. 
Sols and gels are distinguished by the degree of adhesion as particles of a gel adhere 
strongly whereas sol particles disperse discretely [Zelinski and Uhlmann (1984), Kendall 
(2001)]. In diluted solution the collapse of the repulsive double layer results in the growth 
of a fractal aggregate, but a gel forms in a more concentrated solution [Brinker and 
Scherer (1990)]. The coordination (the number of adhesive points within gel particles) of 
a gel which can be from 2 to 12, decides its structure. For example, when the liquid is 
removed if the gel is strong enough it does not crack, but the gel may collapse if it is less 
connected [Kendall (2001), Brinker and Scherer (1990)]. In addition, the structure of a 
gel relies on the size and adhesive strength of particles [Brinker and Scherer (1990)]. A 
gel is distinguished from a paste by the deformation behaviour, and rheology, in that a gel 
is hard, and elastic, but a paste is somewhere between elastic and plastic [Kendall 
(2001)].  
 
The strength of a gel is dependent on whether the bonds within the solid phase are 
permanent or reversible, which depends on the mechanism of gelation. During gelation 
condensed polymers or aggregated particles grow clusters, and then these clusters link 
together to produce a gel. The gel point is identified as the moment when the last bond is 
formed in the clusters. If bond formation does not stop after the gel point, however, 
polymers or particles continue to attach themselves, a process termed as ageing.  
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Ageing has been shown to be critical to the sol-gel structure. The processes of ageing 
after gelation are classified as polymerisation, coarsening, and phase transformation 
[Brinker and Scherer (1990)]. Because of continued polycondensation and reprecipitation 
of the gel network during ageing, the thickness of the interparticle necks increases. 
Therefore, the strength of the gel is increased by the ageing process [Hench and West 
(1990)].   
 
In addition, shrinkage plays an important role in the structure of a gel. Shrinkage of a gel 
occurs as liquid is removed from the pores. Syneresis is the spontaneous shrinkage of the 
gel. The amount of shrinkage occurring during drying affects the strength of gel network. 
Drying by evaporation results in a change of capillary pressure, which brings about the 
shrinkage of the gel.  
 
Sherwood divided the drying process into three stages [Hench and West (1990)]. In the 
first stage the reduction of volume of the gel is equal to the volume of evaporated liquid. 
In a large pore size (>20 nm average diameter), the first stage is a constant rate period 
because the evaporation rate per unit area of the drying surface is independent of time. 
Generally, changes of structure such as volume, weight, and density occur in the first 
stage. When the shrinkage stops, the first stage ends. The second stage starts when the 
critical point is reached. At this stage, the highest capillary pressure is created, and the gel 
resists further shrinkage. Consequently, cracking is likely to occur. Because of the 
decreased rate of evaporation, the second stage is termed the first falling rate period. In 
the third stage, the liquid ceases to flow to the surface, and is removed only by diffusion 
of its vapour. This is named the second falling rate period. The reason for cracking during 
the drying process is that a capillary pressure gradient is generated in the liquid phase of a 
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gel. The difference of pressure leads to differential shrinkage of the gel network since the 
exterior of the gel usually contracts faster than the interior. This causes cracking. The 
methods of drying influence the material structures, for example the degree of 
crystallinity of the gel [Hench and West (1990), Zelinski and Uhlmann (1984)].  
 
In particulate gel, the shrinkage is controlled by the addition of electrolyte because the 
structure of the gel is dependent on the balance between electrostatitc repulsion, and 
attractive van der Waals forces [Hench and West (1990), Brinker and Scherer (1990)]. 
According to the drying process, the resulting gel can be xerogel, cryogel, and aerogel. 
Generally, most gels are amorphous, but become crystalline after heat treatment 
(sintering).  
 
A gel can be categorised in various ways. Gel by Flory’s definitions can be classified as 
being (1) lamellar gels with well-ordered lamellar structures; (2) covalent polymeric gels 
with covalent polymeric networks, with completely disordered structures; (3) physical 
polymeric gels with polymer networks formed through physical aggregation, which are 
also predominantly disordered; (4) particulate, or colloidal gels with particulate 
disordered structure (Figure 4.3) [Pierre (1997), Kendall (2001)]. Furthermore, a gel can 
be classified by the types of dispersed phase for instance, when the dispersed phase is 
water, the gel is a hydrogel (Figure 4.4) [Henisc (1970)]. 
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Figure 4.3 Classification of gels proposed by Flory: lamellar gel, covalent gel, 
polymeric gel, and particulate gel.  
 
 
 
Figure 4.4 The hydrogel is swollen when the gel is in aqueous system whereas the 
hydrogel is collapsed when the water is removed.  
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There are four chemical methods to make gels which are (1) the reaction method, (2) the 
chemical reduction method, (3) the complex and de-complexion method, and (4) the 
solubility reduction method [Arora (1981)]. In the reaction method the crystals grow 
through a chemical reaction, for example two salt solutions are mixed together, and then 
the crystals precipitate as an insoluble phase [Arora (1981)]. The size of crystals of gels 
can be controlled by the reduction rate of crystal growth using governing the diffusion of 
reactive ions. The chemical reduction method, especially for the growth of metal crystals 
such as gold, nickel, copper, originates from the reaction method [Arora (1981)]. In the 
complex and de-complexion method chemical complex crystals are grown in a complex 
agent solution where initially the solution is homogeneously miscible, and then offers an 
external condition to conduct the dissociation of the formed complex. An adapted 
procedure for this method is to increase dilution steadily when the complex solution is 
diffusing through a gel [Arora (1981)]. In the solubility reduction method water soluble 
gels are formed where crystals are dissolved in an acid solution, and as the 
supersaturation of the gel medium is increased, more crystals are formed [Arora (1981)]. 
This method decreases the solubility of the final material by replacing gel medium with 
alcohol initiating the formation of crystals.  
 
Gels can be also physically made from powders by dry compaction, smoke deposition, 
paste drying or phase separation followed by leaching. These physical depositions are 
based on a traditional method which is the plastic processing where powder mixes with a 
polymer solution, and is sheared strongly to break down the agglomerates. Sequentially, 
the powders are extruded to form samples, and the samples are heated to remove the 
water or organic solvent [Kendall (2001)].  
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4.4 Pastes 
As the adhesive barrier of colloids is overcome by heating, adding salts or polymers, the 
coagulated colloids may form pastes. A paste is a semi-fluid material consisting of a 
mixture of liquid and gel which fluidises when the shear stress is high enough (Figure 4.5) 
[Kendall (2001)]. However, a paste can be in the form of liquid or solid, depending on 
the environment. The adhesion of a paste falls between a sol and a gel that is strong 
enough to make gelled cluster, but weak enough to move in the suspension.  
 
Figure 4.5 A paste is a mixture of liquid and gel characteristics with intermediate 
adhesion. 
 
4.5 Sol-Gel processing in ceramics 
The sol-gel process has been largely used to make bioactive glasses, and bioceramics 
[Hench and Jones (2005)]. The sol-gel process occurs where one or many elements are 
used to form a sol from which is obtained a homogeneous and amorphous gel solid by the 
transition from a liquid sol to a solid gel [Colomban (1989), Gupta et al. (2008)]. The 
resulting gel can be a dense ceramic or glass, depending on the drying process and heat 
treatment. These different drying conditions respectively form the gel as a xerogel, 
cryogel or aerogel. 
 
A xerogel is a gel that is dried at or near ambient pressure by thermal evaporation. 
Therefore, the structures of xerogels are influenced by the removal of the liquid phase 
which can be explained by capillary forces [Vollet et al. (2004)]. The word “xerogel” 
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derives from the Greek xeros, meaning dry. Xerogels are generally microporous. 
According to IUPAC convention, micropores are smaller than 2 nm, mesopores are 
between 2 and 50 nm, and macropores are bigger than 50 nm [Pierre (1997)]. The surface 
area of xerogel ranges from 500 to 900 m2 g-1. A xerogel has less selectivity and activity 
in comparison with aerogels. The applications of xerogels are restricted by their 
mechanical properties although some studies have reported that these can be improved by 
surface modification [Laranjo et al. (2007), Ho et al. (2006)]. Xerogels are largely used to 
make dense ceramics, and are employed as catalysts, biosensors, and filters because of 
their high porosity and surface area [Brinker and Scherer (1990), Ho et al. (2006)].  
 
A cryogel is a gel formed by a freeze-thawing process. The name cryogel originated from 
the Greek “kryos”, meaning frost or ice. A cryogel usually has pore size in the range of 5 
to 100 µm, and it is a hydrophilic material [Orrego and Valencia (2009), Plieva et al. 
(2004)]. At present, cryogels have been largely used as a cell scaffold, to deliver 
immobilised molecules and as a monolithic stationary media for chromatography of cells 
because of their controllable porosity [Kathuria et al. (2009), Plieva et al. (2008)]. In 
cryogel technology, the ice crystals serve as the porogens and makes pores on melting, 
which controls the pore size [Kathuria et al. (2009)].  
 
Aerogels are those prepared in an autoclave and then heated to supercritical conditions 
with the addition of a solvent such as water, methanol or carbon dioxide. Because an 
aerogel is formed in the absence of surface tension, the volume of an aerogel is almost 
the same as that of its precursor solution, and the density of an aerogel is as low as 
0.03-0.5 g cm-3 [Colomban (1989)]. Aerogels comprise mostly air so they are relatively 
light materials with little strength, which limits their applications as biomaterials [Hench 
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and Wilson (1993)]. Since capillary forces are eliminated in the supercritical process, this 
process avoids variation of the original solid network [Vollet et al. (2004)]. Aerogels are 
useful for preparation of dense ceramics. In addition, the supercritical process allows the 
manufacture of monolithic aerogel of a volume as big as that of the autoclave. Moreover, 
the surface area of an aerogel ranges from 200 to 1000 m2 g-1 by nitrogen adsorption 
measurements [Brinker and Scherer (1990)]. The advantages of aerogels are transparency, 
highly porosity, open cell structure, and low density. Aerogels also have the lowest 
thermal conductivity, refractive index, sound velocity and dielectric constant of any 
solids [Fricke and Tillotson (1997)].  
 
In general, three methods are used to make sol-gel monoliths (1) gelation of a solution of 
colloidal powders; (2) hydrolysis, and polycondensation of alkoxide or nitrate precursors 
followed by supercritical drying of the gels, and (3) hydrolysis, and polycondensation of 
alkoxide precursors followed by ageing and drying at room temperature [Hench and West 
(1990)]. The preparation parameters of sol-gel processing determine the properties of the 
materials, including reactants, reaction temperature, the ratio of water to alkoxide, and 
acid or base catalyst, and the additions of drying control chemical agents [Colomban 
(1989)].   
 
The advantages of sol-gel processing are high purity, homogeneity, and low temperature 
processing [Hench and West (1990)]. In addition, the low temperature used allows the 
incorporation of different kinds of inorganic, organic, and biomolecules during the 
formation of a gel matrix. Although sol-gel processing of inorganic ceramic and glass 
materials began as early as the mid-eighteenth century, applications of the sol-gel 
processing increased in the last two decades to include the manufacture of optical 
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materials, semiconductor-doped xerogels, silica for chromatography, gel matrices for 
hydrogen storage, and chemical sensors [Gupta and Kumar (2008)]. The first dense 
ceramics obtained by the sol-gel process were nuclear reactor fuels, and zirconia 
[Colomban (1989)].  
 
In contrast to traditional ceramics, the ceramic sol-gels have micro and macro structures 
scales [Colomban (1989)]. Based on the Flory’s classification, there are four types of gels 
[Pierre (1997)]. However, in ceramics, most ceramic gels are colloidal gels where the 
dense colloidal particles are linked to each other so as to make a porous 
three-dimensional network, and only a few are polymeric gels which have only one phase 
in a solution. Although Flory defined the network of the polymeric gel as having a linear 
polymeric nature, in fact ceramic gels do not have a well defined linear atomic structure. 
In addition, the particles and pores of ceramic colloidal gels are bigger than those of the 
polymeric gels, due to the network structure [Pierre (1997)]. Colloidal gels are made 
from metallic salt solutions, oxide and hydroxide sol. Polymeric gels are produced from 
metal alkoxides (M(OR)n where M represents of a metal for example Si, Ti, Zr, Al, B, etc. 
and R represents of an alkyl group through partially hydrolyzed metal alkoxides with the 
addition of water to form oxide networks [Zelinski and Uhlmann (1984)]. For colloidal 
gels, electrolytic and steric effects in the precursor solution are important for the pore 
structure. However, the relative rates and the extent of chemical reaction are critical for 
polymeric gels because the linear or weakly cross-linked structures of polymeric gels rely 
on the rate of hydrolysis and condensation, and the concentration of the catalyst [Pierre 
(1997), Zelinski and Uhlmann (1984)].  
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Silica gel is most commonly fabricated by sol-gel processing. Silica gels are usually 
composed of a solution of polysilicic or silicon alkoxide such as tetraethylorthosilicate 
(TEOS) or tetramethylorthosilicate (TMOS), because they can be readily hydrolysed and 
condensed under mild conditions [Park and Bronzino (2003)]. The silica sol-gel process 
traditionally includes three steps: (1) the hydrolysis of an alkoxysilane; (2) the 
condensation of hydrated silica to form siloxane bonding, and (3) the polycondensation 
by the linkage of an addition silanol group to make cyclic oligomers (Figure 4.6) [Hench 
and Ethridge (1982)]. However, the traditional methods of sol-gel processing include the 
use of low pH or high alcohol, which may destabilise biomolecules and result in the loss 
of bioactive function when the biomolecules are encapsulated into gel matrices [Gupta 
and Kumar (2008)].  
 
The pore structures of ceramic gels are highly dependent on process parameters, such as 
the pH of the sol, the amount of water used for hydrolysis, the acid or base catalyst, and 
the type of solvent [Vollet et al. (2004)]. For example, silica aerogels catalysed by acid 
have smaller pores than base catalysed silica aerogels [Pierre (1997)]. 
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Figure 4.6 The traditional silica sol-gel process includes hydrolysis, condensation, 
and polycondensation. Hydrolysis results in the formation of silanol groups (Si-OH) 
and condensation produce siloxane bonds (Si-O-Si) with by-product such as water or 
alcohol. The condensation continues to occur because of the large concentration of 
silanol (SiOH) groups. This diagram is taken from previous work Gupta and Kumar 
(2008). 
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Chapter 5 Calcium phosphates for encapsulation 
 
5.1 Enhancing the functionality of calcium phosphate materials 
The function of calcium phosphates (CaP) used for bone replacement can be enhanced by 
incorporating drugs, cells, growth factors, and enzymes. The delivery of the drugs and 
enzymes is described next.  
 
5.2 Encapsulation of biomolecules 
It is important to maintain the activity of the biomolecules when these biomolecules are 
used as a medical treatment. The immobilisation methods are critical for preserving the 
function of the biomolecules because they provide a shell to protect the biomolecules 
from attack by the outer environment, and permit them to travel through the pores of the 
shell. The types of immobilisation are described in this section. 
 
5.2.1 Immobilisation  
Immobilisation is defined as the confinement of biomolecules (enzyme, protein) in a 
distinct phase that allows exchange with, but is separated from the bulk phase where 
substrate or inhibitor is dispersed [Trevan (1980)]. Immobilisation can be classified as 
adsorption, chemical covalent bonding, entrapment, and encapsulation.  
 
Adsorption, including both physical and chemical adsorption is accomplished simply by 
mixing the biomolecules and support materials under mild conditions, followed by 
separating the unbounded molecules from the support materials by centrifugation or 
filtration [Bickerstaff (1987), Woodward (1985)]. The difference between physical 
adsorption and chemical adsorption is in the bonding [Eggins (2002)]. The bonding of 
physical adsorption is by van der Waals bond, hydrogen bond whereas chemical 
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adsorption is mediated by the covalent bond. In addition, the biomolecules are easily 
desorbed by varying pH, temperature, or ionic strength, due to weak bonding [Lim 
(1985)].  
 
Chemical covalent bonding occurs when enzymes bind with functional groups of support 
materials [Chibata (1978)]. Most covalent bonds are composed of amino group, carboxyl 
group, hydroxyl groups, and sulphhydryl groups [Bickerstaff (1987)]. By comparison 
with chemical adsorption, the process in chemical covalent bonding is complicated due to 
the chemical reactions. In addition, the use of chemical reagents results in the reduction 
of the activities of biomolecules, offset by greater efficiency of delivery [Kandimalla et al. 
(2006)]. Entrapment is trapping biomolecules through mixing with a monomer solution 
and then polymerising to form a gel network in which the activity of the biomolecules 
may be decreased. The polymer used in the entrapment is polyacrylamide or starch gel or 
polypyrrole [Eggins (2002)].  
 
Encapsulation is the incorporation of biomolecules into substrates. Encapsulation permits 
small molecules to permeate the structure of the materials, but it restricts the access or 
exit of macromolecules, proteins or enzymes [Eggins (2002)]. Unlike the other 
immobilisation methods, encapsulation protects the biomolecules from attack rather than 
providing specific sites for immobilisation [Woodward (1985)].  
 
5.2.2 Drug delivery systems 
Although CaP materials are known for their osteoconductivity, their lack of 
osteoinductivity necessitates the addition of osteogenic factors. In addition, the infection, 
resulting from trauma and surgical operation can necessitate the localised delivery of 
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bactericidal chemicals. CaP materials have a considerable history of being used as 
delivery devices, with the first being reported more than 50 years ago, and interest is still 
focused on the performance of therapeutic molecules encapsulated into the ceramic 
matrices. The release kinetics and properties of the CaP materials determines the efficacy 
of delivery. In this section, the kinetic mechanism of drug release is described.  
 
The kinetics of drug release 
Saltzman et al. defined controlled release as being able to engineer the release rate, 
release period or targeting of a specific therapeutic agent. Sustained release is maintained 
by mixing an active agent with excipients or binders [Saltzman (2001)]. However, burst 
release is unavoidable in such a delivery system, which depending on administration 
strategies may be regarded as negative or positive. For example, an initial burst may be 
the most effective way of relieving symptoms, but sustained release may result in a 
concentration of therapeutic molecules over the toxic level [Huang and Brazel (2001)]. 
Therefore, it is important to predict the kinetics of drug release, to avoid potential 
complications. 
 
The kinetic mechanisms are based on either the zero order kinetics or first order kinetics. 
The kinetic behaviour of drug release can also be reported as physical constants [Costa 
and Lobo (2001)]. The zero order kinetics (Equation 5.1) can be used to describe drugs 
that aggregated and released slowly as in transdermal delivery or in a matrix tablet with 
low solubility of drugs. 
 
KtWW t =−0                                                   Equation 5.1 
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Where W0 is the initial amount of drug, Wt is the amount of drug release at time t and K 
is a proportional constant. Equation 5.1 can be simplified by dividing by W0, allowing 
simplification to Equation 5.2.  
 
tKf 0=                                                       Equation 5.2 
 
in which f represents the fraction of drug dissolved in time t (1-Wt/W0) and K0 is the 
apparent dissolution rate [Costa and Lobo (2001)].  
 
First order kinetics (Equation 5.3) has been used to describe drug dissolution or the 
absorption and elimination of drugs.  
 
)( CCK
dt
dC
s −=                                                Equation 5.3 
 
Where C is the concentration of the solution at time t, Cs is the solubility at the 
equilibrium at experience temperature, and K is the first order proportional constant 
[Costa and Lobo (2001)]. 
 
Empirical models have been developed for specific systems. Higuchi found that there are 
two models that can be used to express the release rate of incorporated drugs in which (a) 
the drug particles are dispersed in a homogeneous diffusion medium, and (b) the drug 
particles are incorporated in an essentially granular matrix and released by the penetrating 
solvent (Figure 5.1) [Higuchi (1963)]. The release from spherical pellets by these two 
models does not follow first order kinetics. Higuchi further proposed the model (Higuchi 
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model, Equation 5.4) assuming that a drug is loaded into a uniform solid matrix 
(diffusion medium) in the planar system which is based on Fick’s First Law.  
 
tCCADQ ss )2( −=                                             Equation 5.4 
 
Where Q is the amount of drug released in time t per unit exposed area, A is the drug 
initial concentration, Cs is the solubility of drug in the matrix and D is the diffusivity. 
 
 
Figure 5.1 Higuchi’s proposed these two models of drug release from pellets 
(Adapted from Higuchi 1963).  
 
Higuchi showed that the rate of drug release is proportional to the square root of time and 
the rate-controlled step is the diffusion of dissolved drug through the matrix. Equation 5.4 
is generally presented as the simplified formula (Equation 5.5). 
 
5.0tKQ H=                                                    Equation 5.5 
 
Where Q represents as the amount of drug released in time t per unit exposed area; KH is 
the Higuchi dissolution constant.  
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Peppas’s empirical model was established for the release of pharmaceutical polymeric 
dosages (Equation 5.6). This model is reliable only if the release occurs in a 
one-dimension direction with a ratio of width to length of at least 10. In addition, the 
release exponent varies. Peppas concluded that the release exponent, n is equal to 0.5 for 
a slab, following Fick’s diffusion, but if the n value is between 0.5 and 1 or n=1 it does 
not obey Fick’s diffusion. In the case of a cylinder, the release exponent n equals 0.45, 
following Fick’s diffusion, whereas 0.89 of the release exponent is governed by the 
non-Fickian diffusion [Costa and Lobo (2001)]. 
 
nt
t atM
Mf ==
∞
                                                 Equation 5.6 
 
Where a is a constant of drug geometric characteristics, n is the release exponent, and ft is 
the fractional release of drug and a function (Mt/M∞) of t. 
 
5.2.3 Enzyme storage system 
Bone diseases such as hypophosphatasia result from the deficiency of tissue nonspecific 
alkaline phosphatase. In addition, the bioactivity of hydroxyapatite (HA) has been 
improved by incorporating cells, growth factors, and enzymes. In contrast to drug 
delivery systems, the objective of the enzyme storage system is to preserve these 
biomolecules inside the materials. However, encapsulation changes the catalytic 
behaviour of enzymes. The alteration can be determined by the affinity between enzyme 
and substrate. There are some kinetic mechanisms from which it is possible used to 
predict the catalytic behaviour of the enzyme for example, the Michaelis-Menten 
equation and the Lineweaver-Burk equation. The kinetic equations are detailed here.  
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The kinetics of enzymes 
The kinetic parameters show that the relation between an enzyme and a substrate. A low 
Michaelis constant (Km) indicates a strong affinity between enzyme and substrate, 
suggesting that only a small amount of substrate is needed whereas the high Km indicates 
a weak affinity [Price and Stevens (1999)]. Michaelis firstly proposed to use 
mathematical analysis for enzyme kinetics [Price and Stevens (1999)]. On the assumption 
of one substrate reaction acted on by an enzyme, the reaction can be present as shown in 
Equation 5.7. 
 
                                                Equation 5.7 
 
Here the reaction is assumed rapid and reversible between enzyme (E) and substrate (S). 
The forward rate constant is k1 and reverse rate is k-1. Then the enzyme complex (ES) 
breaks down in a slow rate of k2 to produce product (P) as expressed by Equation 5.8. 
 
                                                Equation 5.8 
 
As equilibrium is reached, the equilibrium constant K is defined as Equation 5.9. 
 
][
]][[
ES
SEK =                                                    Equation 5.9 
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Micahelis, however, assumed the enzyme complex is in a steady state. The concentration 
of ES remains constant as the rate of ES formation equals the rate of ES breakdown 
which can be described as Equation 5.10.  
 
][][]][[ 211 ESkESkSEk += −                                      Equation 5.10 
 
After rearrangement Equation 5.10 becomes Equation 5.11. 
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                                               Equation 5.11 
 
Providing the total concentration of enzyme is E0, and substituting Equation 5.11 in the 
fraction of enzyme, F ( ][][
][
ESE
ESF
+
= ), then, Equation 5.11 can be expressed as the 
following: 
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As ν is given by ][2 ESk=ν  and 02max ][EkV = , [E]0 can be replaced to 
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, Equation 5.12 is rewritten to the 
Michaelis-Menten equation (Equation 5.13). 
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Other workers rearranged the Michaelis-Menten equation because it is difficult to decide 
Vmax directly from the plot of Michaelis-Menten equation (ν against S). By rearrangement 
of the Michaelis-Menten equation, the kinetics can be obtained by calculating the slope of 
the linear graph. The Lineweaver-Burk equation (Equation 5.14) is derived from taking 
the reciprocals of the two sides of Equation 5.13 [Price and Stevens (1999)].  
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111
+=                                                Equation 5.14 
 
Where ν is the rate of product formation, Vmax is the maximum reaction rate, Km is 
Michaelis constant, and S is the concentration of substrate. 
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Chapter 6 Materials and Methods 
Calcium phosphate gels were used in this study for the storage and release of enzymes, 
and drugs of therapeutic value in bone defects. In addition to standard methods that were 
used to characterise gels throughout, in each result chapter, there is a section to describe 
experimental methods, specific to each study. 
 
6.1 Physicochemical characterisation of calcium phosphate gels 
The calcium phosphate gels were routinely characterised using a range of analytical 
techniques, including X-ray diffraction (XRD), Fourier transform infrared spectroscopy 
(FTIR), dynamic vapour sorption (DVS), mercury porosimetry, helium pycnometer, laser 
diffraction, scanning electron microscopy (SEM), transmission electron microscopy 
(TEM), X-ray photoelectron spectroscopy (XRP), and X-ray fluorescence spectroscopy 
(XRF).  
 
6.1.1 X-ray diffraction (XRD) 
Before characterising the samples by XRD, they were ground using a pestle, and motor. 
Then, the sample was placed between two pieces of magic tape (3M, Berkshire, UK) on 
the sample holder, which was fixed in the X-ray diffractometer (D5000, Siemens-Nixdorf, 
Münich, Germany). XRD data were collected in the 2θ range 5-60º with a step-size of 
0.02º and a step time of 0.5 s, using monochromatic CuKα radiation with a wavelength of 
1.54 Å from a Ge primary beam monochromator. XRD patterns were interpreted by 
comparing with model patterns on the JCPD databases.  
 
6.2 Characterisation of non-crystalline materials  
Although XRD can show the crystalline structure of calcium phosphate matrices, it gives 
little information about compounds that are present in noncrystalline form. Analytical 
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equipment such as Fourier transform infrared, X-ray photoelectron spectroscopy, energy 
dispersive X-ray spectometry, and X-ray fluorescence spectrometers are necessary to 
allow characterisation of materials regardless of crystallinity. In this section, all 
spectrometers mentioned above are detailed.   
 
6.2.1 Fourier transform infrared spectroscopy (FTIR) 
FTIR analysis was performed using a Thermo electron corporation FTIR spectrometer. 
There were two methods to prepare samples in this study. Each of calcium phosphate gels 
was ground using a pestle and a motor. Then the specimen was placed to cover the 
diamond crystal cell of a smart orbit (NICOLET 380, Thermo Electron, Madison, USA) 
and acquired with a spatial resolution of 1.929 cm-1, and 32 scans in the absorbance mode 
at a resolution of 4 cm-1 in the wavenumber range of 400-4000 cm-1. The background was 
collected before the measurement of each specimen. The spectra were automatically 
corrected by the software, OMINIC 32 (Thermo Electron, Madison, USA). The other 
method was prepared by weighing 4 mg of powdered sample of silicon substituted 
calcium phosphate gels and mixing with 300 mg of potassium bromide (IR spectroscopic 
grade, Sigma-Adrich, Germany). The mixture was tableted into 13 mm in diameter and 
100 µm in thickness using a uniaxial pressure of 30 MPa with an aluminium holder. 
 
6.2.2 X-ray photoelectron spectroscopy (XPS) 
XPS generally uses X-rays from AlKα, or MgKα which has respectively binding energies 
of 1200 eV, and 1486 eV. XPS can analyse to a surface depth of 1 µm to 3 nm. The 
results are presented as a graph of intensity (or counts per second) versus kinetic energy, 
EK (or binding energy, EB). In this study, XPS data were obtained using AlKα radiation 
(10kV, base pressure 1.8×10-8 Torr). All spectra were collected at constant pass energy of 
50 eV from a sample of 13.05 mm in diameter, and 130 µm in thickness. High-resolution 
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spectra of the C(1s), Ca(2p), P(2p1), O, Si(2s) and S(2p) core levels were collected at 50 
eV with calcium phosphate samples. As apatite is an insulator, the spectra were shifted to 
higher binding energy because of the accumulation of positive charge on the surface. The 
XPS spectra in this thesis were calibrated by referencing to Ca(2p) at 346.6 eV, and all 
peaks were shifted by a binding energy of approximately 4 to 5. 
 
6.2.3 Energy dispersive X-ray spectroscopy (EDS) 
The specimens were ground and placed on a conducting carbon tag (Agar Scientific, 
Essex, UK ) on an aluminium stub with 20 mm diameter and 6 mm thickness (Agar 
Scientific, Essex, UK). As calcium phosphate gels are inherently non-conducting, the 
specimens cannot allow electrons generated by the incident electron beam to escape. 
Consequently, the quality of images was reduced due to charging of materials. This was 
addressed by introducing a conducting layer to diminish charging. A thin layer of carbon 
(Agar Scientific, Essex, UK) with 8-10 mm in thickness was deposited on each sample, 
requiring 3 min using a sputter coater (Polaron, TB, UK). Once the samples were 
sputtered with a carbon film, the image was acquired using a scanning electron 
microscope (FEI Philips XL30 ESEM-FEG, Oregon, USA) operated at an accelerating 
voltage of 10 kV, spot size between 6 and 7 and a working distance of 10 mm. The INCA 
system (Oxford, Bucks, UK) was used to determine the weight percentage of chemical 
compositions. The spectrum is shown as histograms of X-ray energy; the intensity of 
each peak in the histogram is increased with an increase quantity of an element being 
analysed 
 
6.2.4 X-ray fluorescence spectroscopy (XRF) 
The calcium, phosphorus, silicon, and sulphur content of the apatite powders in this study 
were determined using Rh Kα by X-ray fluorescence spectroscopy (Bruker S8 TIGER, 
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Coventry, U.K.). The powdered calcium phosphate gels were pelleted manually to a size 
of 12.8 mm diameter and 1.8 mm thickness with a die of 13 mm in diameter (Specac, 
Kent, England) by a hydyaulic press of 30 MPa (Graseby Specac, Kent England). 
Elements from beryllium (atomic number of 4) to uranium (atomic number of 92) can be 
analyzed. The spectrum is plotted as the fluorescent intensity versus concentration of an 
individual element using quantitative analysis in comparison to a standard calibration of 
known compositions. Generally, the fluorescence intensity corresponds positively to the 
concentration of elements; however, this relationship may not be linear due to the 
interaction of the radiation with individual elements. Fluorescence can measure samples 
with concentrations in the range of 0.1 to 100 %, and trace elements of per millions range 
[Müller (1972)]. 
 
6.3 Dynamic vapour sorption (DVS) 
It is important to know the specific surface area of calcium phosphate gels as they 
influence the encapsulation efficiency of biomolecules. In addition, it helps us to 
understand the effect of different preparation methods on the calcium phosphate gels. In 
this work, octane was used for determination of specific surface area rather than nitrogen 
gas because of chemical inertness, and it allows working at ambient temperature.  
 
6.3.1 BET analysis of specific surface area  
Specific surface area can be calculated by the value of monolayer capacity, derived from 
a Type II isotherm, which results from the physical adsorption of gases. The monolayer 
capacity can be described as the amount of molecule adsorbate entirely arranging as a 
monolayer on the surface of 1 g of the solid. It pertains to the specific surface area of 1 g 
of solid and can be expressed as a simple equation (Equation 6.1). 
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LanA mm ××=                                                 Equation 6.1                                                                                                          
 
where A is the specific surface area, nm, moles of adsorbate per gram of adsorbent, am is 
the average area occupied by adsorbate in the monolayer, and L is the Avogadro constant. 
 
Brunauer, Emmett, and Teller adapted the Langmuir equation (Equation 6.2 by 
simplifying assumptions to which is now known as the BET equation (Equation 6.3) 
[Malvern Ltd. manual. 2004].  
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Where n is moles of the adsorbed molecules on 1g of adsorbent; nm is the monolayer 
capacity; p is the pressure; a1 is the condensation coefficient; κ is a constant from kinetic 
theory of gases; q1 is the isosteric heat of adsorption; zm is the number of sites per unit 
area; ν1 is the oscillation frequency of the molecule in a direction normal to the surface. 
 
After simplifying three assumptions: Among all layers except the first layer (1) the heat 
of adsorption is equal to the molar heat of condensation; (2) the evaporation condenstion 
conditions are identical, that is ν2 =ν3=…νi, a2=a3=…ai; (3) when p=p0 (p0, saturated 
vapour pressure), the adsorbed molecules condense to a bulk liquid on the surface of the 
solid, Equation 6.2 was derived to Equation 6.3 [Gregg and Sing (1982)]. 
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The specific surface areas exhibited by the calcium phosphate gels were determined by 
applying the Brunauer Emmet Teller (BET) equation to data collected using a dynamic 
vapour sorption (DVS) system (Advantage II, Surface Measurement Systems, Middlesex, 
UK) using octane (Mw 114.23 g mol-1) as the probe molecule with 64 Å2 effective 
molecular area. The control panel for solvent was setup to open loop. The powdered 
specimens were loaded into the sample holder, connecting to the automatically weighing 
system in the microbalance module. A sample was dried out by automatically controlling 
the three stages in preheat method at temperature of 25 °C, and at a percentage of initial 
mass (dm/dt) of 0.1 %/min for each stage of 3 h. The partial pressure (PP) was then 
increased from 0 (start PP) to 96 (stop PP) % at 3 % increments for 30 min in time stage 
type, held in a stream of dry nitrogen (BOC, Birmingham, UK) at a total gas flow rate of 
100 standard cubic centimetres (sccm), and post sequence of 50 sccm. The reported 
surface area is the average of three measurements. 
 
6.4 Particle size characterisation 
In this section, particle sizing was used to evaluate the effect of various drying regimes 
on the microstructure of CaP gels, and whether the surface of calcium phosphate gels 
were successfully modified with sulphhydryl groups. The particle size is generally 
measured by either image analysis, for example light microscopy, scanning electron 
microscopy, transmission electron microscopy or laser diffraction. In this section, relative 
methods of particle size measurement are outlined, including how images and data were 
acquired in this study.  
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6.4.1 Particle size measurement 
The particle size of the CaP gel samples was measured by using the high performance 
particle sizer MS2000 (Malvern Instruments Ltd., Malvern, UK) at 25 ˚C. To maximise 
accuracy, it is important to consider the refractive index of the sample and the dispersed 
solvent into the calculation of particle size distribution that is input into standard 
operation procedure. The sample was prepared by dispersing 1 mg of the powdered CaP 
gel in 100 mL of distilled water. The refractive index of the HA was set at 1.629 
[Mastersizer 2000 Malvern Ltd. (2000)]. Ultrasonic treatment (Nickel electro LTD., 
Somerset, England) was applied for the dispersion solution for 15 min before each 
measurement to avoid aggregation. 0.2 µL of suspension was transferred to a 1.6 mL 
disposable polystyrene cuvette (Fisher scientific, Loughborough, UK). The particle size 
measurement was performed in three successive steps, and each measurement lasted for 
40 min. 
 
6.4.2 Scanning electron microscopy (SEM)  
SEM can image and analyse the surface of specimens by interaction between specimens 
and electrons. The morphology of CaP gels was observed using the SEM. The specimens 
were prepared using the same procedure as the EDS. However, instead of coating with 
carbon film, a gold film was used to analyze the image of CaP gels. A thin layer of gold 
with 8-10 mm in thickness was deposited on each sample, requiring for 3 min using a 
sputter coater (Polaron Range, SC7640). Once the samples were sputtered with a gold 
film, the image was acquired using a scanning electron microscope (FEI Philips XL30 
ESEM-FEG, Oregon, USA) operated at accelerating voltages of 10 kV, spot size between 
6 and 7 and working distance of 10 mm. 
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6.4.3 Transmission electron microscopy (TEM) 
The size and morphology of crystals in CaP gels were evaluated using a TEM (FEI 
Philips TECNAI F20, FEI, The Netherlands) at accelerating voltage of 200 kV. A drop of 
the sample solution, prepared by dispersing the CaP gels into distilled water was placed 
on a 400 mesh carbon film copper grid (Agar Scientific, Essex, UK), and the liquid was 
allowed to evaporate. 
 
6.4.4 Fluorescence and light microscopy  
A drop of the fluorescent containing SiHA with sulphhydryl solution was placed on a 
glass slide (VWR International LTD., Sussex, UK). The image was taken using a 
fluorescent and light microscope (Carl Zeiss, Oberkochen, Germany) equipped with a 
100-W mercury lamp with a LP 590 filter (Carl Zeiss, Oberkochen, Germany) as a light 
source, and a CCD camera (Canon PC 1049, Tapan, Japan) with 320×240 pixels 
processed with Powershot G5 software (Carl Zeiss, Germany). The overall magnification 
can be calculated by eyepieces 10×20, and objective A20PLL 400 µm (160/0.17). The 
reticule (Pyser-SGI limited, Kent, UK) from 1000 to 100 µm was used to evaluate the 
size of particles.  
 
6.5 Porosity characterization 
The strength of CaP gels is highly dependent on pore structure. Also, given that the CaP 
gels incorporated biomolecules, the porosity of the gels change the released rate of drugs 
or enzymes. Therefore, in this part, two methods and principles of porosity evaluation are 
detailed. One is pycnometry which was used to determine the true density of CaP gel 
matrices; the other measures porosity through mercury intrusion.  
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6.5.1 Helium pycnometry 
The true density is defined as the mass of the solid divided by the volume of the solid 
excluding open and close pores. A gas pycnometer is commonly used to measure the true 
volume and density by monitoring the difference of pressure from replacement of gas by 
a solid. As Figure 6.1 shows, there are two chambers. A solid sample with unknown 
volume is placed into a sealed sample chamber with known volumes. The ideal gas law, 
PV = nRT is applied to evaluate the unknown volume (cm3) where P is the absolute 
pressure of gas (Pa), n is the number of gas molecules (moles), T is the temperature of the 
system (K), and R is the gas constant (8.314 J K-1 mol-1). The initial condition can be 
described mathematically by Equation 6.4. 
 
nRTVPVVP rrxss =+− )(                                         Equation 6.4                                                                                     
 
where Vx is the unknown volume (cm3), Vs is the volume of a sealed chamber, and Vr is 
the volume of a reference chamber. The pressure of a sample chamber is Ps (Pa), and the 
pressure of a reference chamber is Pr. 
 
After the valve is opened, the condition can be described by Equation 6.5. 
 
nRTVVVP xrssys =−+ )(                                          Equation 6.5 
 
Where Psys is the pressure of the system after the valve is opened.  
 
Following rearrangement of Equation 6.4 and Equation 6.5, they can be simplified to 
Equation 6.6.  
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The accuracy of the gas pycnometer depends on the sample and analysis gas whether they 
are free from moisture. Helium is generally used for analysis gas because of its small 
atomic diameter (100 pm) [Webb (2001)]. 
 
 
Figure 6.1 A diagram of a gas pycnometer. A sample with unknown volume is sealed 
in the sample chamber. The pressure of a sample chamber is measured after sealing. 
Then, a valve between the two chambers is opened and the pressure of the system 
permits to equilibrate. The volume of the unknown sample is determined by the 
ideal gas law, PV=nRT. 
 
400 mg of solid samples were weighed using an electronic scale (Mettler Toledo, 
Switzerland). The specimen was placed into 1 cm3 chamber of helium pycnometry 
ACCU-PYC ΙΙ 1340 for the measurement of the density (Micromeritics, Georgia, U.S.). 
The purge filling pressure was at 19.5 psig at 21 °C for each cycle. The volume of the 
sample was determined by filling the chamber with 99.99997 % of pure helium gas (BOC, 
Birmingham, UK) at an equilibration rate of 0.005 psi/min. The density was the average 
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value of ten measurements, following ten purges, and ten cycles. Also, the average value 
was presented with standard deviation. 
 
6.5.2 Relative porosity calculation 
The relative density was calculated by the ratio of the apparent density (ρa, g cm-3) to true 
density (ρt, g cm-3). The apparent density was determined by measuring the mass of 
sample (g) divided by the volume (cm3) as calculated from the dimensional measurement, 
in accordance with Equation 6.8. The relative porosity (P) is defined as follows: 
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−=                                               Equation 6.7 
                                                                                         
6.5.3 Mercury porosimetry 
Mercury porosimetry is a technique developed to measure the pore size within a range of 
macropore. Since mercury is a non-wetting liquid with contact angle of 140˚, an excess 
pressure is needed while liquid mercury intrudes into the pores of a solid. Washburn 
firstly brought the idea of using mercury intrusion to determine the pore size, and 
founded an equation, namely Washburn’s equation (Equation 6.8) as shown in Figure 6.2.  
 
p
r p
∆
−=
θγ cos2
                                                Equation 6.8 
 
where rp is the radius of the pore in cylindrical shape, pHg is the pressure of mercury in 
the liquid phase, pg is the pressure of mercury in the gas phase. 
 
Equation 6.8 is a special case of the Young Laplace equation, which may be expressed as 
the Equation 6.9. 
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Since the meniscus is a segment of a sphere, θcos21 prrr ==  and ∆p ( ppp gHg ∆=− ) 
is the pressure generated from mercury intruding into a cylindrical pore of radius, rp.  
 
The Euqation 6.9 by replacing the above parameters is rearranged as the Washburn 
equation (Equation 6.8). 
 
 
Figure 6.2 Mercury intruding into a cylindrical pore. The pore size is measured by 
intruding mercury into pores of solids. As the contact angle of mercury with solids is 
140 ˚, an excess pressure is required to force mercury into the pores. 
 
The mercury intrusion method is used to characterise the microporosity of CaP gels by 
the mercury porosimeter (AutoPore IV 9500, Micromeritics, U.S.A). The instrument 
measures pore from 6 nm to 360 µm in diameter in two pressurised systems: low pressure, 
and high pressure. The equilibration time of low pressure and high pressure is 10 s. The 
density of mercury at 25 °C is 13.5335 g cm-3 at surface tension of 485 dynes cm-1. For 
low pressure, mercury can intrude in the pores of a material with interconnections from 
atmospheric pressure at 14.7 psi to 25 psi whereas for high pressure, it must be applied to 
penetrate through small interconnections at 30 psi to 30,000 psi. Upon different type of 
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penetrometers, various amounts of CaP gels between 900 mg and 400 mg were loaded 
into the penetrometer (920-61710-01 powder 5 mL-1.1 mL 920-61716-01 powder 3 
mL-1 mL, and 920-61715-01 solid 3 mL-1 mL Micromeritics, Georgia, U.S.A). The 
amount of mercury used for intrusion can be examined for the total volume of pores, and 
bulk density. According to the bulk density, and pore volume, the skeletal density can be 
determined. In addition, based on the incremental intrusion (%) versus pore diameter 
curves, the distribution of pores and interconnecting pores were evaluated. Furthermore, 
the voids and pores in the samples can be distinguished from the graph of incremental 
intrusion (%) versus pressure.  
 
6.6 Surface characterization 
The interaction energy of particles results from the electrical charges of surfaces on the 
particles. Zeta potential is usually the parameter used to characterise the charge, potential 
distribution across the interfacial region [Hunter (1981)]. 
 
6.6.1 Zeta potential measurement 
Zeta potential measurements were performed on the Malvern instrument (Malvern, UK). 
The zeta potential was averaged from 10 measurements. The sample was prepared by 
suspending HA particles in 10 mL of distilled water and the pH of the suspension was 
adjusted to 7.4 by 100 mM hydrogen chloride solution. 
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Chapter 7 The influence of ageing on the 
physicochemical properties of calcium phosphate 
gel
 
7.1 Introduction 
The sol-gel process has been widely used in the production of ceramic materials [Liu et al. 
(2001), Jillavenkatesa and Condrate Sr (1998), Hsieh et al. (2001)]. It is of interest here 
as it is a processing methodology that can be undertaken at room temperature. As such it 
can be used for the encapsulation of temperature-sensitive therapeutic molecules [Gupta 
and Kumar (2008)]. The physicochemical properties of gels vary, depending on 
parameters such as the types of precursors, pH of gel formation, and ageing processes. 
These variables may cause secondary phase formation, varying pore structure, and 
particle size.  
 
The pore structure of calcium phosphate (CaP) matrices is most important because of its 
relevance to drug delivery [Teller et al. (2007)], enzyme storage [Gupta et al. (2009)], 
and the infiltration of bone cells [Venugopal et al. (2008)]. Generally, the sol-gel process 
can be divided into two steps: one is the formation of liquid sol; the other is the 
transformation of sol to a solid gel. Numerous studies have attempted to design porous 
structures from a sol. It had been shown that it is possible to increase the porosity through 
gel-casting using agarose [Potoczek et al. (2009)]. Some researchers have even used 
porogens to produce a hierarchical porous structure [Sánchez-Salcedo et al. (2008)]. In 
addition, Yokogawa et al. have reported that heat treatment during drying resulted in 
variation in particle size, and specific surface area of hydroxyapatite [Zhang and 
Yokogawa (2008)]. Previous work has also reported that freeze drying influences 
mechanical properties [Lu et al. (1998)].  
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In this study, various ageing regimes have been applied to process the CaP gels. The gels 
were each stored in different conditions for a set period of time in order to allow 
precipitation of secondary phases and the resulting maturation of the gel microstructure.  
Since it has previously been reported that adjusting conditions during the first stage of gel 
formation [Hench and West (1990)] has the most significant influence on microstructure, 
immediately following gel formation, the samples were stored at different relative 
humidity until no further mass change was noted. The resulting materials were 
characterised using XRD, XRF, EDS, helium pycnometry and mercury porosimetry. 
 
7.2 Calcium phosphate (CaP) gel preparation 
There were two different types of CaP gels used in this study, one made with and the 
other without carbonate ions. Barralet et al. (2002) have previously reported that the use 
of carbonate ions in CaP gels enables the storage of albumin for a period of 52 weeks 
without damage to the encapsulated proteins. Barralet et al. (2002), however, did not 
investigate how carbonate addition influenced the microstructure of the resulting material. 
Since carbonate substitution is known to have a significant influence on crystal 
morphology, it was anticipated that incorporating carbonate into the crystal lattice may 
have a significant influence on pore structure. In the present work the physicochemical 
properties of CaP gels made with carbonate addition, were compared with those made in 
the absence of carbonate. The following section details the methods used for the 
fabrication of the different CaP gels. 
 
7.2.1 Hydroxyapatite (HA) preparation 
To precipitate hydroxyapatite, a burette (Fisher Scientific, Loughborough, UK) was filled 
with 500 mL of 130 mM tri-ammonium phosphate (Rose Chemicals, London, UK). This 
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phosphate solution was then added at the rate of 830 µL/min to 500 mL of 210 mM 
calcium acetate (Sigma-Aldrich, Gillingham, UK) solution, whose pH value was adjusted 
to 12 by the addition of 35 % aqueous ammonia (Fisher scientific, Loughborough, UK).  
The resulting precipitate was washed five times with double distilled water (DDW) by a 
centrifuge (Jouan C422 Thermo, Madison, USA) at 4000 rpm for 10 minute. The pH of 
the suspension was then adjusted to pH 7.4 by the addition of 100 mM hydrochloric acid 
(Fisher scientific, Loughborough, UK). The suspension was filtered through Whatman 
No. 1 filter paper (Fisher Scientific, Loughborough) in a Büchner funnel, connected to a 
water aspirated vacuum pump to form a gel. A manufacturing flow diagram of the 
process is shown in Figure 7.1. 
 
Figure 7.1 Manufacturing flow diagram for CaP gels. The tri-ammonium phosphate 
solution was added into the calcium acetate solution. Then, the mixture was 
repeatedly washed in double distilled water and centrifuged. The final suspension 
was filtered using the Büchner funnel, connected to a water aspirated vacuum 
pump.  
 
To evaluate the influence of the ageing regime on the physicochemical properties of the 
precipitate the CaP was aged during the first stage of gel formation using different 
protocols. The ageing conditions were: 1) a relative humidity (RH) of 70 % by exposing 
the CaP to an ambient condition, which is open to air and the temperature is at 25 °C 
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(CaP xerogel); 2) an RH of 0 % by freeze drying the sample (Edwards, Sussex, England) 
(CaP cryogel); 3) an RH of 85 % by leaving CaP on a piece of wet cotton wool enclosed 
with a Büchner funnel (CaP xerogel); and 4) an RH of 100 % by storing the CaP in a 
sealed container above water (CaP xerogel). The details of the ageing conditions are 
summarised in Figure 7.2. The humidity of each condition (except 0 % RH) was 
quantified using a hygrometer. The time to equilibration is the sum of the time of ageing 
and the time of drying.  
 
 
Figure 7.2 Conditions under which gels were processed during the first stage of 
processing. CaP gels at (a) RH of 70 %; (b) RH of 0 %; (c) RH of 85 %; (d) RH of 
100 %. 
 
7.2.2 Carbonated hydroxyapatite (CHA) preparation  
The carbonate substituted hydroxyapatite (CHA) was made following the method 
described by Barralet et al. (2002). Briefly, 130 mM tri-ammonium orthophosphate and 
320 mM sodium hydrogen carbonate (Fisher scientific, Loughborough, UK) (solution A) 
were poured into a 50 mL burette and dropped at 830 µL/min to 210 mM calcium acetate 
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(solution B), adjusted to pH 12 using 35 % aqueous ammonia. The volume ratio of 
solution A to solution B was 1:1. The resulting precipitate was washed five times with 
double distilled water by a centrifuge at 4000 rpm after which the pH of the CHA 
suspension was corrected to pH 7.4 using 100 mM hydrochloric acid solution. The 
suspension was then filtered through Whatman No. 1 filter paper in a Büchner funnel, 
connected to a water aspirated vacuum pump. Then, the CHA was aged using the same 
protocols as the HA (section 7.2.1).  
 
7.3 Results 
7.3.1 The influence of humidity on gel composition – HA 
Gel crystalline component 
The XRD patterns of the HA gels aged at different RH following processing all showed 
the presence of an apatitic phase with characteristic peaks at 26° and 32° 2θ (Figure 7.3). 
The relative breadth of the peaks suggested that the apatite which was formed was of low 
crystallinity. Except the gel aged at an RH of 0 %, crystalline impurities were formed in 
all samples with evidence of calcite peaks in the range 40° to 52° 2θ. At an RH of 100 %, 
not only calcite was present but also an impurity phase with a peak at 34° 2θ, which 
could have been octacalcium phosphate (OCP), which is known to form at the pH values 
employed in this study.   
 
Composition regardless of crystallinity 
The chemical composition was further characterised using FTIR spectroscopy. The FTIR 
spectra (Figure 7.4) revealed that phosphate groups of HA were present as indicated by 
the splitting of the ν3 band (stretching vibrations) at 1029, and 1092cm-1. In addition, the 
stretching vibration (ν1 band) of the phosphate group was present at 963 cm-1. The 
bending vibrations (ν4) of phosphate groups were evident at 603, 563, and 470 cm-1. 
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Changing ageing conditions did not have a significant influence on the FTIR spectra, 
however, there was evidence of carbonate present in the HA xerogels and HA cryogel at 
872 cm-1.   
 
 
Figure 7.3 X-ray diffraction patterns of the HA gels at RHs %. The peaks of the 
apatite phase are labelled as (□); calcite as (●); OCP as (∆).  
 
Figure 7.4 FTIR spectra of the HA gels at different RH %. The phosphate groups 
were present in the range 963-1092, and 470-603 cm-1. Peaks indicative of CO32- 
were present at 872 cm-1.  
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To further quantify the chemical compositions of the HA gels, EDS (Table 7.1), and XRF 
(Table 7.2) were used to determine the Ca/P ratio of the gels. The EDS indicated, that the 
Ca/P ratio of the HA cryogel (1.52) and that of the HA xerogel (1.58) were less than the 
stoichiometric value for hydroxyapatite (1.67) but the HA xerogel at either RH of 85 % 
(1.99) or 100 % (1.86) by EDS was greater than might have been expected (Table 7.1). 
As compared with EDS, the HA cryogel (1.68) and the HA xerogel (1.65) at RH of 85 % 
were close to stoichiometric values (1.67) as measured by XRF (Table 7.2). Some 
deviation from the stoichiometric Ca/P might be expected, due to the presence of the 
CaCO3 impurities in the samples. 
 
Table 7.1 Elemental analysis of HA gels by the energy dispersive spectrometer (EDS) 
[one measurement]. 
 
Table 7.2 Elemental analysis of HA gels using the X-ray fluorescence (XRF) [one 
measurement]. 
Relative Humidity % 
Ca weight 
(%) 
P weight 
(%) 
Other weight 
(C,O,H) (%) 
Ca/P  
mole ratio 
0 35.8 18.3 45.9 1.52 
70 37.7 18.5 43.8 1.58 
85 39.3 19.7 41.0 1.99 
100 35.5 19.1 45.4 1.86 
Relative Humidity % 
Ca weight 
(%) 
P weight 
(%) 
Other weight 
(C,O,H) (%) 
Ca/P  
mole ratio 
0 35.0 16.0 49.0 1.68 
70 31.1 15.2 53.7 1.58 
85 34.7 16.3 49.0 1.65 
100 43.6 17.0 39.4 1.99 
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7.3.2 The effect of ageing conditions on gel microstructure - HA 
As the RH % was increased, the true density of HA gel generally increased from 2.50 ± 
0.01 g cm-3 at an RH of 0 % to 2.74 ± 0.01 g cm-3, except at an RH of 85 % (Table 7.3). 
Interestingly, the true densities exhibited by the HA gels were approximately 79 %-86 % 
theoretic density of HA (3.156 g cm-3), suggesting the presence of a low-density 
amorphous calcium phosphate phase. The relationship between specific surface area and 
ageing conditions is shown in Figure 7.5. The higher the RH in which the sample was 
aged, the higher the specific surface area of HA gels, which is commensurate with the 
longer period of time allowed for reprecipitation to occur. At an RH of 0 %, the specific 
surface area was 62 m2 g-1. With an increase in RH from 0 to 100 %, there was almost a 
two fold increase in specific surface area to 109 m2 g-1. 
 
Table 7.3 The effect of relative humidity on the physicochemical properties exhibited 
by HA gels: true density, relative porosity, and mean particle size.  
a: The calculation of relative porosity is detailed in section 6.5.2.  
 
Relative 
Humidity (%) 
True Density  
(g cm-3) 
Relative 
Porositya (%) 
Mean 
Particle Size 
(nm) 
Time to  
equilibration 
(h) 
0 2.50 ± 0.01 - 369.4 ± 11.0 24 
70 2.62 ± 0.01 41 ± 5 565 .0 ± 21.9 96 
85 2.57 ± 0.01 30 ± 5 585.0 ± 4.4 792 
100 2.74 ± 0.01 36 ± 4 595.4 ± 91.2 768 
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Figure 7.5 The relationship between ageing condition and the specific surface area 
exhibited by the HA gels. As the relative humidity of storage was increased, so was 
the specific surface area exhibited by the gel. 
 
The particles of HA gels were easily aggregated. Therefore, the particle size of HA gels 
as determined using the particle sizer was larger than the actual crystals. An increase in 
RH resulted in an increase in the particle size of the sol (Table 7.3). The mean particle 
size of HA xerogels was from 565 to 595 nm in the range of RH % at 70 to 100 whereas 
the mean particle size of the HA cryogel at the RH of 0 % decreased to 369 nm. The 
particles were homogeneously distributed in the HA gels (mono modal distribution), 
other than the HA xerogel at RH of 70 % which exhibited a bimodal distribution (modal 
values of 50 nm and 800 nm) (Figure 7.6 (a)-(d)).  
 
Crystal size was also determined by examining a sample using TEM. TEM images 
indicated that varying the ageing conditions resulted in a significant change in crystal 
morphology and size (Figure 7.7 (a)-(d)). In the case of the gel aged at 70 % RH, the 
crystals were acicular and approximately of length 70 nm and width 5 nm and distributed 
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evenly throughout the sample (Figure 7.7 (a)). At an RH of 0 %, the crystals comprising 
the gel were considerably shorter and broader than those aged at 70 % RH exhibiting 
approximately a length of 50 nm and a width of 20 nm (Figure 7.7 (b)). Although the HA 
xerogel at an RH of 85 % exhibited crystals of similar length to the HA xerogel aged at 
an RH of 70 %, the crystals were of a rod shape and approximately of width 10 nm 
(Figure 7.7 (c)). The crystals of HA xerogel at an RH of 100 % were rod shaped and 
about 80 nm in length and 3 nm in width (Figure 7.7 (d)). The influence of ageing 
conditions on the morphology of the HA crystals may provide an explanation for the 
large variation in specific surface area (Figure 7.5) when the samples were formed using 
different ageing conditions. 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.6 The influence of RHs on particle size distributions at (a) 70 % (HA 
xerogel); (b) 0 % (HA cryogel); (c) 85 % (HA xerogel); (d) 100 % (HA xerogel). The 
mean particle size of HA xerogel (ab. 565 nm) was larger than the size of the HA 
cryogels (ab. 369 nm). 
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Figure 7.7 The effect of RHs on the morphologies of crystals precipitated at (a) 70 % 
(HA xerogel); (b) 0 % (HA cryogel); (c) 85 % (HA xerogel); (d) 100 % (HA xerogel). 
The crystals were in rod shape with various sizes. 
 
7.3.3 The influence of ageing on pore structure - HA 
The porosity exhibited by the HA gels was influenced by the ageing conditions that were 
employed and the relative porosities exhibited by the gels ranged from 30 to 41 % (Table 
7.3). The variation in values, however, was well within the variability of the 
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measurements, as indicated by relatively high standard deviations. It is worth noting that 
due to excessive shrinkage in the freeze dried samples, it was impossible to accurately 
determine the porosity from geometrical measurements. One interesting observation was 
that the porosity determined from the geometrical measurements was considerably less 
than that measured by means of mercury porosimetry (57 to 70%; Table 7.4 (a)).  
 
The pore size distribution as determined using mercury porosimetry showed that each of 
the gel samples contained a relative large proportion of pores of diameter >10 – 100 µm 
(Figures 7.8). In the case of the sample that was freeze dried, there was also evidence of 
pores of approximately 11 nm and 60 nm in diameter. When the gels were stored at 70 % 
RH, pores of around 11 nm in diameter were no longer apparent in the structure, although 
a similar population of pores of diameter around 60 nm were evident in the samples. In 
the samples aged at 85 % RH, the smallest pores apparent in the sample again increased 
in size to >100 nm. Interestingly, when aged at 100 % RH, although no pores of 60-500 
nm were present, there was a population of pores of diameter 5-10 nm. The formation of 
these pores is further evidence for reprecipitation in the gel structure. 
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Table 7.4 Characterisation of pore structure of HA gels (a) total pore volume, skeletal 
density, and bulk density; (b) porosity, median pore diameter, and total pore area at 
different relative humidity % of ageing methods.  
 
 
(a) 
Relative Humidity % 
Porosity 
(%) 
Skeletal Density 
(g cm -3) 
Bulk Density 
(g cm-3) 
0 69.88 ± 5.60 2.48 ± 0.35 0.74 ± 0.19 
70 57.59 ± 2.94 2.18 ± 0.25 0.92 ± 0.04 
85 56.85 ± 3.65 2.08 ± 0.20 0.90 ± 0.16 
100 63.74 ± 6.62 2.73 ± 0.45 1.01 ± 0.35 
(b) 
Relative Humidity % 
Total Intrusion 
Volume (cm3 g-1) 
Median Pore 
Diameter (nm) 
Total Pore Area 
(m2 g-1) 
0 0.94 ± 0.51 32.90 ± 10.75 93.11 ± 7.54 
70 0.62 ± 0.01 19.05 ± 9.26 26.39 ± 5.63 
85 0.64 ± 0.16 16.41 ± 6.07 22.25 ± 20.00 
100 0.69 ± 0.30 11.75 ± 0.35 123.18 ± 39.18 
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Figure 7.8 Mercury Intrusion curve of the HA gels at RH of 0 %; RH of 70 %; RH of 
85 %; RH of 100 %. The larger voids were distributed from 300 to 360 µm, and the 
interstitial pores were in the ranged of 9 nm to 100 nm. 
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7.3.4 The influence of humidity on gel composition - CHA 
Gel crystalline component 
As might be expected, the XRD patterns collected from the samples made using solutions 
containing carbonate ions showed peaks indicative of a poorly crystalline apatite phase 
(Figure 7.9). In addition to apatitic peaks, the diffraction pattern of the CHA exhibited 
peaks that were indicative of the presence of calcite at 29º 2θ and 37º to 50º 2θ, as might 
be expected given the large excess of carbonate ions in the reaction medium. Interestingly, 
however, the calcite phase was not present at RHs of 0 % and 100 %. Further 
investigation of carbonated groups in the CHA gels was carried out through the FTIR 
analysis. 
 
Figure 7.9 X-ray diffraction patterns of CHA gels at RH of 0, 70, 85, and 100 %. The 
peaks of apatite phase at 26º and 32º 2θ are labelled as square (□); calcites at 29º, and 
37º to 50º 2θ as (●).  
 
Composition regardless of crystallinity 
The carbonate band of ν2 vibrations from carbonate of the CHA was evident at 875 cm-1 
(Figure 7.10). In addition, other distinctive peaks for carbonate could be seen at 1409 and 
1486 cm-1, which were indicative of the ν3 vibrations. The phosphate (PO4-3) of the 
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apatites were in the ranges of 560-605 and 950-1100 cm-1. The predominant phosphate 
peaks at 1023 cm-1 were due to ν3 vibrations. A small peak at 960 cm-1 resulted from ν1 
vibrations of phosphate. There were also broad split phosphate peaks indicative of ν2 
vibrations and ν4 vibrations at 561 and 603 cm-1 when the gels were formed at RHs of 85 
and 100 %. In contrast, when the RH was either 0 or 70 %, the phosphate peak of ν4 
vibrations was diminished. These spectra of the CHA were in agreement with the XRD 
patterns. These spectra showed that the CHA formed was the B-type CHA since the peak 
at 873 cm-1 was not present, corresponding to an earlier study [Lee et al. (2006)]. 
However, there was no distinct evidence to show either the increase of carbonate groups 
or the decrease of phosphate groups with the humidity.  
 
Figure 7.10 FTIR spectra of CHA gels at different RHs % of ageing regimes. The 
carbonate groups exhibited peaks at 875, 1409, and 1486 cm-1, resulting from 
different vibration modes. In addition, the phosphate groups mainly present 
approximately at 1023 cm-1, and 561 cm-1. The position of carbonate groups 
suggested that the precipitate was a B-type substituted CHA. 
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EDS and XRF were used to quantify the Ca to P ratio of CHA gels after the addition of 
carbonate. Both results indicated that CHA gels were calcium rich HA as the Ca/P ratio is 
over 1.67 (Table 7.5, and Table 7.6). However, there was no positive relationship 
between RH % and Ca/P ratio. After heating the CHA xerogels formed at an RH of 70 % 
to 1300˚C, the weight loss of carbonate and water was 21.7 wt% and 12.5 wt%, 
respectively which meant the remaining contained 65.8 % of CaPs. The entire combined 
amount of calcium and phosphate were between 55.4 wt% and 64.3 wt% according to the 
EDS, and XRF, corresponding to 65.8 %. The excessively high Ca/P ratios exhibited by 
the gels are suggestive of the formation of a large proportion of a calcium-rich phase, 
such as calcium carbonate, in the gel matrix. 
 
Table 7.5 Elemental analysis of CHA gels by the energy dispersive spectrometer 
(EDS) [one measurement]. (Carbonate was neglected because of the carbonated 
coating) 
 
 
 
 
 
 
Relative 
Humidity % 
Ca weight (%) P weight (%) 
Other weight 
(C,O,H) 
(%) 
Ca/P mole 
ratio 
0 23.8 11.9 64.3 1.99 
70 38.9 6.5 54.6 4.66 
85 20.0 11.1 68.9 1.81 
100 40.1 15.5 44.4 2.59 
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Table 7.6 Elemental analysis of CHA gels by X-ray fluorescence (XRF) [one 
measurement]. 
 
7.3.5 The influence of humidity on gel microstructure - CHA 
The true density was 74-83 % of the theoretical density of HA (3.156 g cm-3). The value 
of the CHA cryogel was slightly different from the HA cryogels produced in this work. 
As Table 7.7 (a) indicates, the true density of CHA cryogel (2.35 g cm-3) was lower than 
the HA cryogel (2.50 g cm-3). The true density of the CHA xerogel at an RH of 100 % 
(2.43 g cm-3) was also less than the true density of the HA xerogel at the same RH %. 
There was no difference in the true densities of the CHA xerogels at the RH of 70 % and 
85 % as compared to the HA xerogels at those RHs. The true densities of the CHA 
xerogels at the RH of 70 % and 85 % were respectively 2.63 and 2.51 g cm-3 (Table 7.7 
(a)).  
 
In contrast to that of the HA gels, the specific surface area of CHA gels did not increase 
with an increasing in ageing period. The specific surface area of CHA xerogels at RH of 
70 % and 85 % was 42 and 43 m2 g-1, respectively which was considerably smaller than 
the HA xerogels at the same RH (98-126 m2 g-1) (Figure 7.5). However, the CHA xerogel 
at RH of 100 % (276.9 m2 g-1) was twice as much as the HA xerogel at RH of 100 % (109 
m
2
 g-1). As the specific surface areas of the CHA gels were decreased, the particle sizes 
Relative 
Humidity % 
Ca weight (%) P weight (%) 
Other weight 
(C,O,H) 
(%) 
Ca/P mole 
ratio 
0 44.5 10.9 44.6 3.16 
70 41.4 10.7 47.9 2.99 
85 36.0 15.6 48.4 1.81 
100 41.2 10.3 48.5 3.08 
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were increased. On the other hand, the particle size of CHA xerogels at RH of 100 % 
decreased while its specific surface area was raised (Table 7.7 (b)). 
 
Table 7.7 The effect of carbonate on the physicochemical characterisation of HA gels:  
(a) true density, and relative porosity; (b) specific surface area, and mean particle 
size. 
 
The mean particle size of the CHA gels was larger than the HA gels (Table 7.3 and Table 
7.7 (b)). The mean particle size of the CHA xerogel at an RH of 70 % was 961 nm where 
42.1 % of particles were dispersed between 712 and 955 nm (Figure 7.11 (a)). As an RH 
was increased to 85 %, 53.5 % of particles were dispersed in the range of 400 nm to 900 
nm (Figure 7.11 (c)), and the mean particle size of the HA xerogel at RH of 85 % was 
reduced to 669 nm. When the RH was 100 %, the particle size of the CHA xerogel with 
mean size of 312 nm was largely distributed (97 %) between 200 and 400 nm as Figure 
7.11 (d) shows. However, the particles of CHA cryogels with mean size of 536 nm were 
(a) 
Relative Humidity 
(%) 
True Density  
(g cm-3) 
Relative Porosity 
% 
Time to  
equilibration (h) 
0 2.35 ± 0.01 - 24 
70 2.63 ± 0.01 47 ± 4 96 
85 2.51 ± 0.01 30 ± 6 192 
100 2.43 ± 0.01 50 ± 11 1008 
(b) 
Relative Humidity 
(%) 
Mean Particle 
Size (nm) 
Specific surface 
area (m2g-1) 
Time to  
equilibration (h) 
0 536.3 ± 124.4 48.3 ± 4.6 24 
70 961.0 ± 7.0 42.3 ± 1.6 96 
85 669.1 ± 18.6 43.1 ± 9.7 192 
100 312.1 ± 98.7 276.9 ± 33.7 1008 
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bimodal distribution in which 17.7 % of particles distributed around 459 nm, and 12.3 % 
around 122 nm (Figure 7.11 (b)).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.11 The effect of carbonate substitution on the particle size distribution of 
HA gels (CHA) at RH of (a) 70 %; (b) 0 %; (c) 85 %; (d) 100 %.  
 
Figure 7.12 shows that the crystals of the CHA gels were in various rod shapes with a 
small size approximately from 14 nm in length and 50 Å in thickness to a large size from 
50 nm in length and 42 nm in thickness. In comparison with HA gels, as expected, the 
addition of the carbonate resulted in a distinct reduction of the crystal size. The CHA 
xerogel at an RH of 70 % was around 50 nm in length and 10 nm in thickness (Figure 
7.12 (a)). As the RH was increased to 85 %, the sizes of crystals were approximately 
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from 20 to 50 nm in length and 1 to 3 nm in thickness as the Figure 7.12 (c). When RH 
was 100 %, the crystals of the CHA xerogels were grown to four times in thickness as 
much as the CHA xerogels at RH of 70 % (Figure 7.12 (d)). After reducing to RH of 0 %, 
the CHA cryogel exhibited rod-like crystals of around 70 nm in length and 1 nm in 
thickness (Figure 12 (b)).  
 
 
Figure 7.12 TEM micrographs of carbonate substituted HA gels (CHA gels) at RH of 
(a) 70 %; (b) 0 %; (c) 85 %; (d) 100 %. 
 
98 
7.3.6 The effect of carbonate on the porosity-CHA 
The relative porosity of the CHA xerogels varied from 30 to 50 %, which was a slight 
increase when compared with that of the HA gels (30 to 41 %).The relative porosity of 
the CHA gels was reduced from 47 % to 30 %, at RHs of 70 % and 85 %, respectively 
(Table 7.7 (a)).  
 
By comparison, the porosity of CHA xerogels (42 to 54 %) at RHs in the range of 70 to 
100 % was lower than that of the HA gels (56 to 63 %). However, the porosity of the 
CHA cryogel (81 %) was higher than the HA cryogel (70 %). The porosity was decreased 
with the increasing RH % as illustrated in Table 7.8 (a)-(b). The larger voids of the CHA 
gels were ranged between 10 and 1000 µm, but the interstitial pores were primarily at the 
range of 10 and 100 nm except the RH of 85 % (Figure 7.13).  
 
Unlike the HA gels, the median pore diameter of the CHA gels were decreased with the 
increasing RH. Interestingly, the median pore diameter of the CHA xerogel (27.5 nm) at 
RH of 70 % was nearly 1.5 times as much as the HA xerogels (19.0 nm). However, there 
was no difference in median pore diameters at other RHs after the addition of carbonate 
in the HA gels. In addition, it did not cause the high porosity of the CHA xerogel at RH 
of 100 %, in comparison to the HA xerogel without carbonate.  
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Table 7.8 The influence of carbonate on the pore structures of HA gels: (a) porosity, 
skeletal density, and bulk density; (b) total intrusion volume, median pore diameter, 
and total pore area. 
 
 
 
 
 
 
 
 
 
(b) 
Relative 
Humidity % 
Total Intrusion 
Volume (cm3 g-1) 
Median Pore 
Diameter (nm) 
Total Pore Area 
(m2 g-1) 
0 2.20 ± 0.92 36.15 ± 19.73 66.05 ± 1.72 
70 0.85 ± 0.05 27.45 ±0.92 37.56 ± 1.30 
85 0.53 ± 0.14 17.15 ± 13.36 7.89 ± 1.49 
100 0.42 ± 0.27 10.30 ± 1.13 59.48 ± 25.78 
(a) 
Relative 
Humidity % 
Porosity 
(%) 
Skeletal Density 
(g cm -3) 
Bulk Density 
(g cm-3) 
0 81.37 ± 6.63 2.15 ± 0.03 0.40 ± 0.14 
70 54.01 ± 19.00 1.59 ±1.07 0.63 ± 0.19 
85 50.05 ± 6.66 1.93 ± 0.01 0.96 ± 0.13 
100 42.74 ± 17.17 2.01 ± 0.04 1.15 ±0.35 
100 
 
Figure 7.13 Mercury Intrusion curve of the CHA gels at RH of 0 %; RH of 70 %; RH 
of 85 %; RH of 100 %. 
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7.4 Discussion 
7.4.1 The effect of ageing on the formation of the CaP gels 
The physicochemical properties exhibited by CaP gel were strongly related to sol-gel 
processing conditions. The drying process is particularly an important step for gels 
formed from the liquid sol (shrinkage) as it has been demonstrated that the pore structure 
of the gel is heavly dependent upon capillary pressure generated during the drying stage. 
Also, during drying, a continuous increase in capillary pressure forces the particles to 
rearrange, and dissolution-reprecipitation phenomena may occur within the gel. This 
dissolution-reprecipitation can result in the formation of impurity phases or can form 
necks between the particles, enhancing mechanical integrity [Brinker and Scherer (1990)]. 
In the study, the various RHs were used to control the duration of the first stage of drying 
process. The generated capillary pressure of gels from the drying process was decreased 
as the duration of the first stage increased. Different RHs in drying regimes were 
designed to control the extent of these phenomena: capillary pressure forces and 
dissolution-reprecipitation, during processing.  
 
By placing the gels into different RH environments, the period of ageing time available 
for dissolution-precipitation reactions to occur and the rate of evaporation were adjusted. 
In the first falling rate period (second stage) of drying process where shrinkage stops, the 
gel matrices can be hetergeneous because the liquid containing solutes (e.g., phosphates) 
evaporate at the surface causing the precipitation of a different phase [Brinker and 
Scherer (1990)]. The RH decides how long the dissolution-reprecipitation can occur and 
the rate of evaporation of liquid during the ageing process. Despite the significant change 
in processing, the XRD patterns of the CaP gels showed that an apatitic phase was 
formed in all conditions. This suggests that the different RHs in the drying regimes did 
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not interfere with the formation of the apatite, although impurity phases of OCP and 
calcite were detected in some cases. The presence of peaks indicative of calcite in the 
‘non-carbonate’ containing gels may be attributed to the surface adsorption of carbonate 
to calcium phosphate phase. This is in agreement with the FTIR spectra, which showed 
the presence of phosphate groups of apatitic phases and a trace amount of carbonate. 
Although there was no calcite present at an RH of 0 % in the XRD patterns, the 
absorption of carbonate groups were displayed in FTIR analysis, implying the presence 
of amorphous calcite in HA gels, or the adsorption of carbonate onto the surface of the 
samples post-processing. In addition, small quantity of OCP appeared in the HA xerogel 
when aged at an RH of 100 %. The formation of trace amount of OCP in CaP gels at high 
RH might result from OCP being thermodynamically more stable than HA. Moreover, 
the solubility of OCP is higher than HA and is a metastable phase formed during the 
precipitation of a range of biominerals. OCP, therefore, is often present as a transient 
intermediate during precipitation from aqueous solutions [Dorozhkin (2007)]. As 
expected, the CaP gels were poorly crystalline, and were formed from submicrometer 
crystals more akin to those found in the body than with sintered ceramic monoliths.  
 
Previous studies have reported that the ageing is responsible for the formation of pure 
apatite [Liu et al. (2001), Liu et al. (2002), Hsieh et al. (2001)], but have not evaluated 
the influence of changing process conditions. This is of significant importance since the 
the interaction between calcium and phosphate ions during processing determines 
composition and therefore gels of different Ca/P ratios may be formed. The EDS and 
XRF results (Table 7.1 and Table 7.2) showed different Ca/P ratios of the HA gels 
formed at various RH %, implying that chemical compositions are related to the RH %, 
which was not apparent from XRD. This may suggest the formation of X-ray amorphous 
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impurity phases, the presence of which was also suggested by the lower true density of 
the ceramic than would be expected for apatite. Theoretically, the calcium deficient HA 
would be formed in this study as the pH of sol mixture at 7.4 is below 9. However, it was 
found that only HA xerogels produced at RH of 70 % were calcium deficient HA as 
shown by the measured Ca/P ratio (1.58). It must be noted, however, that the formation 
of calcium rich phases such as CaCO3 within the ceramic matrix could increase the Ca/P 
of the HA gel to higher than would be representative of the apatite phase within the gel. 
 
7.4.2 The effect of ageing on the microstructure of HA gels 
The true density of HA gels (2.5 to 2.7 g cm-3) is considerably lower than the calculated 
density for stoichiometric HA (3.16 g cm-3). This suggests that an amorphous calcium 
phosphate phase is present, as suggested by the large background apparent on the XRD 
pattern. The pore structure is also responsible for the low true density of the HA gels. As 
a new bonding was continuously formed during shrinkage in the drying process, the pore 
volume, and surface area of gels vary [Brinker and Scherer (1990)]. It has demonstrated 
that the shrinkage leads to the changes of the relative porosity, specific surface area, and 
particle size produced by the different drying behaviours (Table 7.3). While it is unlikely 
that any of the pore structure was not permeated by the helium gas, any hermetically 
closed porosity would have led to the measured values for true density being lower than 
expected. 
 
Given that the volume of the HA gels following shrinkage (~12 to 18 %) was the same 
for each RH %, the shrinkage rate is considerably increased while the RH % is low. 
Because the RH % is low, the equilibration is reached more quickly. The stiffness of the 
network depends on the amount of shrinkage occurring during the drying process, as the 
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growth of necks improves the strength of the gel network [Brinker and Scherer (1990)]. 
In addition, the generated capillary pressure at lower RH is higher than that at high RH. 
At high RH %, the capillary pressure produced when water is expelled from the gel 
network is less than at low RH %. The low capillary pressure may result in the formation 
of a dense and strong gel network, and the precipitation of a secondary phase within the 
pore structure. This may explain why as the RH % was increased, the relative porosity of 
the HA gels was reduced (Table 7.3). Also, the true densities of HA gels (Table 7.3) were 
lower than the theoretical density of HA.   
 
7.4.3 A comparison of porosity as determined by calculation and 
measured by mercury porosimetry 
The results of mercury intrusion porosimetry would suggest that a network of 
interconnected pores was present within the CaP gel matrix. The presence of such a pore 
network in CaP gels has previously been demonstrated to improve bone in growth [Omae 
et al. (2006)]. The relative porosity as determined from geometrical measurements and 
the true density of the samples was not in accordance with the porosity by mercury 
porosimetry (Table 7.3 and Table 7.4 (a)). This disparity in values may be due to the 
presence of closed pores in the CaP gels. The total porosity by mercury porosimetry was 
evaluated by the skeletal density, and bulk density (Table 7.4 (a)). Unlike helium, 
mercury cannot intrude pores with small volume. Unless, there were no closed pores in 
the HA gels, the skeletal density would be in accordance with the true density. However, 
the skeletal density was slightly lower than the true density, suggesting that the HA gels 
may have blind pores. Therefore, the open porosity determined by mercury porosimetry 
was greater than that determined from geometrical measurements and the true density of 
the samples.  
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The proportion of porosity closed to penetration by mercury can be evaluated by 
subtracting the skeletal volume from the true volume, and then dividing by the true 
volume. There were 16 % and 19 % of closed pores present in HA xerogel at RH of 70 %, 
and 85 % respectively. In addition, irregular aggregation of CaP gel particles as shown in 
the TEM images (Figure 7.7) contributes to the accuracy of the skeletal volume. The 
irregular aggregation of CaP gel particles may contribute to the large voids between 
particles in the HA gels. Figure 7.8 shows that mercury intruded the ceramic structure 
even at the low pressure, which suggested the presence of large voids. 
 
Excluding the reasons mentioned above, the difference of porosity produced by the 
different RH might also result from the pore size and numbers of pores. The HA gels tend 
to have small median pore as the RH % is increased, again likely because of 
reprecipitation of a secondary phase within the pore structure. Because of the large pore 
diameter of the HA cryogel (32.9 nm), the porosity (70 %) is increased. Although the 
pore diameter of the HA xerogel (11.7 nm) at RH of 100 % was less than half of that of 
the HA cryogel, the greater number of pores existing results in the high porosity (64 %, 
Table 7.4 (a)), and the increased intrusion volume (0.69 g-1mL), compared with the other 
two drying regimes (Table 7.4 (b)). It is also a possibility that in some samples, pores 
were present that were below the detection limits of the instrument. 
 
The TEM images (Figure 7.7 (a)-(d)) revealed irregularly shaped crystals, which may be 
responsible for a deviation between the real pore diameter and the calculated value by 
mercury porosimetry. Since the Washburn’s equation is based on the assumption of 
spherical particles and cylindrical pores, this might cause the reduced accuracy of 
evaluation of the pore size of these irregular crystals, which explains why the specific 
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surface area measured by DVS (Figure 7.5) is not directly comparable with the total pore 
area measured by mercury porosimetry (Table 7.4 (b)). In addition, the total pore area did 
not increase with the reducing median pore diameter, which resulted from heterogeneous 
aggregation of particles and the subsequent pore structures.  
 
7.4.4 The effect of carbonate on the formation of HA gels 
After the addition of carbonate ions in addition to the apatitic phase, some of CHA gels 
also exhibited peaks in the XRD pattern indicative of calcite (Figure 7.9). In some 
samples there was no crystalline calcite present (0 and 100 % RH) but adsorption peaks 
were present on the FTIR spectra (Figure 7.10) that were indicative of the presence of 
carbonate groups, which may suggest that an X-ray amorphous calcite phase was present.  
 
The alteration of compositions with ageing condition was shown by the massive 
fluctuation in Ca/P ratios. As expected, the incorporation of carbonate ions resulted in the 
increasing of Ca/P ratio (Table 7.5 and Table 7.6). However, there was no positive 
relation between the RH % and Ca/P ratio. The extremely high Ca/P by EDS of the CHA 
xerogel at RH of 70 % may be as a result of heterogeneity within the ceramic matrix and 
the formation of as much as 19.40 wt% of calcite (as determined from the stoichiometric 
equation) in the gel matrix. The addition of carbonate ions to the precipitation may also 
explain the changes in the true density exhibited by the gel. As the density of calcite is 
2.71 g cm-3, it might cause the reduction of the true densities.  
 
The total intrusion volume of the CHA gels at RH of 100 % between 10 and 100 nm was 
not as much as that of the HA gels (Figure 7.13), suggesting that the porosity of the CHA 
xerogel at RH of 100 % was attributed to large voids. The larger pore size of the CHA 
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gels compared with the HA gels may be explained by the comparatively large size of 
calcite crystals reducing the efficacy of crystal packing. The presence of closed pore 
volume can be evaluated by the difference of the skeletal density and the true density. 
The result showed that 39.54 % of the pores present in the CHA xerogel at RH of 70 % 
were closed. As the RH was increased, the closed pore volumes were reduced, excluding 
the CHA cryogel. There were 23.1 % and 17.28 % of closed pores, respective of RH of 
85 % and 100 %. However, at RH of 0 %, the volume of closed pores was reduced to 8.5 
%.  
 
Carbonate substitution results in reduction in the crystal size of the apatite when 
compared with HA gels, corresponding to a previous study [Barralet et al. (1998)]. The 
small size and irregular shape of the crystals causes loose aggregatation of particles, 
resulting in both increasing particle size and volume of closed pores (Table 7.7 (a)-(b), 
and Table 7.8). As the TEM images showed, the crystals of the CHA xerogel at RH of 70 
% were the smallest and less irregular among all drying regimes, which imply strong 
adhesion between crystals. It has been demonstrated that the RH of the drying process of 
gels results in different chemical compositions. In addition, the calcium phosphate gels 
exhibited distinguished pore structures at certain RHs.  
 
7.5 Conclusion 
The effect of ageing on the physicochemical properties of calcium phosphate gels has 
been demonstrated. The various chemical compositions were dependent on RHs. The 
micro porous structures of CaP gels variously created by controlling the RH of drying 
procedures were significantly increased with respect to specific surface area, particle size, 
and open porosity. The differences in composition and microstructure can be attributed to 
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the formation of secondary phases such as calcite and the dissolution-reprecipitation 
reactions which can occur during ageing. It has shown that, to some extent, it is possible 
to control the pore size exhibited by CaP gels, simply by controlling process conditions
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Chapter 8 Comparing the efficacy of calcium 
phosphate based matrices for the release of 
vancomycin hydrochloride 
 
8.1 Introduction 
Bone related infections such as osteomyelitis, which causes a loss of blood supply to the 
infected bone and spreads to adjacent tissues, are complications associated with open 
fractures and the placement of implants. Methiciline-resistant Staphylococcus aureus 
(MRSA) are the most refractory pathogens capable of causing such infections, and it is a 
major challenge to prevent infection during the surgical procedure. The treatment of 
osteomyelitis typically requires the removal of the injured tissue; however, bacteria are 
not thoroughly eradicated by debridement, and so the systemic administration of an 
antibiotic may also be required [Riggs et al. (1992)]. Vancomycin hydrochloride (VH) is 
an antibiotic that is specifically used against Staphylococcus aureus (S. aureus) in the 
treatment of bone related infections. In order to achieve the desired antibacterial effect, it 
is necessary to supply a relatively high dose for example, 500 mg to 5 g [Shinto et al. 
(1992), Korkusuz et al. (1993), Baker et al. (1988)], which can lead to both nephro- and 
ototoxicity [Saito et al. (2002), Carvalho Vila et al. (2007)]. A number of researchers 
have investigated the use of synthetic materials to allow the localised administration of 
VH to avoid systemic toxicity, which are capable of maintaining a bactericidal dose 
locally without systemic exposure. A local drug delivery system is advantageous because 
it is thought to decrease the systemic toxicity and side effects of parenteral antibiotics and 
it may also improve efficacy by delivering higher drug concentrations to infected bone 
[Radin (1997), Radin (2001)]. 
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Poly(methyl methacrylate) (PMMA) beads or cements have been investigated widely for 
the localised delivery of VH [Vecsei and Barquet (1981), Habraken et al. (2007)], 
however, as they are non-resorbable following implantation, a second surgery is required 
to remove the beads following treatment. Furthermore, the highly exothermic 
polymerisation reaction of the PMMA cements has been shown to diminish the 
bactericidal efficacy of VH following an implantation [Gautier et al. (2000a)]. As a result, 
workers have focused on the development of degradable materials such as plaster of Paris 
[Dahner and Funderburk (1987)], fibrin [Zilch and Lambiris (1986)], poly (lactic acid) 
[Kanellakopoulou et al. (2000)], and hydroxyapatite (HA) [Saito et al. (2002), Habraken 
et al. (2007), Palazzo et al. (2005)]. The successful application of which would negate the 
need for a second procedure. Calcium phosphate (CaP) based materials such as HA, 
β-tricalcium phosphate (β-TCP), biphasic calcium phosphate, and dicalcium phosphate 
dehydrate-brushite in particular, have shown promise in their ability to locally deliver a 
therapeutic dose of bactericidal drugs [Radin et al. (1997), Palazzo et al. (2005), Xu et al. 
(2007), Kim et al. (2005), Stigter et al. (2004), Gbureck et al. (2008)]. 
 
Due to their compositional similarity to the mineral component of bone, CaP based 
ceramics have been used widely for the replacement of hard tissues [Barralet et al. (2002), 
Komlev et al. (2002)]. The first embodiment of HA used as a hard tissue replacement was 
supplied as a sintered ceramic monolith [Monroe et al. (1971)]. Although well tolerated 
following implantation in the body and able to form a bond with both hard and soft 
tissues, the monolithic nature of the graft replacement meant that preoperative knowledge 
of the defect was required prior to surgery, which limited clinical application. This major 
limitation led to the development of a range of technologies intended to widen clinical 
application by solving problems associated with manipulation.   
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Currently, CaP based bone graft replacements are supplied as granules [Komlev et al. 
(2002), Seshima et al. (2006)], carvable blocks [Shinto et al. (1992), Saito et al. (2002), 
Itokazu et al. (1998)], composites [Korkusuz et al. (1993), Tampieri et al. (2001), 
Suchanek and Yoshimura (1998)] and cement materials [Joosten et al. (2005), Gbureck et 
al. (2005a), Gbureck et al. (2007), Hamanishi et al. (1996)]. CaP cements (CPCs) have 
received significant attention as they are plastic following the combination of the powder 
and liquid components and can either be moulded to the irregular defects frequently 
encountered in orthopaedic and craniofacial surgery or can be applied in a minimally 
invasive manner using a hypodermic needle [Gbureck et al. (2005b)]. In addition, the 
majority of cement setting reactions proceed with only a minor exothermic and can 
proceed in ambient conditions, meaning that temperature sensitive molecules such as 
growth factors and some drugs can be incorporated into the cement matrix without the 
risk of thermal degradation.   
 
As a result, some studies have reported the delivery of bone morphogenic proteins 
[Gammill and Sive (2000)], VEGF [Lode et al. (2007)] and nanomicelles [Itaka et al. 
(2007)] from hardened cement matrices with significant success. Furthermore, a number 
of research groups have investigated the local delivery of antibacterial drugs such as 
vancomycin from CPCs for the prophylactic treatment of implant related infections. 
Although there is little change in the temperature of CPCs during setting, there can be 
significant fluctuations in the pH of the setting cement slurries, which it is hypothesised, 
can have a marked influence on the eventual potency of drugs such as vancomycin.   
 
In this study, the effect of pH on the release properties of a tetracalcium phosphate 
(TTCP)/dicalcium phosphate anhydrate (DCPA) cement system, the pH of which can 
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reach values of ~10 during setting, and a carbonated substituted HA (CHA) xerogel, 
which can also be processed at room temperature but with little or no fluctuation in pH 
were investigated. The release mechanisms of these calcium phosphate based materials 
were explored using the Higuchi and Peppas models and the efficacy of the released drug 
was determined using the broth dilution method. 
 
8.2 Drug release in vitro study 
8.2.1 Encapsulation of vancomycin chloride release  
The CHA xerogel was manufactured in accordance with the method of CHA xerogel 
formed at an RH of 70 %, described in the section 7.2.  
 
HA cements were made by mixing equimolar quantities of TTCP and DCPA (Merck, 
Germany). TTCP was prepared by sintering an equimolar mixture of DCPA 
(Mallinckrodt-Baker, Griesheim, Germany) and calcium carbonate (Mallinckrodt-Baker, 
Griesheim, Germany) at 1500 °C for 18 h followed by quenching in air. The cake was 
crushed with a pestle and mortar so that it would pass through a 355 µm sieve. The 
powder was milled in agate jars in a dry state to a median particle size of 10-15 µm. 
DCPA was ground in ethanol for 24 h to a median particle size of 1-2 µm. The cement 
was mixed to a powder to liquid ratio of 3.5 g cm-3.     
 
Vancomycin hydrochloride, VH (Sigma-Aldrich, Louis, USA) was mixed with the CHA 
xerogel, and HA cement in the ratio 200 mg gel to 1 mg VH. The mixture of CHA 
xerogel with VH was then homogenised within a nitrile mixing vessel, which 
subsequently resulted in the formation of a sol containing 0.5 wt% VH. After the VH had 
been loaded into the samples, cylindrical samples with final dimensions of approximately 
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diameter 6 mm and height 10 mm were fabricated using a 5 mL syringe. The samples 
were then dried in ambient conditions. The cement sample was then formed into 
cylindrical samples of around diameter 6 mm and height 12 mm in a PTFE split mould. 
The cement samples were then allowed to harden for a period of 24 h in ambient 
conditions before further study. 
 
CaP based materials loaded with and without VH were immersed in 15 mL of 100 mM 
tris-buffered saline (pH 7.4) (Fisher Scientific, Loughborough, UK). All samples were 
placed on a horizontally rotating shaker at 90 rpm in the 37 ˚C environment. At each set 
time point (0.5, 1, 2, 4, 7, 24, 48, 72, 96, 120, 144, and 168h) 7 mL of eluent was 
withdrawn from VH-containing CHA xerogel/HA cement and control CHA xerogel/HA 
cement. The eluent was then stored at -4 ˚C before VH content was determined. After 
each withdrawal, the elution medium was refilled with 7 mL of tris-buffered saline. 
 
8.2.2 Vancomycin hydrochloride release in vitro study 
VH release was monitored by measuring the absorbance of the elution medium at 280 nm 
using a UV-visible spectrophotometer. VH concentration was determined from the 
average of three absorbance readings using a corresponding calibration curve (0.05-0.2 
mg/mL), expressed in terms of mg of VH per mL of tris-buffered saline. To minimise any 
potential interference from the calcium and phosphate ions in solution, corresponding 
control CaP based materials at each time point were used to baseline the data. After the 
elution period, each sample was dissolved in 20 mL of 3 wt% 
ethylenediaminetetraacetatic acid tetrasodium salt hydrate (Na4-EDTA) (Sigma-Aldrich, 
Gillingham UK) to release any residual VH within the CaP based materials. The 
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concentration of the resulting solution was calculated by the calibration curve based on a 
VH- Na4-EDTA solution. 
 
8.2.3 Microbiological activity assay 
Agar diffusion 
The effectiveness of the VH loaded HA cements and CHA xerogels was measured by 
agar diffusion. S. aureus (0.9×106 cells/mL) was grown in tryptone soya broth (OXOID, 
Hampshire, England) and cultured on nutrient agar (OXOID, Hampshire, England) with 
~ 0.2 g of each sample placed in the centre of the agar plate. The zones of bacterial 
inhibition were recorded and compared with the inhibition zones of cements and gels 
without VH.  
 
Broth dilution 
The antibacterial activity of VH released from the CaP based materials was analysed by 
the broth dilution method, using which the minimum inhibitory concentration (MIC) of 
VH is 1 µg mL-1 [Dion et al. (2005)] determined by recording the drug concentration that 
inhibited visible growth of S. aureus (ATCC 29523, NCIMB, Aberdeen, UK). A bacterial 
culture was prepared prior to conducting the assays by introducing Müeller-Hinton broth 
(OXOID, Hampshire, England) with S. aureus, and allowing the bacteria to proliferate 
overnight in an incubator at 37 ˚C. Then 4 mL of Müeller-Hinton broth with S. aureus 
was withdrawn into 10 mL of Müeller-Hinton broth, corresponding to approximately 1×
106 CFU/mL. A VH-containing sample was added into the Müeller-Hinton broth with S. 
aureus at a 1:1 ratio. A bijou containing 500 µL of Müeller-Hinton broth with S. aureus 
served as a positive control and a negative control was prepared only with 500 µL of 
Müeller-Hinton broth. All samples were incubated at 37 ˚C for 16-24 h. Antibacterial 
activity was determined by the lack of turbidity of the sample. Antibacterial activity 
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assays were conducted for both control samples and CaP based materials loaded VH 
samples at each time point (see page 131).  
 
8.3 Result 
8.3.1 Physicochemical properties of calcium phosphate materials 
After setting, the TTCP/DCPA cement was shown to form a matrix that consisted 
predominantly of HA with some un-reacted TTCP (Figure 8.1). The broad peaks at 32º 
2θ were indicative of the presence of a poorly crystalline apatitic phase. The diffraction 
pattern for brushite cement exhibited peaks distinctive of brushite (~20º, 23º, 29º, 30º, 33º, 
35º, 37º, 39º 2θ) with a small quantity of unreacted β-TCP (Figure 8.1). As expected, the 
diffraction pattern for the CHA xerogel exhibited an even broader and less defined peak 
of apatite at ~32º 2θ (Figure 8.2). In addition to the broad peak which indicated the 
presence of apatite, the diffraction pattern for the CHA xerogel exhibited calcite peaks at 
29º, 36º and 39º 2θ which suggested the calcite was formed in the xerogel matrix.   
 
Figure 8.1 X-ray diffraction patterns of the HA cement indicated that some TTCP 
remained unreacted (28˚ and 29˚ 2θ), and presence of apatite at ~32˚ 2θ. The CHA 
xerogel showed that there exhibited apatite (at ~ 32˚), and calcite (at 29-39˚). The 
peaks marked on the patterns indicated the presence of □: apatite, ●: calcite. ◊: 
TTCP. 
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The presence of carbonate ions in the CHA xerogel was further demonstrated by FTIR 
analysis (Figure 8.2), which exhibited peaks at 870 and 1412 cm-1 attributable to the ν2 
and ν3 vibrations of the carbonate molecule. The carbonate peak at 1650 cm-1 resulted 
from the surface adsorption rather than the substitution. Prior to elution, the spectra for 
the CHA xerogel contained peaks that were indicative of the presence of PO43- groups 
(562, 673 and 1016 cm-1). The hydroxyl group of the CHA xerogel was present at 600 
cm-1. The intensity of the CHA xerogel after the elution period remained relatively 
unchanged. In the case of the HA cement, the HPO42- peak at 603 cm-1 was shown to 
increase in intensity after the elution period whereas the remainder of the spectra 
remained relatively unchanged, suggesting no compositional transformation. (Figure 8.2). 
Although the VH was expected to show at 1700 to 1380 cm-1 [Radin and Ducheyne 
(2007)], the presence of carbonate was predominant in the similar range (Figure 8.3). 
Therefore, no peak indicative of VH was appeared. Encapsulation of VH in the CHA 
xerogel did not influence the chemical compositions of CHA. 
 
The specific surface areas exhibited by the HA cement, and CHA xerogel were markedly 
different. The HA cement exhibited a specific surface area of 17 ± 3 m2 g-1, whereas the 
CHA xerogel exhibited a specific surface area of 42 ± 2 m2 g-1 (Table 8.1).  
 
Table 8.1 The physical properties exhibited by the calcium phosphate based 
matrices.  
 
 
Sample 
Relative porosity 
(%) 
Specific surface area 
(m2 g-1) 
Modal pore 
diameter (nm) 
HA cement 43 ± 2 17 ± 3 
580 [Barralet et 
al.2002] 
CHA xerogel 55 ± 5 42 ± 2 
9 [Barralet et 
al.1996]] 
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Figure 8.2 FTIR spectra of the CHA xerogel and HA cement. The presence of 
carbonate of the CHA xerogel was indicated by peaks at approximately 1412 cm-1. 
The spectra of all calcium phosphate based materials indicated that the presence of 
phosphate groups at the range of 1070-1140 cm-1. In addition, the peak at 870 cm-1 of 
the CHA xerogel was indicative of the presence of carbonate groups. 
 
 
Figure 8.3 FTIR spectra of the CHA xerogel with VH. The presence of VH has not 
changed the chemical composition of CHA.  
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The HA cement exhibited a relative porosity of 43 ± 2 %, and the CHA xerogel exhibited 
a higher relative porosity of 55 ± 5 % (Table 8.1). Although the porosities of both HA 
based matrices were similar, according to literature values, the modal pore diameter of 
the HA cement (580 nm) was much higher than the CHA xerogel (9 nm).  
 
The HA cement exhibited a total porosity of 39 % less than the total porosity of CHA 
xerogel (67 %) as listed in the Table 8.2. Figure 8.4 showed that the pore size distribution 
of the CHA xerogel ranged between 12 nm and 95 nm. By comparison, the pores of the 
HA cement were distributed in the broader range of 11 nm to 1 µm (Figure 8.4). The 
skeletal density of HA cement (2.76 g cm-3) was 87.3 % of theoretical value (3.16 g cm-3). 
After loading the VH, the main pore size distribution remained in the same range as the 
CHA xerogel without VH (Figure 8.4), but minor pores were distributed at 1 µm. In 
addition, the porosity of the CHA xerogel with VH was obviously reduced to 57 % 
(Table 8.2). For the HA cement, there was a slightly change of pore size distribution, and 
porosity. The porosity was reduced to 36 % after loading the VH into the HA cement 
(Table 8.2). Moreover, both HA based matrices had similar median pore diameter (26.8 
nm for CHA xerogel, 26.4 nm for HA cement), and both median pore diameter were 
reduced half after loading VH (Table 8.2). 
 
The morphology of the CHA xerogel and HA cement was featureless although it 
indicated that the particles of CHA xerogel and HA cement were aggregated (Figure 8.5 
(a)-(b)).  
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Table 8.2 Porosity of the calcium phosphate based matrices with/without VH by 
mercury intrusion [one measurement]. 
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Figure 8.4 Mercury Intrusion curve of the CHA xerogel (black line with dot) and the 
CHA xerogel with VH (black line with hollow dot); the HA cement (grey line with dot) 
and HA cement with VH (grey line with hollow dot).   
 
Samples 
Total Intrusion 
Volume (cm3 g-1) 
Median Pore 
Diameter (nm) 
Skeletal Density 
(g cm-3) 
Porosity 
(%) 
CHA xerogel 0.88 26.8 2.34 67 
CHA xerogel 
with VH 
0.57 14.5 2.33 57 
HA cement 0.27 26.4 2.76 39 
HA cement 
with VH 
0.21 16.1 2.66 36 
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Figure 8.5 The SEM images of (a) CHA xerogel; (b) HA cement. 
 
 
121 
8.3.2 Efficacy of vancomycin release in vitro study 
The significant difference in pore size distributions of these calcium phosphate based 
materials were expected to result in distinct release profiles, with the CHA xerogel 
releasing VH at a slower rate than the HA cements. Over the first 24 h, however, VH was 
released more rapidly from the CHA xerogel than from the HA cement matrix (Figure 
8.6). Indeed, between 24 and 96 h of ageing, the VH was released significantly (p<0.05) 
more slowly from the HA cement than the CHA xerogel. After 48 h, the VH release from 
the CHA xerogel achieved a constant release rate. At the end of elution, there were 82 % 
of VH released from the CHA xerogel. 76 % of VH was released from the HA cement. 
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Figure 8.6 VH was released more rapidly from the CHA xerogel than the HA cement 
within 24 h. The cumulative release of VH (%) of the CHA xerogel was higher than 
that of VH of the HA cement after 168 h elution. 
 
8.3.3 Evaluation of vancomycin release kinetics 
The VH release kinetics were analysed using the Higuchi and Peppas models since the 
Higuchi model can adequately described the release of water soluble/low solubility drug 
incorporated in semi-solid/solid matrices. Following appraisal of the release profiles, 
Peppas derived n values (release exponent) for different diffusion conditions and shapes 
of drug were also determined. The VH release from the CHA xerogel suggested that the 
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drug release followed Fick’s law (Table 8.3). The release of VH from the HA cement, 
demonstrated a poor fit with both the Peppas and Higuchi models, suggesting either that 
the VH released from the HA cement followed more than one diffusion mechanism or 
heterogeneity within the ceramic matrix.  
 
Table 8.3 The release kinetics of VH of calcium phosphate based matrices by Higuchi 
and Peppas models. M [%]: cumulative released amount, KH: release constant, a: 
release constant, b: release exponent.  
 
8.3.4 Microbiological activity of vancomycin  
Figure 8.7 (a)-(d) shows the sizes of the inhibition zones formed around each matrix 
when the CHA xerogel and the HA cement with/without VH were placed onto a culture 
of S. aureus. HA cement showed its inhibition zone (2.67 ± 0.72 mm) was as much as the 
CHA xerogel (2.78 ± 1.13 mm), meaning there was sufficient active VH inside these 
matrices to inhibit the growth of bacteria. By comparison, the CHA xerogel without VH 
showed no bactericidal effect. However, interestingly, the HA cement control has formed 
the inhibition zone around 6.67 ± 0.54 mm (Table 8.4).  
 
Table 8.4 Comparison of the inhibition zone of CHA xerogel and HA cement 
with/without VH. 
Matrices 
Higuchi model 
M=KH×t0.5 
Peppas model 
M=a×tb 
 KH r2 a b r2 
CHA xerogel 7.39 0.98 9.78 0.44 0.98 
HA cement 4.77 0.85 3.94 0.54 0.85 
Delivery Matrix  Inhibition Zone (mm) 
Control 0 CHA xerogel 
VH 2.78 ± 1.13 
Control 6.67 ± 0.54 
HA cement 
VH 2.67 ± 0.72 
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Figure 8.7 The image of inhibition zone of (a) CHA xerogel control and (b) CHA 
xerogel encapsulated VH; (c) HA cement and (d) HA cement encapsulated VH. 
 
In the case of the CHA xerogel, the sufficient VH was released to inhibit bacterial growth 
until 72 h elution (Figure 8.8). Therefore, the release VH from the CHA xerogel in S. 
aureus was shown a transparent solution (Figure 8.9). Sufficient VH was also released for 
168 h from the HA cement following immersion (Figure 8.8). Surprisingly, however, the 
release VH from the HA cement was opaque (Figure 8.9). The VH released from the HA 
cement did not inhibit bacterial growth at any point during the elution period (Table 8.5), 
explaining the cloudy broth solution with the release VH from the HA cement. To further 
verify the assumption of the effect of pH on the microbiological activity of VH, the pH 
variation of the HA cement during setting was monitored with time (Figure 8.10). These 
results showed that the HA cement exhibited a basic pH value peaking at pH 9.4 after 5 
min.  
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Figure 8.8 Concentrations of the eluent following different periods of ageing. Also, 
included in the figure is a line representing the minimum inhibitory concentration 
(MIC) required to inhibit the growth of S. aureus.. 
 
 
Figure 8.9 The release VH from the CHA xerogel in S. aureus was as clear as the 
Müeller Hinton broth, but the release VH from the HA cement in S. aureus was 
opaque, like the broth with S. aureus.  
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Table 8.5 Summary of the results obtained from the antimicrobial assays performed 
using the VH elution from each calcium phosphate based matrices.  
 
 
Sample 
VH 
(mg cm-3) 
of Day 1 
VH 
(mg cm-3) 
of Day 2 
VH 
(mg cm-3) 
of Day 3 
VH 
(mg cm-3) 
of Day 4 
VH 
(mg cm-3) 
of Day 5 
CHA 
xerogel 
(control) 
0 0 0 0 0 
 + + + + + 
CHA 
xerogel 
loaded  VH 
0.04±0.02 0.04±0.01 0.03±0.01 0.02±0.00 0.01±0.00 
 - - - - - 
HA cement 
(control) 0 0 0 0 0 
 + + + + + 
HA cement 
loaded VH 
3.43e-3 5.51e-3 5.59e-3 9.23e-3 0.02±0.00 
 + + + + + 
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Figure 8.10 The pH variation in the HA cement during setting. The pH of cement 
paste with time was shown that the cement matrix exhibited a basic pH value peaking 
at pH 9.4 after 5 min. 
 
8.4 Discussion 
8.4.1 The effect of calcium phosphate matrices on the delivery 
antibiotics 
CaP based ceramics and composites have been investigated widely in the delivery of 
prophylactic doses of drugs following implantation. The majority of studies have 
investigated the incorporation of active molecules into ceramics following manufacture, 
since high temperatures are likely to have a derogatory effect on the activity of the 
release drug. In these systems, CaP matrices are typically impregnated with the drug by 
soaking the granules in a solution of the drug (in the presence and absence of a vacuum) 
and by dynamic compaction and isostatic compression [Gautier et al. (2000b), Itokazu et 
al. (1998), Obadia et al. (2003), Gautier et al. (2001),]. Using these mechanisms, most 
studies have demonstrated the successful delivery of gentamycin, bisphosphonates, 
polymyxin B, and VH [Komlev et al. (2002), Seshima et al. (2006), Obadia et al. (2003), 
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Gautier et al. (2000b), Stallmann et al. (2006), Kimakhe et al. (1999)] in vitro and in vivo. 
Clinically, antibiotic loaded HA blocks have been shown to be successful for the delivery 
of gentamicin sulphate/VH in the clinical treatment of implanted-associated chronic 
osteomyelitis in an animal model [Shinto et al. (1992), Korkusuz et al. (1993)]. Although 
some studies has successfully demonstrated with the adsorption of active molecules into 
preformed CaP matrices, in the most part the drugs were absorbed onto the surface of the 
implants, meaning that the drug release was rapid and difficult to control. CaP cements 
have the significant advantage of setting at ambient temperatures, which means that 
active molecules can be incorporated into the matrices during manufacture; as a result of 
the distribution of active molecules throughout the cement matrix is homogeneous.   
 
8.4.2 The effect of pH on the function of vancomycin 
This study, however, has demonstrated that although the VH can be released by a HA 
cement matrix, the released VH exhibited no bactericidal properties. The ineffectiveness 
of the VH against S. aureus can be attributed to pH fluctuations during the cement setting. 
The pH of the cement was shown to have a peak at pH 9.4 (Figure 8.10). The 
pharmaceutical literature [Antipas et al. (1994)] has demonstrated that at such high pH 
values, the asparagine residues of VH become deamidated, which diminishes its potency 
against S. aureus. Deamidation changes the conformation of VH, which in turn influences 
the ability of VH to complex N-acetylmuramic acid (NAM) and N-acetylglucosamine 
(NAG), which are essential components of gram positive bacterial cell walls [Reynolds 
(1989)]. To achieve optimum activity, the VH must form a cyclic imide intermediate. The 
formation of such an intermediate is favoured at lower pH values. At high pH values the 
structure of the polypeptide becomes less compact and as consequence the distance 
128 
between reacting atoms increases and therefore the cyclic imide intermediate is 
thermodynamically less likely to form.   
 
8.4.3 Kinetics of released vancomycin 
Interestingly, in this study, it has been found that the release of VH from the HA cement 
followed neither the Higuchi or Peppas model and therefore the matrix does not conform 
to the underlying assumptions of these models. This may result from there being so little 
water in the HA cement paste while VH was added. The trace amount of water in the HA 
cement paste might affect the even distribution of VH, and reduce the dissolution of VH. 
It is hypothesised therefore that the ceramic matrix was not homogeneous or that two 
distinct forms of the drug of different solubility were present. Indeed, the HA based 
cement contained un-reacted and basic TTCP particles which would have caused a 
distinct rise in pH in their immediate vicinity causing the formation of the less soluble 
free VH base. The presence of such basic regions within the cement matrix may explain 
why the rate of release followed neither model. 
 
8.4.4 The bactericidal effect of calcium phosphate matrices 
Although some studies have shown that similar CaP based cement formulations can 
exhibit an antimicrobial effect surrounding the cements following an implantation 
[Korkusuz et al. (1993), Gbureck et al. (2005a)], it is possible that the basic pH values 
surrounding the implant themselves inhibited bacterial growth [Gbureck et al. (2005c)] 
rather than the release of an active dose of the antibiotic. Indeed, it has previously been 
demonstrated that without VH, HA cements comprising TTCP and DCPA exhibited an 
inhibition zone in a culture of S. aureus higher than when the same material was loaded 
with VH [Jiang et al. (2008)]. This effect also has been exploited in the development of 
antibacterial cement formulations by the incorporation of potassium substitutions into the 
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cement precursors. The bactericidal effect of the cement was attributed to a local pH 
increase alone [Gbureck et al. (2005c)].   
 
8.4.5 The effect of microstructures on the release kinetics 
In addition to calcium phosphate cements, bioceramic gels can also be processed at room 
temperature and consequently they have been investigated for the delivery of heat 
sensitive molecules. They typically exhibit a higher specific surface area than cements, 
meaning that a larger quantity of drug molecules per unit mass can be adsorbed onto the 
CHA xerogels (42.3 m2 g-1, Table 7.7 (b)) than the HA cements (17.4 m2 g-1). Calcium 
polyphosphate gels, for example, have been shown to deliver VH over a period of 144 h 
in vitro [Dion et al. (2005)]. This study has demonstrated that VH could be continuously 
released from the CHA xerogels for 168 h (Figure 8.6). Radin et al. have evaluated the 
use of silica based gels in the release of a range of biologically active molecules, 
including drugs, growth factors and proteins. They have demonstrated that it is possible 
to control the release of macromolecules of >10 kDa and have concluded that the pore 
size of molecules of silica sol-gels are contributed to the release kinetics of a dextran with 
various molecular weights [Radin et al. (2008)].  
 
In this work, the CHA xerogels was used to release VH as the particle sizes of CHA 
xerogels (9 nm) [Barralet et al. (1996)] are smaller than HA cements (580 nm) [Barralet 
et al. (2002)]. Nevertheless, the data suggest that the small pore size of the ceramic 
matrix does not have a marked influence on VH release. This might be attributed to the 
spherical size of VH (5 nm2), the aggregation of VH by forming dimer, and the weak 
bonding exists between CHA xerogel and VH [Loll et al. (2000)]. In addtion, the porosity 
of CaP matrices plays an important role in the release of VH as the release rate of VH 
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was increased with the increasing porosity (Table 8.1). The VH was released faster from 
the CHA xerogel than the HA cement due to 67 % of the porosity inside the CHA xerogel 
(Table 8.2). 
 
8.5 Conclusion 
In this study it has been demonstrated that sufficient VH can be delivered from the CaP 
bioceramic matrices at sufficient concentrations to exceed the MIC for S. aureus for 168 
h. The pH in the ceramic matrix during processing is a very important consideration in 
the effectiveness of the released drug against the bacteria. In the basic cement 
formulation (pH 9.4), the VH that was delivered was ineffective against S. aureus and 
this was thought to be due to deamidation of the asparagine residues in the drug during 
the setting. The findings of this study illustrate the importance of evaluating the 
antibacterial efficacy of drugs loaded into material for in vivo drug release, rather than 
simply monitoring release. 
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Chapter 9 Calcium phosphate cryogels for enzyme 
encapsulation 
 
9.1 Introduction 
The sol-gel process has been used for the encapsulation of biomolecules in biosensors, 
and to produce carriers for the delivery of therapeutic molecules in reparative medicine 
[Jin and Brennan (2002)]. Silica gels, for example, have been successfully used for the 
encapsulation of horseradish peroxidase (HRP). They are, however, traditionally made 
using the tetraethyl orthosilicate (TEOS) or tetramethoxy silane (TMOS), which have 
been shown to be toxic and can reduce enzyme activity [Kadnikova and Kostić (2002), 
Radin et al. (2001)]. Consequently, rather than using TEOS or TMOS, some researchers 
have used sodium silicate precursors. Although this may have solved issues related to the 
toxicity of the sol-gel, loading efficiency was shown to be low [Bhatia et al. (2002), 
Masahiro et al. (2007)]. Efforts have also been made to enhance enzyme activity by the 
addition of polymers, dendrimers and sugars into the matrix of silica sol-gels with limited 
success [Lin et al. (2007), Wang et al. (2007), Miller et al. (2006), Kitsugi et al. (1995)].     
 
Although silica based materials have been shown to be tolerated in vivo, the use of toxic 
reactants and the dissimilarity of the composition to that of hard tissue, means that they 
could not form a significant bond with hard tissues [Kitsugi et al. (1995)]. In comparison, 
calcium phosphate (CaP) based ceramic materials have been used as hard tissue 
replacements and prosthesis coatings for several decades [Appleford et al. (2009)]. Since 
they share a similar composition to the mineral component of bone, they are well 
tolerated in the body and form a little understood bond with both hard and soft tissues 
[Kitsugi et al. (1993)]. Traditionally, CaP based ceramics were made by a high 
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temperature process, which precluded the incorporation of temperature sensitive 
therapeutic proteins during manufacture. The subsequent development of CaP based 
cement (CPC) materials [Brown and Chow (1983)], which set in ambient conditions, 
allowed the delivery of proteins such as bone morphogenic protein [Ruhé et al. (2004)] 
and transforming growth factor β [Kroese-Deutmana et al. (2005)].   
 
Although CPCs have been successfully used as a carrier of therapeutic compounds 
[Otsuka et al. (1994), Bohner et al. (1997)], the macroporous structure (10-100 µm) of the 
hardened product has restricted their use for the encapsulation of enzymes. By forming 
hydroxyapatite (HA) using a precipitation reaction, it is possible to manipulate process 
conditions to form a CaP based sol-gel [Barralet et al. (2002)]. In common with the 
cement hardening reaction, these sol-gel materials are formed in ambient conditions and 
with relatively little pH fluctuation. What gives them an important advantage over CPCs 
is that by controlling the rate of removal of the liquid phase, it is possible to exercise 
some form of control over pore size, thus enabling control over release rate. Previous 
work [Barralet et al. (2002)] has shown that apatite based gels can store proteins such as 
albumin for a period of 52 weeks in vitro with little undesired release from the matrix. 
 
Alkaline phosphatase (ALP) is one enzyme that has been encapsulated in glass, ceramic 
and polymeric matrices, as well as being immobilised on the surface of metallic implants 
[Nishioka et al. (2006), Beortsen and van den Bos (1992)]. ALP has been investigated 
widely as it has been implicated with the mineralisation of newly forming bone [Hessle et 
al. (2002)]. Indeed, tissue non-specific ALP (TNAP) is found on the surface of osteoblast 
membranes and is present in high concentrations in the matrix vesicles excreted from 
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these cells during the mineralisation process [Bernhardt et al. (2008)]. Recent work has 
shown that ALP functions by removing pyrophosphate ions, potent inhibitors of HA 
crystal formation, which creates localised supersaturation with respect HA and crystal 
deposition [Anderson et al. (2004)]. ALP has previously been encapsulated in TMOS 
based silica gels, although the activity of the encapsulated ALP was shown to be 
relatively low [Braun et al. (1990)]. Other studies have shown that encapsulation of ALP 
in silica based sol-gels could preserve activity, even during storage in acidic 
environments [Frenkel-Mullerad and Avnir (2005)]. In previous studies, relatively low 
ALP activity has been proposed to be as a result of poor mass transport through the 
mesoporous gel systems, low loading efficiencies and enzyme desorption. Attempts have 
been made to address the mass transport problem, through the incorporation of bimodal 
pore size sol-gel (2-3 nm/10-40 nm) [Wang and Caruso (2005)].   
 
Here, the use of a CaP based cryogel material for the encapsulation of ALP was evaluated.  
The activity of the ALP was monitored over a period of 14 days and compared with the 
activity of HRP, a model enzyme often used for evaluating the efficacy of encapsulation.  
The influence of protein incorporation into the CaP matrix during fabrication on the 
composition and pore structures of the gel material were investigated. In addition, 
Michaelis-Menten equation and Lineweaver-Burk equation were used for comparison of 
the kinetic data in the enzyme storage experiment. 
 
9.2. Horseradish Peroxidase/ Alkaline phosphatase storage  
9.2.1 Encapsulation of Horseradish Peroxidase/ Alkaline phosphatase 
The carbonate substituted hydroxyapatite (CHA) cryogel was formed at an RH of 0 % the 
same as the method described in the section 7.2 in Chapter 7.  
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For HRP encapsulation, HRP (169 units/mg, Sigma, Germany) was mixed with the CHA 
cryogel in the ratio 800 mg CHA cryogels: 2 mg HRP. The mixture was then 
homogenised within a nitrile mixing vessel resulting in CHA cryogels containing 0.25 wt 
% HRP. After the HRP had been loaded into the samples, the gels were then dried in a 
freeze drier. For ALP encapsulation 1.46 units/mg of ALP (Fluka, Gillingham, UK) were 
mixed with CHA cryogel in the ratio 97 g CHA cryogels: 3 g ALP. The mixture was then 
homogenised for 15 min in a nitrile mixing vessel the resulting apatite slurry containing 3 
wt % ALP was filtered using a water aspirated vacuum pump before freeze drying. 
 
9.2.2 Efficacy of Horseradish Peroxidase/ Alkaline phosphatase in 
vitro storage 
The amount of protein released from the CHA cryogel with ALP/HRP was determined 
using the BCA assay. According to the amount of reduction of the Cu2+ to Cu+ by protein, 
the protein can be quantified by monitoring the cuprous cation, using UV-Vis 
spectrophotometer at 562 nm [Sigma Ltd. (2001)]. The calibration curve consisted of a 
known concentration of bovine serum albumin (BSA) between 0-1000 µg/mL. The blank 
was made of a phosphate buffer with no enzyme. 100 µL of a sample/blank was mixed 
with 2 mL of the BCA working reagent. Then, the solution was incubated in the 37 ˚C 
incubator for 30 min. CHA cryogel loaded with HRP (n=3) were immersed in 10 mL of 
100 mM KH2PO4 buffer (pH 6) over a week, and control CHA cryogel were immersed in 
an identical process. All samples were placed in a horizontally rotating shaker at 90 rpm 
in a 37 ˚C environment. At selected time points between 0.5 h, and 216 h observations 
were made by collecting all released medium and refreshing the buffer after each 
withdrawal from the CHA cryogel with HRP. Then the absorbance of the ABTS [2,2’- 
azino-di-(3-ethylbenzthiazoline-6-sulphonic acid)] cation at 414 nm and the activity of 
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HRP were measured. CHA cryogel loaded with ALP (n=3) were immersed in 5 ml of 100 
mM tris-HCL buffer (pH 7.4) over a week, and control CHA cryogel were immersed in 
an identical process. At the end of immersing, each sample was dissolved in 20 mL of 3 
wt% ethylenediaminetetraacetatic acid tetrasodium salt hydrate (Na4-EDTA) to dissolve 
any residual HRP within the CHA cryogel.   
 
9.2.3 Activity of Horseradish Peroxidase/ Alkaline phosphatase 
The activity of HRP was measured based on the oxidation of 30 µM ABTS catalysed by 
2 mg HRP loaded into CHA cryogel in the presence of 9.79 µM H2O2 to the ABTS cation. 
The interconversion of ABTS (λmax=340 nm) to its radical cation (λmax=414 nm) was 
monitored using a UV-Vis spectrophotometer as a function of time. The formation of 
ABTS cation indicated the HRP activity by the appearance of a green coloured solution. 
The control experiment was performed using an equal concentration of HRP in the 100 
mM pH 6 phosphate buffer solutions under the same conditions. 
 
The activity of ALP was determined by measuring release of phosphate ions from 
pyrophosphate solutions [Xu et al. (1991)]. 5 mL of each pyrophosphate concentration 
ranging from 0-20 mM was added to 5 mL of 1U/mL ALP and then mixed. 160 µL of the 
pyrophosphate/ALP solution was sampled every 2 minutes during the reaction. Then, 330 
µL of 5 % trichloroacetic acid and 5 mM copper sulphate (Fisher scientific, 
Loughborough, UK) was added, following by the introduction of the colour reagents, 
containing 500 µL of 5 % iron sulphate and 1 % ammonium molybdate (Acros Organics, 
Loughborough, UK), and each sample was measured at 690 nm. All phosphate, 
pyrophosphate and ALP solutions were made in a 100 mM tris-HCL buffer. Possible 
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interference by phosphate release from the matrix was accounted for by measuring the 
phosphate concentration of the eluent in the absence of ALP. 
 
9.2.4 Determination of kinetic parameters  
HRP undergoes a two substrate reaction (Reduced ABTS + H2O2 → Oxidized ABTS + 
2H2O). In this study, it was assumed that 10 nM of HRP catalyses one substrate reaction 
(ABTS) varied from 5.37 µM to 50 µM by fixing the constant concentration of 9.79 µM 
of the other substrate, H2O2.  
 
9.3 Results 
9.3.1 The effect of encapsulated enzymes on the chemical structures 
of CHA cryogels  
After freeze drying, the resulting CHA cryogels were shown to consist of a combination 
of apatite, as evidenced by a characteristic peak at 26˚, and 32˚ 2θ (Figure 9.1), and 
calcite with peaks at 23˚, 29˚, 39˚, 47˚, 49˚, and 53˚ 2θ. The broadness of the peaks 
indicative of apatite suggested the formation of a poorly crystalline phase. The 
incorporation of either ALP or HRP into the CHA cryogels had no effect on the 
crystalline composition of the material (Figure 9.1).   
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Figure 9.1 X-ray diffraction patterns showing the influence of ALP or HRP addition 
on the crystalline compositions of the CHA cryogels and the addition of carbonate. 
The open circle (○) labels as apatite; the square (■) labels as calcite. 
 
FTIR spectra of the samples further confirmed that the incorporation of ALP or HRP into 
the ceramic matrix did not affect the composition of the material. Peaks present at 863, 
1415, and 1479 cm-1 were indicative of the ν2 and ν3 vibrations of carbonate ions. The 
presence of these vibrations could indicate either the presence of carbonate substitution of 
the apatite lattice or simply the presence of CaCO3 in the sample. As expected, there were 
also peaks present at 561 and 1031 cm-1, which were indicative of PO43- vibrations 
(Figure 9.2).  
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Figure 9.2 FTIR spectra of the CHA cryogels, with and without the addition of ALP 
or HRP. The addition of either enzyme to the material during processing had little or 
no influence on the final composition of the material. 
 
9.3.2 The effect of encapsulated enzymes on the microstructures of 
apatite cryogels 
Although the addition of ALP and HRP to the CHA cryogels had little influence on the 
true density of the material (Table 9.1), each true density was significantly lower (2.3 to 
2.6 g cm-3) than would be expected for calcite (2.71 g cm-3) or apatite (3.16 g cm-3). This 
may suggest the presence of an X-ray amorphous phase of lower true density than either 
of these minerals. The incorporation of the enzymes into the CHA cryogels resulted in a 
slight difference in the specific surface area exhibited by the gel material. The control 
material exhibited a specific surface area of 48.33 ± 4.60 m2 g-1, whereas the CHA 
cryogel formed in the presence of HRP exhibited a specific surface area of 53.12 ± 1.48 
m2 g-1 (Table 9.1), the specific surface area of the CHA cryogel containing ALP was 
lower than either of other materials (42.62 ± 1.55 m2g-1); although this difference could 
be attributed to variations between different batches of the materials.   
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Table 9.1 The true density, specific surface areas and particle sizes exhibited by the 
apatite from which the CHA cryogel was formed following precipitation in the 
absence of enzymes, in the presence of HRP and in the presence of ALP. 
 
The crystallite size was shown to be significantly smaller than the particle size of the 
precipitate, which consisted of blade-like crystals of approximately 100-150 nm in length 
and 20-30 nm in width (Figure 9.3A). Examination of the surface of the CHA cryogel 
illustrated the presence of very few surface features as may be expected for a mesoporous 
cryogel material (Figure 9.3B). 
 
The incorporation of the enzymes into the CHA cryogel matrix also resulted in a 
reduction in the total porosity of the final material from 81 ± 6 % for the control CHA 
cryogel to 37 ± 28 % for the CHA cryogel containing HRP (Table 9.2), but a slight 
increase in the case of the ALP loaded material (88 ± 2 %). The reduction in the porosity 
that was exhibited by the CHA cryogel was accompanied by a reduction in the median 
pore diameter exhibited by the material from 36 ± 20 nm, in the case of the control 
material, to 11 ± 1 nm following the addition of HRP to the material during processing 
(Table 9.2). The high standard deviation of the median pore diameter of the CHA cryogel 
(36 ± 20 nm) might result from the irregularly geometric structure of cryogels. However, 
the pores were mainly distributed in the range of 10 to 100 nm, which has not changed 
after the incorporation of ALP (Figure 9.4). In the case of HRP, numbers of pores with 
Sample True Density  
(g cm-3) 
Specific surface 
area (m2 g-1) 
Mean Particle Size 
(nm) 
CHA cryogel 2.35 ±0.02 48.33 ± 4.60 536 ± 124 
CHA cryogel with 
HRP 
2.53 ±0.03 53.12 ± 1.48 618 ± 17 
CHA cryogel with 
ALP 
2.59 ± 0.19 42.62 ± 1.55 436 ± 97 
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size between 70 and 20 nm were increased, in comparison to the blank CHA cryogel 
(Figure 9.4). The addition of ALP to the CHA cryogel resulted in an increase in the 
median pore diameter of the material to 56 ± 21 nm. The particle size of the CHA cryogel 
with and without enzymes was in the order of 400-600 nm in all processing conditions 
(Table 9.1). Interestingly, the CHA cryogel after loading these two enzymes had 
increased its size for encapsulation of HRP, but decreased for incorporation of ALP. As 
the total intrusion volume of mercury increased, the porosity of CHA cryogel 
with/without enzymes also was increased (Table 9.2). 
 
 
Figure 9.3 Electron micrographs showing A. the morphology of apatite crystallites 
dispersed in water prior to gel formation and B. the surface of a CHA cryogel 
following processing. 
 
Table 9.2 The influence of protein addition on the microstructure of the CHA 
cryogels, including the total intrusion volume, porosity, and median pore diameter. 
Sample Total Intrusion 
Volume (cm3 g-1) 
Porosity 
(%) 
Median Pore 
Diameter (nm) 
CHA cryogel 2.20 ± 0.93 81 ± 6 36.2 ± 19.7 
CHA cryogel  
with HRP 
0.40 ± 0.16 37 ± 28 11.3 ± 0.8 
CHA cryogel  
with ALP 
3.13 ± 0.39 88 ± 2 55.7 ± 20.5 
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Figure 9.4 Mercury intrusion of the CHA cryogel with/without enzymes. The pores 
of the CHA cryogel matrix were distributed in the range of 10 to 100 nm. The pore 
distribution of the CHA cryogel has not been changed after incorporation of ALP. 
However, there was a slightly alteration of the CHA cryogel with HRP. 
 
9.3.3 Storage efficacy of Horseradish Peroxidase/ Alkaline 
phosphatase in vitro study 
Once immersed in the elution medium, there was a burst release of HRP with 36 wt% of 
the enzyme released from the ceramic matrix within one day (Figure 9.5). After one day 
of ageing, the rate of release from the matrix slowed so that over a period of eight days of 
ageing only a further 8 wt% of the HRP was released into solution. In contrast, there was 
only a small release of ALP during the first day of ageing (10 wt%), with only 15 wt% of 
the ALP being released over a period of 10 days in solution (Figure 9.5). 
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Figure 9.5 The release of ALP or HRP from the CHA cryogel over a period of ten 
days of ageing. There was an initial burst release of HRP from the matrix, followed 
by a plateau, whereas in the case of the ALP, after the first day of ageing, there was 
little further release from the gel matrix. 
 
The activities of the encapsulated enzymes were evaluated over a period of 14 days of 
ageing. In the case of the HRP, activity was expressed in terms of the rate of ABTS+ 
production per minute. When free in solution, the rate of conversion of the ABTS to 
ABTS+ varied little and after 14 days of ageing, the HRP exhibited a rate of ABTS+ 
production of 1.2 µM/min (Figure 9.6). The production of ABTS+ catalysed by the 
encapsulated HRP was reduced initially from 0.8 to 0.1 µM/min after 2 days as shown in 
the Figure 9.6. This reduction corresponded with the rapid release of the surface bound 
enzyme. After this time point, the ABTS+ was produced at the rate of 0.22 µM/min. To 
investigate whether this reduction in activity could be attributed to mass transport 
limitations imposed by the presence of the gel, following 14 days of ageing the gel was 
crushed and the HRP released by dissolving the CHA cryogel into Na4-EDTA, and 
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quantified by the BCA assay. After release from the gel, the rate of ABTS+ production 
increased to 0.8 µM/min.  
 
The activity of ALP was assessed by the hydrolysis of pyrophosphate ions and was 
expressed as µM/min (Figure 9.6). The rate of phosphate production was higher at all 
time points for the encapsulated ALP than for the ALP that was free in solution. In the 
case of the free ALP, the rate of phosphate production could not be measured following 6 
days of ageing. In comparison, phosphate production could be measured for a period of 
12 days following encapsulation. All reported data were zeroed against the amount of 
phosphate eluted into the ageing medium in the absence of the ALP.   
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Figure 9.6 The activity of HRP expressed as the rate of production of ABTS+ with 
time. HRP was free in solution and encapsulated within the CHA cryogel matrix.  
The pyrophosphatase activity of the encapsulated and un-encapsulated ALP was 
measured over a period of twelve days of ageing. Encapsulation significantly reduced 
the rate of ABTS+ production, when compared with the HRP free in solution but 
encapsulation was shown not to have a detrimental influence on the rate of phosphate 
production and also seemed to prolong the period of time during which the activity of 
the enzyme was measurable. 
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9.3.4 The kinetic behaviour of free enzymes and encapsulated 
enzymes 
The Km of free HRP was respectively 15.32 µM for the Michaelis-Menten equation and 
8.48 µM for the Lineweaver-Burk equation. The Vm of free HRP (0.58 µM/min) by the 
Michaelis-Menten equation was 1.3 times as much as the Vm of the Lineweaver-Burk 
equation (0.45 µM/min) (Table 9.3). Compared with the HRP, the release of ALP fitted 
the Michaelis-Menten equation and the Lineweaver-Burk equation according to the R2 
(0.98). The affinity of enzyme to substrate can be evaluated by the value of Km, as the 
higher Km the lower affinity whereas the lower Km the higher affinity. The kinetic 
parameters of HRP encapsulated into apatite cryogels did not fit either of the kinetic 
equations as Table 9.4 indicates, R2 being very low. 
 
Table 9.3 The kinetic parameters of free HRP/ALP in the buffer solution.  
 
 
 
 
 
a: The unit of Km is µM and of Vm is µM/min. b: The unit of Km is mM  
and of Vm is mM/min. 
 
Table 9.4 The kinetic parameters of encapsulated HRP in the buffer solution. The 
unit of Km is µM and of Vm is µM/min.  
 
 
 
 
Michaelis-Menten Lineweaver-Burk 
Enzyme 
Km Vm R2 Km Vm R2 
HRPa 15.32 0.58 0.86 8.48 0.45 0.89 
ALPb 2.32 0.12 0.98 3.22 0.14 0.98 
Michaelis-Menten Lineweaver-Burk 
Enzyme 
Km Vm R2 Km Vm R2 
CHA 
cryogel 
with HRP 
12.79 2.58 0.17 7.49 1.58 0.31 
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9.4 Discussion 
9.4.1 Encapsulation of Alkaline phosphatase in sol-gel bioceramics 
The first successful encapsulation of a functional enzyme was reported by Braun et al. 
[Braun et al. (1990)]. The potential for this system to act as a molecular biosensor was 
well recognised and consequently there have since been numerous reports of silica gels 
being used to entrap enzymes such as HRP and ALP, as well as a host of other proteins 
[Kadnikova and Kostić (2002), Frenkel-Mullerad and Avnir (2005), Nicoll et al. (1997)]. 
While silica gels have numerous advantages over other encapsulation technologies, such 
as their chemical inertness and ease of synthesis in ambient conditions, the use of 
TMOS/TEOS in their fabrication leads to the formation of methanol or ethanol, which 
can compromise enzyme activity. Indeed, previous work has shown that when 
incorporated into CHA layers on 45S5 bioactive glasses, the enzymes exhibited 
comparatively low activities and when encapsulated within silica gel layers, activity was 
completely lost [Lobel and Hench (1998)].  
 
Since they are well tolerated in vivo and can form an intimate bond with both hard and 
soft tissues, CaP based ceramics such as HA, β-TCP, and biphasic calcium phosphate are 
widely used for the replacement of hard tissues. Numerous researchers have investigated 
the efficacy of these materials for the delivery of therapeutic molecules such as 
vancomycin, ibuprofen-lysine and indomethacin [Palazzo et al. (2005), Xu et al. (2007), 
Gbureck et al. (2008)]. Few studies, however, have investigated the ability of HA to 
encapsulate enzymes.   
 
There has recently been significant interest surrounding the immobilisation of ALP onto 
polymeric materials [Filmon et al. (2002)]. This work has been inspired by the increased 
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understanding of the role of ALP in bone formation. ALP is found throughout the body in 
five different isoenzymes (intestinal, kidney, placental, tissue non-specific, germ cell).  
TNAP is present in high concentrations on the surface of the cells responsible for 
depositing new bone matrix (osteoblasts) and in the matrix vesicles from which apatite 
crystals are deposited [Hessle et al. (2002)]. Its function in bone mineralisation is to 
remove an inhibitor to HA precipitation (P2O74-) to form PO43- resulting in localised 
supersaturation and therefore precipitation [Osathanon et al. (2009)]. It has also recently 
been shown that TNAP can act on amorphous calcium polyphosphate particles [Omelon 
et al. (2004)], which have been found in newly mineralising tissue and are thought to 
provide ‘phosphate reservoirs’ to enable new bone formation. By locally increasing ALP 
concentration in an implant, therefore, it may be possible to reduce the local P2O74- to 
PO43- ratio and thereby stimulate new bone deposition. This effect has been shown to be 
effective in vitro by enhancing the extent of mineralisation in osteoblast cultures 
[Osathanon et al. (2009)].   
 
9.4.2 The effect of porous structures on the storage of ALP/HRP 
While some success has been noted, surface immobilisation of ALP can result in the 
interference of enzyme function through interaction with the plethora of other proteins 
and enzymes found in the body [Boyan et al. (1996)]. The mesoporous apatite gel 
reported here enables immobilisation and subsequent protection from other 
macromolecules.   
 
The encapsulation of both proteins within the CHA cryogel seemed to have an influence 
on the microstructure of the gel. While the incorporation of HRP into the CHA cryogel 
matrix reduced the median pore diameter of the matrix by half, the addition of ALP 
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during processing increased the median pore diameter to 55.7 nm (Table 9.2). This 
change in microstructure could most likely be attributed to the incorporation of a 
significantly higher mass of ALP into the CHA cryogel than HRP, due to the lower 
activity of the ALP when compared with the HRP. The fluctuations in the specific 
surface area exhibited by the CHA cryogel could also be attributed to the use of relatively 
high masses of ALP. Importantly, although the ALP altered the pore size distributions 
exhibited by the material, this did not detrimentally affect the ability of the CHA cryogel 
to store the enzyme. The addition of both proteins to the CHA cryogel during processing 
did not seem to influence the chemistry of the material. Interestingly, however, the true 
densities exhibited by the gels were considerably lower than one might expect for gels 
consisting predominantly of apatite (ρ=3.16 g cm-3) and CaCO3 (ρ=2.71 g cm-3) (Table 
9.1). This may suggest the presence of an amorphous phase that was undetectable by 
X-ray diffraction. It is possible that a metastable calcium phosphate phase of relatively 
low density such as brushite (ρ=2.32 g cm-3) was formed in the matrix during processing.   
 
Over the period of study, the CHA cryogel was shown to retain 85 wt% of the loaded 
ALP (Figure 9.5), which was comparable with the reported loading efficiency of gels 
loaded using non-surfactant template sol-gel processes [Wei et al. (2000)]. Furthermore, 
encapsulation of the ALP enhanced the stability of the enzyme when compared with that 
left free in solution. While the CHA cryogel encapsulated and preserved the activity of 
the ALP, such success was not demonstrated for encapsulation of the HRP (Figures 9.5 
and 9.6). In comparison, the CHA cryogel encapsulated the HRP with a relatively low 
efficacy (66 wt%) and the activity of the encapsulated enzyme was significantly 
diminished when compared with that stored free in solution. Up to one day after 
encapsulation, the activity of the HRP was considerably higher than at any additional 
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time-point. The relatively high activity at this point could be attributed to surface 
adsorbed HRP and the HRP that was released in a burst from the matrix on the first day. 
After this point, the activity of the enzyme was considerably reduced. The most likely 
reason for the reduction in activity on encapsulation could be poor mass transport through 
the mesoporous pore network in the cryogel, hindering the access of the substrate to the 
enzyme’s active site [Bhatia et al. (2002), Silva et al. (2007), Jain et al. (1998)]. This 
hypothesis was confirmed by the increase in ABTS+ production once released from the 
ceramic matrix at the end of the study.   
 
The activity of the ALP may not have been influenced by the mesoporous pore network 
since the substrate of the reaction, the pyrophosphate anion (Mr=174 g/mole), is 
significantly smaller than ABTS (Mr=514.62 g/mole). Furthermore, the pyrophosphate 
anion [Fleisch.and Bisaz (1962)] is well known to have a high affinity to CaP salts and 
therefore is likely to exhibit more rapid perfusion of the CHA cryogel and to attach 
strongly to the surface of the apatite. Charge may also have played a role in preventing 
mass transport of the ABTS+ through the CaP based matrix. The positive charge 
exhibited by the surface of the CaP may have prevented permeation of the transport of 
the ABTS+ through the matrix. Indeed, electrostatic repulsion has previously been shown 
to have a significant influence on the catalytic efficacy of HRP [Kadnikova and Kostić 
(2002)]. Besides the material itself, the pH and other ions of the buffer solution play an 
important part in the electrostatic repulsion. Therefore, this might contribute to the 
unsteady state kinetics of free HRP. As a result of unsteady state, the free HRP may not 
follow either of the kinetic equations (Table 9.3). After the incorporation of HRP, the 
pore structure of the cryogel has been changed, suggesting the complicated diffusion 
behaviour. This results in the poor fitting of the kinetic equations (Table 9.4). 
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9.5 Conclusion 
This study reports the successful encapsulation of ALP within a CaP based gel matrix. 
The CHA cryogel immobilised 85 wt% of the ALP for the duration of the experiment and 
preserved enzyme activity when compared with the ALP that was free in solution.  
Evaluation of the CHA cryogel structure demonstrated that the material consisted in the 
most part of apatite and calcium carbonate with the presence of a comparatively low 
density phase that was undetectable using X-ray diffraction. 
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Chapter 10 Surface modification of calcium phosphate 
gels using sulphhydryl groups 
 
10.1 Introduction 
Calcium phosphate composites have been used widely as implant materials due to the 
non-toxicity of their ionic components and the intimate bond that they are able to form a 
range of bonds with hard and soft tissue. More recently, calcium phosphate particles have 
also been used in the transfection of cell for gene therapy [Kovtun et al. (2009), Maitra 
(2005)]. With an increasing understanding of the interaction between CaP materials and 
biological systems there is an interest in modifying the surface chemistry of these 
materials to change biological interaction or prevent the agglomeration of CaP particles 
in solutions. The attachment of biomolecules such as protein to the surface of the CaP 
materials is of particular interest. Recently, the biological properties of calcium 
phosphate bone cement following modification with heparin have been improved [Lode 
et al. (2008)]. Reactive thiol groups have been used to attach polymers to implant 
surfaces for enhanced biological integration of bone implants [Lee et al. (2007)]. One 
way of attaching proteins to the surface of CaP materials is through the creation of 
disulphide bridges between thiol groups of the surfaces and the cysteine residuals of the 
proteins [Wright et al. (2006)].  
 
Due to the lack of functional groups of hydroxyapatite (HA), a chemical reaction is used 
to derive amino groups or sulphhydryl groups on the surface of the HA. It has been 
reported that HA can be functionalised by a reaction of the OH group of HA with 
carboxyl containing SH chemicals [Lee et al. (2007)]. However, conclusive evidence of 
the presence of SH groups on the surface of modified HA has been scarce. The most 
common modification uses silanisation [Duan and Wang (2006)]. Amongst many 
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organosilanes, the amino-terminated, and the thiol-terminated are of particular interest. 
Previous work has demonstrated that the adhesion of osteoblast is increased when HA is 
functionalised with 3-aminopropyltriethoxysilane [Nelson et al. (2006)]. Although much 
attention has been given to the use of mercaptopropyltriethoxysilane (MPTS) for the 
surface modification of silicon oxide [Nakamura and Ishimura (2007)], there is scarcely 
any research on the surface modification of HA with MPTS.  
 
The main objective of this work has been to develop a technique for the surface 
modification of calcium phosphate gels. Two thiol-containing chemicals were used to 
modify the surface features of calcium phosphate gels and their efficiency was evaluated.  
 
10.2 Surface modification of calcium phosphate gels 
To enhance the bonding power of calcium phosphate gels, their surfaces were modified 
by introducing thiol groups. As sulphhydryl groups are important in biological systems, 
sulphhydryl-containing chemicals were selected to functionalise the surfaces. Two 
chemicals were chosen in this study: mercaptopropionic acid, and mercaptopropyl silane.  
 
10.2.1 Preparation of silicon substituted hydroxyapatite (SiHA) 
The method of silicon substituted hydroxyapatite preparation was adapted from previous 
work [Palard et al. (2008)]. 100 mL of 130 mM triammonium phosphate containing 43 
mM silicon tetra-acetate (Sigma-Aldrich, Gillingham, UK) was poured into a 100 mL 
burette, and added at the rate of 830 µL min-1 to a 100 mL of 210 mM calcium acetate 
solution with pH 12. The pH value of the 210 mM calcium acetate solution was adjusted 
by the addition of 35 % aqueous ammonia. After the addition of the triammonium and 
silicon tetraacetate solution, the mixture was washed five times with double distilled 
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water (DDW) by a centrifuge at 4000 rpm for 10 minute. The suspension was then 
adjusted to pH 7.4 by the addition of 100 mM hydrochloric acid solution, and then 
filtered through Whatman No. 1 filter paper in a Büchner funnel, connected to a water 
aspirated vacuum pump. The SiHA xerogel was dried at room temperature as shown in 
Figure 7.1.
10.2.2 Surface modification of hydroxyapatite with 
3-mercaptopropionic acid 
The surface modification method was adapted from Lee et al. (2007). 130 mM 
triammonium phosphate and 47 mM 3-mercaptopropionic acid (MPA) (Sigma-Aldrich, 
Gillingham, UK) was added to a 210 mM calcium acetate solution with pH 12 at equal 
volume. The resulting HA xerogels modified with thiol groups were washed five times 
with double distilled water (DDW) by a centrifuge. The pH of the suspension was then 
adjusted to pH 7.4 by the addition of 100 mM hydrochloric acid solution. The suspension 
was filtered through Whatman No. 1 filter paper in a Büchner funnel. Then, the HA 
xerogels with sulphhydryl groups were dried at the room temperature. The reaction 
mechanism of MPA is shown in Fgure 10.1 A.  
 
10.2.3 Surface modification of silicon substituted hydroxyapatite with 
3-mercatopropyl trimethoxysilane  
1 g of SiHA xerogel formed as described in section 10.2.1 with 100 mL of 43 mM 
3-mercatopropyl trimethoxysilane (MPTS) in ethanol (Fisher scientific, Loughborough, 
UK) was placed in an Atmos Bag (Sigma-Aldrich, Gillingham, UK) and was given 1 h at 
room temperature to react. The precipitate was washed firstly with ethanol and then four 
times with double distilled water. The suspension was filtered through Whatman No. 1 
filter paper in a Büchner funnel to form SiHA xerogels, containing thiol groups, and then 
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dried at room temperature. The modification of SiHA xerogels with MPTS is expressed 
as the reaction mechanism shown in Figure 10.1 B.  
 
 
Figure 10.1 The scheme of A. the modification of SiHA xerogels with MPA; B. 
modification of SiHA xerogels with MPTS. MPTS is hydrolysed following the 
attachment to SiHA xerogels. 
 
10.2.4 Preparation of fluorescence staining surface modified SiHA 
xerogels with sulphhydryl particles 
SiHA sulphhydryl modified gel particles were tagged fluorescently using a maleimide 
reaction, which was adapted from the method described by Nakamura and Ishimura 
(2007). 33 mg of SiHA xerogel with sulphhydryl was added to 10 µL of 2.3 mM 
fluorescein-5-maleimide (Invitrogen, Paisley, UK) solution for 2 h at room temperature 
with 500 rpm mixing rate. After 2 h, the mixture was centrifuged to remove the 
remaining reagents, using a 2 mL Eppendorf centrifuge (Fisher Scientific, Loughborough, 
UK). The xerogels were washed with ethanol and distilled water until the fluorescein was 
not observed under the fluorescence microscopy. The control SiHA xerogels were 
prepared under the same conditions to investigate whether there was a reaction between 
the SiHA xerogels and the fluorescein.  
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10.2.5 Quantification of sulphhydryl groups on CaP surfaces 
The sulphhydryl groups on the HA/SiHA xerogels were quantified using Ellman’s 
reagent. 10 mg of HA with sulphhydryl groups was put into 780 µL of phosphate buffer 
saline with a pH of 7.4. Then 15 µL of DTNB reagent (0.4 %w/v) was added to this 
suspension [Lee et al. (2007)]. This mixture was incubated for 15 min at room 
temperature at 3000 rpm of mixing. The supernatant was obtained using centrifuge at 
4000 rpm for 15 min and analysed by UV-Vis spectroscopy at 412 nm. The sulphhydryl 
groups attached on the surface of the HA/SiHA xerogels were calculated on the basis of 
the molar extinction coefficient (14150 M-1cm -1), and the known equation shown as 
Equation 10.1.  
 
]
3
4[ 3rdNan pi×××=                                           Equation 10.1 
 
where n is amount of sulphhydryl per crystal, a is the mol of SH on HA/SiHA per g, d is 
the density of HA/SiHA (3.15 g cm -3), r is the radius of the HA/SiHA on the assumption 
of sphere HA/SiHA xerogel particles, and N is Avogadro’s number (6.022×10 23 mol-1). 
 
10.3 Results 
10.3.1 Characterisation of HA with thiol groups  
The apatitic phases of HA xerogels with MPA occurred at 26˚, and 32˚ 2θ. In addition, 
there was a trace amount of calcite shown in the range of 40˚ to 52˚ 2θ in HA xerogels 
modified with MPA (Figure 10.2). As compared to those of the unmodified HA xerogels, 
the crystalline phase and structure of HA xerogels with MPA remained unchanged. In 
addition, the broad peaks indicated that the apatite phase was poorly crystallne.  
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Modification with MPA can be assessed through the C=O bonding at ~1700 cm-1, and 
C-H bonding between 2850 and 3000 cm-1 using FTIR analysis. The FTIR spectra 
(Figure 10.3) showed phosphate absorption of HA xerogels in the ranges 870 cm-1 to 
1030 cm-1, and 570 to 607 cm-1. There were peaks at 1644, and 3280 cm-1 in unmodified 
HA xerogels and modified HA xerogels. However, the intensity of peaks at 1644, and 
3280 cm-1, respectively, were slightly increased in the HA xerogels modified with MPA 
as compared with the unmodified HA xerogels.  
 
 
Figure 10.2 XRD patterns of the HA xerogels and the modified HA xerogels with 
MPA. The peaks of apatite phase were present at 26˚, and 32˚ 2θ labelled as square 
(□); a few calcites were shown at 40˚ to 52˚ 2θ labelled as circles (●). 
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Figure 10.3 FTIR spectra of the unmodified HA xerogels and the HA xerogels 
modified with MPA. Phosphate groups (870 to 1030 cm-1, and 550 to 610 cm-1) were 
predominantly present in the both of the HA xerogel matrices. In addition, there 
were trace of carbonate from surface absorption (874 cm-1), and moisture in the both 
of the HA xerogel matrices (3280 cm-1). 
 
To verify the presence of the sulphur atoms on the surface of the precipitate, XPS 
analysis was carried out. The XPS spectra (Figure 10.4) showed a calcium (2s) peak at 
437.8 eV, phosphate peak (2p3) at 130.1 eV and an oxygen peak at 530.5 eV in both of 
the HA xerogel without, and with modification. In addition, the calcium peaks at 347.1 
eV resulted from the Ca-O bonding of calcite which corresponds to the result of XRD 
pattern. In comparison with the HA xerogels, the HA xerogels with MPA showed 
carbonate peaks from C=O of MPA at 287 eV rather than C1s (285 eV). However, there 
was no S2p peak of the S-H bond at the binding energy of 163.3 eV of the HA xerogels 
with MPA.  
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Figure 10.4 The XPS wide scan spectra of surface modification of the HA xerogels 
and the HA xerogel with MPA; and the elemental region of S narrowly scanned to 
provide high resolution. Not only calcium phosphate peaks of HA were exhibited but 
also few Ca-O peaks of calcite in the HA xerogel and the modified HA xerogel. No 
sulphur peaks appeared in the modified HA xerogel with MPA. 
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In addition to the XPS survey, the presence of sulphur was determined using EDS, XRF, 
and Ellman’s reagent (Table 10.1). There no S signal showed in the EDS but the result of 
XRF by contrast, indicated 0.02 wt% of S in the HA xerogels with MPA, corresponding 
to Ellman’s analysis. The Ca/P ratio from the EDS (1.60) was in accordance with that of 
XRF (1.62).  
 
The other evidence of the sulphur can be evaluated through the alternative of particle 
characterisation. The true density of the HA xerogel with MPA (2.70 g cm-3, Table 10.2) 
was not far from that of the unmodified HA gel (2.62 g cm-3, Table 7.3). Although the 
mean particle size of HA xerogels with MPA was not much different from that of the 
pure MPA (Table 10.2), the number of particles of the HA xerogel with MPA distributed 
in the range of 300 to 400 nm increased (Figure 10.5 (a)-(b)). In comparison with the HA 
xerogel without the modification (ab. 565 nm), the mean particle size of the HA xerogel 
with MPA decreased which suggests the aggleromation of HA gel particles was reduced. 
The specific surface area of the HA xerogel with MPA (Table 10.2) was less than half 
times of the HA xerogel (98.0 ± 4.6 m2 g-1).  
 
Table 10.1 Quantification of thiol groups on HA xerogel particles using EDS, XRF, 
and Ellman’s reagent [one measurement]. 
 
Elemental 
analysis 
Ca weight % P weight % S weight % 
Other 
weight % 
Ca/P 
mole ratio 
EDS 35.55 17.19 0 47.26 1.60 
XRF 32.96 15.73 0.02 50.29 1.62 
Ellman’s 
reagent 
- - 3.82E-05 - - 
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Table 10.2 The physicochemical characterisation of pure MPA, and of HA xerogels 
with MPA 
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Figure 10.5 Particle size distribution of (a) pure MPA; (b) HA xerogels with MPA. 
There was an obvious increased in the number of particles in the range of 300 to 400 
nm after the surface of HA xerogels was modified with MPA. 
Samples 
True Density  
(g cm-3) 
Mean Particle 
Size (nm) 
Specific surface 
area (m2 g-1) 
Pure MPA - 313.0 ± 11.8 - 
HA xerogels with 
MPA 
2.70±0.01 316.7 ± 14.0 39.3 ± 13.1 
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10.3.2 Characterisation of SiHA with thiol groups  
The XRD patterns for the SiHA xerogels with and without modification of MPTS 
appeared to be identical (Figure 10.6). In addition to the main apatite phase at 26˚ and 32˚ 
2θ, there was evidence of a small quantity of calcite as suggested by peaks in the range of 
40˚ to 52˚ 2θ. The incorporation of silicon in the HA xerogels did not change the 
crystalline structure as a similar poorly crystalline apatite was shown to be present. After 
the surface of SiHA xerogels was functionalised by the thiol group of MPTS, the phase 
compositions of SiHA xerogels remained the same. 
 
 
Figure 10.6 XRD patterns of the SiHA xerogel with and without modification as 
compared to the HA xerogel. The peaks of apatite phase at 26˚ and 32˚ 2θ are labelled 
as square (□); calcite at 40˚ to 52˚ 2θ as circles (●). 
 
The effect of silicon substitution on the functional groups of HA xerogels, and the surface 
modification of SiHA xerogels can be respectively evaluated by FTIR analysis (Figure 
10.7). The spectrum of the SiHA xerogel was expected to show the peak of silicate (or 
SiOx where x=2-4) at approximately 760, and 890 cm-1, but the absorbed bands of the 
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phosphate groups at these regions were dominant in the range of 876 to 1100 cm -1, and 
570 to 607 cm-1. In addition, the carbonate abosorption was exhibited at 1644 cm-1 in all 
HA matrices. Moreover, all HA matrices contained some moisture as the peak of 
hydroxyl groups was present at 3280 cm-1. 
 
 
Figure 10.7 FTIR spectra of HA xerogels, SiHA xerogels, and SiHA xerogels with 
MPTS by pelletizing samples with KBr. There were mainly phosphate groups in the 
range of 960 to 1100 cm-1, and 470 to 610 cm-1 in the HA.  
 
As Figure 10.8 shows, the zeta potential at pH 7.4 of the SiHA xerogel (-3.7 mV) was 
lower than that of the HA xerogel (-1.3 mV). 
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Figure 10.8 Zeta potential of HA and SiHA gels at pH of 7.4 was -1.3 mV and -3.7 mV 
respectively. 
 
Using high resolution XPS analysis, the calcium peak of the calcite (Ca-O) was recorded 
at 349.5 eV, and that of the HA (Ca2p) at 346 eV (Figure 10.9). In addition, the 
phosphate peaks at 132.3 eV decreased with the addition of SiHA with MPTS. However, 
there was little difference between HA xerogels and SiHA xerogels. The presence of 
MPTS can be further demonstrated through the high resolution XPS of the Si, SiO2, and 
S. Except for the calcium phosphate peaks of HA, the XPS spectra showed that there was 
an S2p peak of the SiHA xerogels with MPTS at 164 eV. In addition, the intensity of the 
SiO2 (102.3 eV) and Si2s (153.3 eV) peaks respectively of the SiHA xerogels with MPTS 
increased compared with those of the SiHA xerogels (Figure 10.9). As reported by Balas 
et al., the SiO2 can be assigned to the silicon atom resulting from the SiO4 of SiHA [Balas 
et al. (2003)].  
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Figure 10.9 The XPS wide scan spectra of surface modification of the HA xerogels, 
SiHA xerogels and the SiHA xerogel with MPTS. The elemental region of C, Si, and S 
is narrowly scanned to provide high resolution.   
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The Ca/P ratio of SiHA xerogels (1.76) was higher than that of HA xerogels (Ca/P ratio 
of 1.58 as listed in Table 7.1 and 7.2). After counting the wt% of silicon, the Ca/(P+Si) of 
SiHA xerogels was 1.33. The amount of silicon (wt%) was reduced after the surface of 
the SiHA xerogels was functionalised by MPTS (Table 10.3) whereas there was 0.03 wt 
% of sulphur increase in the SiHA xerogel with MPTS. The Ca/P ratio of the SiHA 
xerogel, corresponding to that recorded in previous work [Gibson et al. (1999)] was the 
same as that of SiHA xerogels with MPTS, although the Ca/(P+Si) of the SiHA xerogels 
was less than the Ca/P (1.79) of the SiHA xerogels modified with MPTS. 
 
Table 10.3 Chemical composition of the SiHA xerogels, and modified SiHA xerogels 
with MPTS using XRF [one measurement]. 
 
To further confirm the existence of thiol groups, the SiHA xerogels with MPTS were 
stained with fluorescein containing maleimide. The maleimide groups react 
predominantly with sulphhydryl, and the fluorescein reagents are effective for 
observation using fluorescence microscopy. Figure 10.10 b and d show that the SiHA 
xerogels with MPTS, and control SiHA xerogels fluoresced green before washing. In 
contrast, the fluorescence was less intense for the control SiHA xerogels after washing 
once (Figure 10.11 d); however, the fluorescence of that with MPTS remained (Figure 
10.11 b). After repeated washing, the fluorescence of the SiHA xerogel dissipated (Figure 
10.12 d), but the SiHA gels with MPTS retained their fluorescence (Figure 10.12 b), this 
Samples 
Ca weight 
% 
P weight 
% 
S weight % 
Si weight 
% 
Ca/P mole 
ratio 
SiHA 32.66 14.30 0.00 4.29 1.76 
SiHA with 
MPTS 
32.41 13.98 0.03 3.50 1.79 
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suggests that the fluorescent dye had been covalently attached to the surface of the 
particles and hence provides proof for successful surface modification. 
 
 
 
Figure 10.10 Fluorescence microscopy of a) SiHA modified with MPTS and b) SiHA, 
containing fluorescein-5-maleimide before extensively washing with water and 
ethanol. Observation was made under bright field (a and c), and with excitation at 
490 nm (b and d). 
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Figure 10.11 Fluorescence microscopy of a) SiHA modified with MPTS and b) SiHA, 
containing fluorescein-5-maleimide after washing first time with water and ethanol. 
Observation was made under bright field (a and c), and with excitation at 490 nm (b 
and d). 
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Figure 10.12 Fluorescence microscopy of a) SiHA modified with MPTS and b) SiHA, 
containing fluorescein-5-maleimide after washing ten times with water and ethanol. 
Observation was made under bright field (a and c), and with excitation at 490 nm (b 
and d). 
 
The true density of the SiHA xerogel (2.27 g cm-3) was 86 % of that of the HA xerogel 
(2.62 g cm-3, Table 7.3). After the additional silicon of MPTS, the true density of the 
SiHA xerogel with MPTS increased to 2.35 g cm-3, as the density of silica is 2.2 g cm-3.  
 
After modification of SiHA xerogels with MPTS, the particles were distributed in the 
higher range of 600 to 1300 nm in comparison with those of the SiHA xerogels (Figure 
10.13 a and b), meaning the mean particle size of the SiHA xerogel with MPTS (928 nm) 
was larger than the SiHA xerogels (448 nm), suggesting the modified SiHA with MPTS 
gel particles agglomerated more readily the unmodified SiHA. However, the specific 
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surface area of the SiHA xerogel with MPTS (Table 10.4) was greater than that of the 
SiHA xerogels, because of the irregular shape of crystals of SiHA with MPTS as the 
TEM images show (Figure 10.14 b).  
 
Table 10.4 Physicochemical characterization of the SiHA xerogels and SiHA xerogels 
modified with MPTS. 
 
 
 
 
 
 
 
 
 
 
Figure 10.13 The particle distribution of (a) SiHA, and (b) SiHA modified with 
MPTS. The average particle size of SiHA xerogels with MPTS was increased as 
compared to the SiHA xerogels. 
 
The crystal of SiHA xerogels without modification was approximately 63 nm in length, 
and 15 nm in width (Figure 10.14 a). The shape of crystals of SiHA xerogels was needle 
like. There was a slightly change in crystal shape between the SiHA xerogel and SiHA 
xerogel with MPTS (Figure 10.14 a and b). The crystal size of SiHA xerogels with MPTS 
was slightly less than that of SiHA xerogels. The size of fluorescein containing SiHA 
Samples 
True Density  
(g cm-3) 
Mean 
Particle Size 
(nm)  
Specific surface 
area (m2 g-1) 
SiHA 2.27 ± 0.01 448.0 ± 72.8 53.5 ± 25.6 
SiHA with MPTS 2.35 ± 0.01 928.0 ± 27.3 165.0 ± 0.7 
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xerogels with MPTS (ab. 57 nm) was smaller in length than of that of the SiHA xerogels 
without, and with modification, but was of greater width (Figure 10.14 c). In addition, the 
crystal of SiHA with MPTS was a rod shape. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10.14 TEM images of (a) SiHA; (b) SiHA with MPTS; (c) SiHA with MPTS, 
containing fluorescein 
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The median pore diameter of SiHA xerogels was decreased when the silicon was 
incorporated into the HA xerogels. The pore distribution of SiHA xerogels with MPTS 
was bimodal; one was in the range of 10 to 100 nm and the other was distributed between 
1 and 10 µm (Figure 10.15). Also, the numbers of pores of SiHA xerogels with MPTS 
increased in the range of 10 to 100 nm as compared to the SiHA xerogels (Figure 10.15). 
The porosity of SiHA xerogels with MPTS increased with the increased intrusion volume 
(Table 10.5).  
 
Table 10.5 Characterisation of pore structure of SiHA xerogels without and with 
modification of MPTS. 
 
 
 
 
 
 
Sample 
Porosity 
(%) 
Skeletal Density 
(g cm -3) 
Bulk Density 
(g cm-3) 
SiHA  42.09 ± 5.86 1.82 ± 0.32 1.06 ± 0.29 
SiHA with MPTS- 54.52 ± 1.31 2.04 ± 0.09 0.93 ± 0.02 
Sample 
Total Intrusion 
Volume (g-1 cm3) 
Median Pore 
Diameter (nm) 
Total Pore Area 
(g-1 m2) 
SiHA 0.42 ± 0.17 13.35 ± 8.70 24.12 ± 17.49 
SiHA with MPTS- 0.59 ± 0.01 12.45 ± 5.16 29.65 ± 11.22 
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Figure 10.15 Mercury intrusion curves of the SiHA xerogels without, and with, 
MPTS. The interstitial pores were in the range of 10 to 100 nm for SiHA xerogels, 
and the interstitial pores of SiHA with MPTS were distributed in the range of 10 to 
100 nm, and 1 to 10 µm.   
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10.4 Discussion  
10.4.1 The effect of silicon on the structure of hydroxyapatite 
Recently, Lee et al. confirmed that the sulphhydryl groups of MPA have been attached to 
the surface of HA as indicated by XPS spectra, and by Ellman’s reagent analysis [Lee et 
al. (2007)]. However, their work is controversial since in the published paper, the 
proposed presence of the sulphur peak is not convincing. It could simply be noise, 
resulting from the background. Indeed, our findings suggest that this method of surface 
modification was highly ineffective. According to FTIR spectra (Figure 10.3), although 
there was a peak of carbonate at 1644 cm-1, it was difficult to identify whether the 
absorption arise from C=O of MPA, or C-O of CO2 because a small peak at 1644 cm-1 
was present in the unmodified HA xerogels. The C-H bonding (2850-3000 cm-1) was 
alternative measurement for MPA, but it might result from an overlap with the moisture 
in the sample as the absorption of water appeared approximately at 3280 cm-1 in the 
unmodified HA xerogels. From the high resolution XPS (S2p) spectra (Figure 10.4), 
there was no indication of sulphur at the binding energy, 164 eV although there was 0.02 
wt% of sulphur present as determined using other analyses (Table 10.1).  
 
It was proposed that the surface modification mechanism resulted from the carboxyl 
groups on the modifying chemical reacting with calcium ions, but it is more likely that 
they reacted with absorbed carbonate on the surface of HA, which would explain the 
trace amount of sulphur found using XRF, which is a surface characterisation method 
(Table 10.1). The hypothesis is further demonstrated by the particle size. In comparison 
to the MPA, the surface properties of HA modified with MPA did not show significant 
changes in particle size after modification (Table 10.2) although the particle size of HA 
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xerogel with MPA was smaller than the HA xerogel (565 nm as listed in Table 7.3). This 
might result from the reduction of adhesive forces between the HA xerogels with MPA.  
 
Presuming that the surface modification was limited by the availability of carbonate 
absorbed to the surface of the precipitate, the decision was made to incorporate silicon 
into the CaP gels, which would provide further sites for modification with functional 
groups. The addition of silicon during the precipitation of the apatite, had no significant 
influence on the crystalline phase composition of the resulting gel when compared with 
the HA xerogel (Figure 10.6), suggesting the incorporation of silicon does not affect the 
formation of the apatitic phase. According to the XPS spectra, the silicon was present in 
the form of a SiO4 group. Consequently, the mechanism of substitution was proposed as 
in Equation 10.2. 
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                    Equation 10.2                                         
 
The high concentration of silicon in the reaction medium substitutes for phosphate groups 
of the HA xerogel and results in a considerable reduction in the Ca/P ratio [Gibson et al. 
(2002)]. The low Ca/(P+Si) of SiHA xerogels (1.33) could also be due to the calcium 
deficiency of the HA xerogel (1.58) (Table 10.3 and Table 7.1 and Table 7.2). 
Furthermore, because the density of silica is 2.2 g cm-3, it was more likely that there were 
some poorly X-ray amorphous calcium phosphates present (Table 10.4). Although it is 
unclear whether the intensity of hydroxyl increased after the substitution of silicon, the 
reduction of zeta potential of SiHA xerogels after the modification suggests a loss of 
charge because of the replacement of PO43- by SiO44- to maintain the charge balance 
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(Figure 10.8), which agrees with Botelho et al.’s finding [Botelho et al. (2002)]. The 
effect of silicon on the surface characterisation demonstrates the surface properties of the 
precipitate (Table 10.4). After the addition of silicon, the particle size of HA xerogels 
was distinctly reduced. This might result from a decrease of crystalline size with the 
addition of silicon, especially when the concentration of silicon is increasing [Thian et al. 
(2006)]. Therefore, the pores of HA xerogels shifted from 40 nm to 32 nm with increased 
mercury intrusion after the addition of silicon.  
 
10.4.2 The effect of surface modification by thiol groups on the 
microstructure 
To test the hypothesis that ‘the addition of silicon enhances the number of binding sites 
for surface modification’, the surface of the precipitate was modified using thiol groups.  
Amongst surface modified techniques, the self-assembled monolayer or mutilayers of 
organosilanes has been widely used to promote or inhibit specific molecular attachment 
[Ulman (1991)]. It has been confirmed that self assembly MPTS layers were deposited on 
silicon oxide [Hu et al. (2001)]. Here, it has been demonstrated that the thiol functional 
group can attach on the surface of the SiHA xerogel without the alteration of crystal 
structure (Figure 10.6). An XPS survey of the precipitate (Figure 10.9) showed that the 
sulphur peak was present in the SiHA xerogels with MPTS. These results correspond to 
the images of fluorescence microscopy (Figure 10.10-10.12). The SiHA xerogels with 
MPTS labelled with fluorescein fluoresced green when excited using the fluorescence 
microscope whereas the control SiHA xerogels after extensively washing with ultrasonic 
treatment did not. The attachment between fluorescein and SiHA xerogels with MPTS is 
covalent bonding. This is proven since the bond could not easily be destroyed either by 
washing with double distilled water/ethanol or by ultrasonic treatment. Furthermore, 
there was no difference between the SiHA xerogel, and the SiHA xerogel with MPTS, 
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implying that modification of thiol groups occurred on the surface of SiHA xerogels 
(Table 10.3). In addition, XRF showed 0.03 wt% of sulphur existed in the SiHA xerogels 
with MPTS.  
 
The porous structures of the SiHA xerogels with MPTS were improved by an increase of 
28 % porosity in comparison with the unmodified SiHA xerogel (Table 10.4). This is due 
to the formation of an Si-O-Si network. The formation of an Si-O-Si network results in a 
slightly denser structure as the true density of SiHA xerogels with MPTS is increased as 
compared to SiHA xerogels. The more dense structure of SiHA xerogels with MPTS also 
can be found in the reduction of large voids (Figure 10.15). Moreover, there is three times 
more specific surface area resulting from the increase of interstitial pore size (1-10 µm), 
which suggests more binding sites are available for attaching of biomolecules. The 
alteration of surface properties further explains the successful modification of SiHA 
xerogels with MPTS. It is critical to supply sufficient binding sites for surface 
modification.  
 
10.5 Conclusion 
In this study, it has been demonstrated that SiHA can be prepared by the sol-gel process.  
In addition, the presence of silicon groups on the surface of the particles provided a 
greater number of binding sites for surface modification than the HA xerogel without 
silicon groups. This method for surface modification of apatite, therefore, is a significant 
improvement on those currently reported in the literature. The surface properties of SiHA 
xerogel can be engineered through modification of the thiol functional groups. These 
results suggest that it is feasible to form covalent bonds on the surface of the apatite. 
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Chapter 11 Conclusions  
Since the 1970’s hydroxyapatite based calcium phosphate ceramics have been 
synthesised for use as bone graft replacements. These materials were traditionally 
synthesised using methods that required treatment at elevated temperatures. Although 
these materials are well tolerated in the body following implantation, they have not 
surpassed autograft as the ‘gold standard’ in bone replacement. One reason for this is 
although they exhibit a similar composition to the mineral component of bone, the 
crystals from which they are formed are significantly different. Calcium phosphate 
ceramics formed using sintering are typically microcrystalline rather than the 
nanocrystalline nature of the hydroxyapatite in bone or tooth. Also, the inclusion of heat 
treatment during processing means that it is impossible to incorporate heat sensitive 
therapeutic molecules into the material during processing. This study has shown that it is 
possible to form a predominantly apatitic ceramic monolith in ambient conditions.  
Importantly, the results have shown that this monolith can be used for the encapsulation 
and delivery of both heat sensitive drugs (vancomycin hydrochloride) and enzymes of 
therapeutic benefit (alkaline phosphatase). Furthermore, it has demonstrated a novel 
method for the surface modification of these apatite monoliths that will enable covalent 
immobilisation of molecules on the surface of the material. 
 
11.1 Influence of process conditions on the physicochemical 
properties of CaP gels 
It has been demonstrated that the physicochemical properties of CaP gels can be modified 
by varying process conditions. Following an investigation of the influence of process 
conditions on gel formation, it can be concluded that: 
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 By changing the relative humidity (RH) at which the gel monoliths are stored during 
processing, it is possible to exhibit some control over composition and the pore 
structure. 
 Apatitic phases are formed within the CaP gels regardless of the RHs in which the gels 
are aged. 
 The addition of carbonate causes a reduction of crystal size, but an increase in the 
relative porosity exhibited by the gel matrix.  
 The formation of the secondary phases results from the dissolution-reprecipitation 
that can occur during the ageing process. 
 
11.2 Comparing the efficacy of calcium phosphate based 
matrices for the release of vancomycin hydrochloride 
The CaP gels were successful in delivering a therapeutic dose of vancomycin 
hydrochloride for an extended period of time, and were significantly more effective than 
calcium phosphate based cements. It can be concluded that: 
 
 The therapeutic function of the incorporated vancomycin hydrochloride is maintained 
when encapsulated in a CaP gel, when compared with calcium phosphate cement 
based matrices.  
 The effectiveness of the delivery matrix is determined by both the activity of the 
released vancomycin, and the rate of release from the ceramic matrix. 
 The intrinsic pH of calcium phosphate matrices during the process determines the 
activity of vancomycin hydrochloride. 
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 The predictive kinetics of the incorporated vancomycin of the CaP gels suggests that 
vancomycin hydrochloride is homogeneously dispersed throughout the matrix, since 
the release curve follows the Higuchi and Peppas models. 
 
11.3 Calcium phosphate cryogels for enzyme encapsulation 
The CaP gels were shown to be effective at storing both HRP and ALP for an extended 
period of time following immersion in the eluent. It can be concluded that:  
 
 The activity of HRP/ALP is preserved within the mesoporous structure of the apatitic 
cryogels.  
 The encapsulation of HRP/ALP affects the microstructure of apatitic cryogels 
because of the high molecular weight of these enzymes. 
 The loading efficiency of ALP (85 %) is higher than that of HRP (66 %). 
 In contrast to that of the ALP, the catalytic behaviour of the incorporated HRP is 
affected by the mass transport of ABTS cations through the matrix.  
 The catalytic behaviour of ALP can be expressed by the Michaelis-Menten or the 
Lineweaver-Burk equations. However, neither of these two kinetic equations is fitted 
by HRP as a result of unsteady state kinetics of HRP. 
 
11.4 Surface modification of calcium phosphate gels via 
sulphhydryl groups 
By considering the mechanism of surface modification of calcium phosphate based 
particles, it has been possible to design a method for surface modification that is 
considerably more efficient than those reported in the literature. From the findings of this 
study, it can be concluded that: 
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 The number of binding sites of calcium phosphate matrices for attaching functional 
groups can be increased by the incorporation of silicon. 
 The crystalline structures of calcium phosphate gels were not changed following the 
incorporation of silicon. 
 There was no difference shown between the apatitic phases following modification by 
thiol groups.  
 The increased specific surface area and the fluorescence of silicon substituted apatites 
with the thiol modification demonstrated that surface modification using MPTS is 
more efficient than the method using MPA. 
 The thiol terminated functional groups on the surface of the silicon substituted 
apatites can be introduced by forming the chemical bonding of silanol groups. 
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Chapter 12 Future Work 
The calcium phosphate gels studied for this thesis have shown a variety of porosity 
consequent on applying different ageing regimes. In addition, the mild pH and mesopores 
of calcium phosphate gels enable the preservation of the activity of therapeutic molecules. 
For these materials to be used as bone replacements, it will be necessary to further 
characterise both mechanical performance of the ceramic monolith and also the 
biological reponse to the material. 
 
12.1 The properties of calcium phosphate gels 
The different ageing regimes have been shown to create different pore size distributions 
in the calcium phosphate gels. However, as the results showed, there were secondary 
phases produced because of the incomplete reaction between calcium and phosphate ions. 
According to the previous studies [Liu et al. (2001)], it has been found that sufficient 
ageing time is significant for the formation of the pure apatitic phase. Therefore, a further 
ageing study is required to determine the best ageing conditions to allow the formation of 
impurity free CaP gels.  
 
Although it has been demonstrated that calcium phosphate gels can be used as drug 
carriers, their limited mechanical strength restricts their use in load bearing applications.  
It may be possible to form a calcium phosphate ‘concrete’ by combining granules of the 
CaP gel containing therapeutic molecules with calcium phosphate cements, which 
typically exhibit superior mechanical properties. In this material, the gel could protect the 
functionality of the drug/protein [Dion et al. (2005)], while the cement provides the 
mechanical integrity. 
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12.2 The evaluation of functionality of calcium phosphate gels 
Calcium phosphate gels are known for their osteoconductivity, but they generally lack 
osteoinductivity. In Chapter 9, it was shown that calcium phosphate gels can entrap ALP 
and allow the activity to be maintained over a period of time in vitro. It is possible that 
ALP or another biological active moiety such as bone morphogenic protein (BMP) may 
cause the materials to be osteoinductive. In addition, it may be possible to attach BMPs to 
the surface of the ceramic using the attached thiol groups.  
 
12.3 Formation of disulphide bonds to improve the mechanical 
properties of calcium phosphate gels 
In the Chapter 10 of surface modification, it has demonstrated that it is feasible to attach 
the thiol groups on the surface of calcium phosphate gels. In addition, disulphide bridges 
can be formed by effectively oxidised thiol groups by reacting with hydrogen peroxide in 
the presence of a catalytic amount of iodine [Kirihara et al. (2007)]. By forming 
disulphide bonding between gel particulates, the adhesive forces within gel particulates 
can be enhanced. Also, with disulphide linkage, there is the opportunity to control the 
local delivery of proteins. Wright et al. have shown disulphide-linked conjugates are 
readily cleavable by cystein in vitro [Wright et al. (2006)]. 
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Chapter 13 Appendix 
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Figure 13.1 The calibration curve of vancomycin hydrochloride (VH) in pH 7.4 tris 
buffer solution 
 
calibration curve of VH in Tris buffer with EDTA at
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Figure 13.2 The calibration curve of VH in 3 wt% of ethylenediaminetetraacetatic 
acid tetrasodium salt hydrate (Na4 -EDTA) solution. 
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Figure 13.3 The calibration curve of albumin in phosphate solution. 
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